Dissecting the molecular mechanism and spatiotemporal dynamics controlling senescence entry by Sofiadis, Konstantinos
 
Dissecting the molecular mechanism 
and spatiotemporal dynamics 




for the award of the degree 
Doctor rerum naturalium (Dr. rer. nat) 
of the Georg-August-Universität Göttingen 
 
 
Within the Doctoral Program  
International Max Planck Research School for Genome Science 
of the Georg-August-University School of Science (GAUSS) 
 
 





Goettingen, December 2019  
Page | 2  
 
Thesis Advisory Committee 
Prof. Argyris Papantonis (Supervisor) 
Institute of Pathology, University Medical Center Göttingen  
Prof. Ralph Kelhenbach 
Institute of Molecular Biology, University Medical Center Göttingen 
Prof. Matthias Dobbelstein 





Members of Examination Board 
First Reviewer: Prof Argyris Papantonis (Supervisor) 
Institute of Pathology, University Medical Center Göttingen 
Second Reviewer: Prof. Nico Posnien 
Department of Developmental Biology, Johann-Friedrich-Blumenbach-Institute of Zoology and 





Extended Examination Board 
Prof. Michael Zeisberg 
Department of Nephrology und Rheumatology Universitätsmedizin Göttingen 
Dr. Ufuk Günesdogan  
 
Department of Developmental Biology, Göttingen Center for Molecular Biosciences, University of 
Göttingen 
PD. Dr. Laura Zelarayán-Behrend  
Institute of Pharmacology and Toxicology, University Medical Center Göttingen 
 
 



































The first words of this manuscripts marks the last moments of a four-year journey that started 
when I first stepped at the Center of Molecular Medicine of Cologne to start my PhD. A journey that 
did not seem that long, because it was full of priceless experiences, memories feelings and The first 
words of this manuscript mark the last moments of a four-year journey that started when I first stepped 
at the Center of Molecular Medicine of Cologne to start my PhD. A journey that does not seem that 
long, because it was full of priceless experiences, memories feelings and knowledge. Of course, hard 
moments, stressful days and sad feelings were not absent, but a moment of happiness would always 
show up to make up for them. This journey offered me the means to satisfy my scientific interests and 
opened the door to enter the magical world of science. During this PhD journey a smart person told me 
that a PhD is not only about the scientific part· it also about changing you as a human being and making 
you a better person. I hope that I took a step forward in that direction. 
This previous line belongs to Prof. Argyris Papantonis, who offered me the opportunity that I 
was looking for many months, while anxiety was gradually accumulating. It is very hard to find the 
exact words to describe and thank him for these years. It is hard to realize if I respect him more for his 
bright, (not only) scientific brain or for his amazing personality. A wonderful mentor, a role model, a 
boss with smart motivational skills other than yelling or misbehaving. A glimpse of enthusiasm and 
interest for your work from his side and suddenly you find yourself on the bench trying harder and 
harder. Outside of work, a very amusing company. I have learned so much during these years next to 
you 
Fortunately, more people contributed to make my PhD an amazing experience. I was very lucky 
to meet very nice people and great instructors. I am very grateful for having Dr. Anne Zirkel, a postdoc 
back in the lab in Cologne, as a direct supervisor of mine. She really set me in the scientific rails and 
tried hard to teach me, apart from the scientific part, discipline and responsibility. She was always 
supervising me with patience and sincere guidance. Her continuous encouragement helped me 
successfully overcome the difficulties during the beginning of my PhD.  
Two meters away from my office, I could always find Dr. Theodore Georgomanolis, our Lab 
Manager. At least Lab Manager in the beginning, short after a good friend. I learned so many things 
from Theo and he was always there to help me when I was struggling. Most importantly a fun person to 
spend some time during the day in order to relax a bit and discuss any random topic. 
What should I say for Natasa Josipovic? Anyway, I have learned to be careful with my words 
around you (kidding!). We started our PhDs almost at the same time and soon developed a beautiful 
friendship. Always fair, always tough, but paradoxically always sensitive. We were always there to 
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support each other scientifically and mentally. Luckily, a third person shared the load of complaints, fun 
and party nights. Spyridon Palikyras you are a very good friend and a great host. A friend that appreciates 
all my silly jokes and vice versa. 
Of course, I would need several lines to thank all the rest of the members of the lab both in 
Goettingen and in Cologne. Great scientists, but most importantly very nice people. They were all 
working hard to establish a professional environment in which each of us could develop individually or 
as a team. Constant communication and scientific discussion was part of our daily routine, and this 
taught me so much and really broadened my scientific interests. Finally, the moments we were fed up 
from work pressure, a call would lead us all to the round table in the kitchen for some coffee and fun 
discussions. Each one of you played a part in enjoying my PhD years 
I would like to thank my committee members especially Prof. Ralf Kehlenbach and Prof. Nico 
Posnien for being my TAC, especially Prof. Posnien who agreed to review my thesis. I am also grateful 
to Prof. Michael Zeisberg and Dr. Ufuk Guenesdogan for agreeing to be on my examination committee.  
Outside the scientific community, there were people that really supported me all these years. 
My best friends “Billares” (Vassilis Nikolaou, Vassilis Tselios) during my bachelor years and up to date, 
even from far away they are always there when I need them. I know that the plan to do our PhDs at the 
same place did not work out well, but we managed to find a way to feel close together. Similarly, I want 
to thank my best friends from my childhood. They are so many and I will probably need unlimited space 
to write about them. I miss you all guys. Finally, I would like to thank Christina for all the very nice 
memories and the fun we have had together all these years. I know it was hard (and oftentimes annoying) 
for you to understand the reasons that kept me so many weekends in the lab, but still you were patient 
and willing to deal with it. 
Last part in Greek for my family. Το μεγαλύτερο ευχαριστώ το χρωστάω στους γονείς μου. 
Στους καλύτερους γονείς του κόσμου οπως δεν θα ντρεπόταν να πει ο πεντάχρονος εαυτός μου. 
Θυσίασαν τη ζωή τους, το κόπο τους να με/μας στηρίξουν δίνοντας ανιδιοτελώς και ισότιμα ότι είχαν 
και δεν είχαν για να πραγματοποιήσουμε τα όνειρα μας. Μπαμπα πιθανόν σου στέρησα μερικά χρόνια 
απο τη ζωή σου εκεινα τα δυσκολα βραδυα (ξερεις εσυ) και ελπιζω η χαρά και η υπερήφανεια που ξέρω 
ότι θα νιώσεις να σου επιστρέψουν μερικά απο αυτά. Μαμά σε ευχαριστώ που δεν ήσουν η τυπική 
ελληνίδα μάνα του ζακέτα να πάρεις. Πάντα με απεριόριστη αγάπη αλλά ποτέ με αυταπάτες. Το 
παράδειγμα εργατικότητας και αφοσίωσης και των δυο σας και είναι οδηγός για μένα. Τέλος ευχαριστώ 
τον αδερφό για μου και την αδερφή μου για την αγάπη τους και τη στήριξης τους, όσο και αν μας 
στεναχωρεί όλους που δεν είμαστε κοντά. 
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Senescence represents a programmed cell cycle arrest against aberrant proliferation and tumour 
development due to accumulated genotoxic or metabolic stress. The tumour-suppressive properties of 
senescence attracted the attention of the scientific community and led to pioneering studies to fully 
understand the rules governing the establishment of this homeostatic mechanism. Several groups 
attempted to characterize the features of senescence and elucidate the molecular pathways that lead to 
the transition from a proliferating state and to a senescent one. This attempt led to the characterization 
of a number of intriguing phenotypes associated with the entry into senescence. Interestingly, it was 
shown that extensive chromatin re-arrangements and altered genomic conformation is part of these 
phenotypes and contributes to the inhibition of proliferating genes and expression of senescent ones. 
Nowadays, the contribution of three-dimensional (3D) genome structure in the orchestration of 
transcriptional pathways in a cell-type and context-dependent manner is well established. The 
spatiotemporal crosstalk between regulatory elements, such as enhancers and promoters, requires strict 
organization of 3D genome structure to reassure coordinated wiring of these transcriptional elements. 
Disruption of genomic structure leads to aberrant gene regulation and has been linked to various 
pathophysiological phenotypes. Although it was shown that senescence is accompanied by robust 
alterations in 3D genome architecture, the molecular events that lead to these alterations and their impact 
on the establishment of senescence were still elusive, especially in a physiological context like that of 
replicative senescence. 
In Chapter I of this thesis, I studied the contribution of the architectural protein HMGB2 in the 
alteration of genomic organization and the coordination of transcriptional pathways upon entry into 
senescence in three different human cell types. In Chapter II, I focused on the multifaceted role of 
HMGB1 as an architectural and RNA binding protein, as well as a secreted factor to demonstrate its 
important contribution in the establishment of senescence and the emergence of associated phenotypes. 
In Chapter III, I exploited a small anti-inflammatory inhibitor that selectively targets HMGBs and 
studied the impact of its administration on HMGB kinetics and on the pathways they control. I also 
studied the influence of this drug has on the proliferation capacity of primary and cancer cell types. 
Collectively, in my PhD work I applied a number of different molecular techniques to fully understand 
the impact of HMGBs on architectural changes upon entry in senescence, and on the establishment of 
the transcriptional repertoire linked to either the proliferating or the senescent state.  
 Introduction 
2. Introduction  
 
2.1 The three-dimensional genome organization in the eukaryotic cell 
 
The conventional one-dimensional (1D) representation of the transcriptional process, which 
assumes the RNA polymerase sliding alongside a respective gene to produce a nascent RNA, which in 
turn will give rise to a protein product, has changed dramatically over the last decades (Rowley and 
Corces, 2018). This simplistic view of events leading to protein synthesis could not explain the high 
complexity of the eukaryotic genomes, with the large number of differentially-expressed genes 
coordinating multiple cellular functions across tissues. Eukaryotic transcription represents one of the 
most complex cellular processes, requiring the interplay of various molecules (DNA, RNA, protein 
factors) in a controlled manner (Rada‐Iglesias et al., 2018). Although it is common to associate 
transcription only with the processivity of RNA polymerases towards production of nascent RNA 
transcripts, in essence transcription involves all necessary steps that orchestrate co-association of various 
regulatory elements and of important protein factors to load the polymerase at the transcription start site 
(TSS). Thus, in order to describe the complex process of transcription, additional dimensions, time and 
space, need to be considered, and thus increase the complexity of eukaryotic functions from 1D to 
3D(Rada‐Iglesias et al., 2018). 
Human DNA is a long molecule of ~2 m that needs to be packed in the ~10 μm nucleus of a 
eukaryotic cell. This very remarkable task is achieved through a series of different packaging events 
(Figure 2.1) that involves the coordinated interplay between DNA and various protein factors 
(Lawrence et al., 2016). The most abundant eukaryotic proteins -collectively termed histones- possess 
prominent roles in this process of DNA packaging. Two dimers of H2A and H2B histones in its interior 
and two dimers of H3 and H4 histones in its exterior form the core of the nucleosome, around which the 
DNA is wrapped every ~146 bp (Lawrence et al., 2016). The fifth member of the family, linker histone 
H1, binds the nucleosome at the entry and exit sites of the DNA (Hergeth and Schneider, 2015). The 
extraordinary feature of the histone octamer is that the tails of histone H3 and H4 extent outside the 
nucleosome and are subjected to chemical modifications (Law et al., 2015). A large amount of studies 
have described the importance of these modifications in a variety of cellular processes, with particular 
focus in the regulation of transcription (either activation or repression) (Lawrence et al., 2016; Li et al., 
2007). Notably, histone tails and their respective modifiers can directly interact with RNA polymerases, 
various transcription factors and transcription auxiliary proteins affecting the transcription fate of a 
given genomic locus (Li et al., 2007). Thus, DNA packaging mediated by nucleosomes resolves a spatial 
necessity, whereas histone tails provide an additional regulatory layer to orchestrate the multiple 
functional outcomes. 
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Figure 2.1. The multiple layers of packaging in the eukaryotic nucleus.  
Human DNA is a long molecule sized 2 m that needs to be placed in the nucleus. Mainly histone proteins and 
other architectural proteins compress DNA in a series of packaging steps to fit DNA in every cell of the human 
organism. Adapted from (Pierce, Benjamin. Genetics: A Conceptual Approach, 2nd ed). 
 
Although histones are the most abundant proteins residing on DNA, they still only represent a 
fraction of the numerous protein factors and RNA molecules that either constantly or occasionally bind 
to DNA. In fact, the macromolecular complex comprised of DNA, RNA and protein molecules 
collectively termed chromatin. Based on the dense staining under the microscope, Emil Heitz described 
a very compacted configuration of the chromatin later termed as constitutive heterochromatin. 
Constitutive heterochromatin, which frequently resides in the transcriptional-depleted nuclear periphery, 
is characterized by high occupancy of repressive histone marks, absence (albeit not complete) of 
transcriptional activity, gene deserts and high levels of compaction (Wang et al., 2016). 
Transcriptionally active chromatin, termed euchromatin, possesses active histone marks, high 
transcriptional activity, gene-rich regions and lower degree of compaction, thus enabling higher mobility 
(Rowley and Corces, 2018). Facultative heterochromatin represents an intermediate between the two 
aforementioned chromatin states, consisting of both active and repressive histone marks and being often 
poised for transcriptional activation (Saksouk et al., 2015). Chromatin represents one of the most 
complex macromolecular entities in the nucleus, harboring all the regulatory elements in the linear 
genomic sequence that serve as a direct or indirect scaffold for gene regulatory machines. Strikingly, 
these regulatory elements often reside thousands of kilobases apart rendering impossible the explanation 
of the complicated transcriptional events via conventional 1D models (Rada‐Iglesias et al., 2018). The 
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latter challenge and the accumulation of the Genome-Wide Association Studies (GWAS) studies 
pinpointing mutations of intergenic regions as drivers of a plethora of diseases (Maurano et al., 2012; 
Schaub et al., 2012) have heightened scientific interest towards the organization of the chromatin and 
the spatial interplay between distant genomic regions. 
Colossal progress has been made over the last two decades in understanding the significance of 
chromatin architecture in the execution of cellular processes such as DNA replication, transcription, 
DNA repair, etc. Transcription is a suitable and extensively used model to study genomic organization, 
as it requires the spatiotemporal coordination of cis regulatory elements (enhancers, promoters, TSSs) 
even located Megabases apart, with trans-acting factors launching transcription of the respective genes. 
The introduction of chromosome conformation capture (3C) technique by Job Dekker in 2002 (Dekker 
et al., 2002) was a landmark for a series of subsequent pioneering studies to cross over from the 1D 
interpretation of the events governing transcriptional regulation to the 3D (Figure 2.2). The highlight of 
these improvements was the release of the first Hi-C dataset in 2009 (Lieberman-aiden et al., 2009). The 
continuous improvements of Hi-C and its derivatives, in combination with the continuous upgrade of 
super-resolution microscopy and the development of single-cell techniques, continuously provide new 
insight into the organization of the chromatin and the control of transcription at a high-throughput scale 
(Denker and De Laat, 2016; de Wit and de Laat, 2012) 
The typical Hi-C workflow involves cross-linking of chromatin, enzymatic digestion with a 
restriction enzyme and incorporation of biotinylated nucleotides in the newly digested ends followed by 
ligation. At this step, the ligated products are the result of ligation of fragments that are in close 
proximity in the 3D space, although they may lie kilobase apart in the linear genomic sequence. The 
biotinylated ligation products are pulled down using streptavidin beads and are subsequently processed 
for sequencing. Typically, each ligation product between two fragments represents an interaction and 
the genome-wide interaction profiles deduced by Hi-C are used to define the 3D folding of the genome. 
The final output of a Hi-C experiment is a heat map with a plaid pattern containing all the interactions 
across and within individual chromosomes. 
 Based on the resolution of the generated map it is possible to visualize certain genomic features. 
The plaid pattern of a Hi-C map at the Mbp-level segregates the genome into two distinct compartments, 
termed A and B compartments, with mostly active and repressive properties respectively. These are 
preferentially found in close proximity and interact with higher frequency in cis (Lieberman-aiden et 
al., 2009). The segregation of genomic sites in A and B compartments is organized in a lineage-specific 
manner and is instructed by the respective transcriptional landscape. Higher resolution Hi-C maps allow 
for visualization of genomic features at sub-Mbp level. Notably the 40-kbp resolution maps generated 
by Dixon et al (Dixon et al., 2012) led to the pioneering characterization of “topologically associated 
domains” (TADs) and of TAD boundaries. TADs are genomic domains of high interaction frequency, 
depicted as well-defined triangles along the diagonal of a typical Hi-C heatmap.  Disruption of the 
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interaction signal at the corners of adjacent TADs indicates a TAD boundary with insulatory role, i.e. 
of impeding interactions across TADs. TAD boundaries are thought to represent insulating blocks that 
restrict interactions and transcriptional crosstalk of regulatory elements with genes in neighboring 
TADs. TAD boundaries are also characterized by extensive CTCF binding, a well-studied architectural 
factor that facilitates genome folding through the formation of CTCF-specific loops and enhances 
insulation at TAD boundaries. CTCF acts synergistically with another family of architectural proteins 
called cohesins. These are able to slide along and extrude DNA, thus facilitating formation of loops. 
Remarkably, the aforementioned structural elements are highly conserved across multiple cell lineages 
or even species (Dixon et al., 2012; Phillips-Cremins et al., 2013; Szabo et al., 2019), indicating that 
they evolved early in the evolution of eukaryotic organisms (Harmston et al., 2017; Krefting et al., 
2018). 
A variety of studies in several cell types, species and physiological contexts accentuated the 
high conservation of the basic architectural features shaping genomic organization in interphase nuclei. 
On the other hand, during mitosis, the structural organization of the genome collapses and chromosomes 
acquire a homogenous, locus-independent conformation (Gibcus et al., 2018; Naumova et al., 2013). 
Remarkably, it was shown that during early prophase TADs lose insulation strength and progressively 
collapse, the compartmentalization into A and B compartments is lost and site-specific contact frequency 
decreases especially at longer distances, indicating a swift to a higher compaction (Gibcus et al., 2018; 
Naumova et al., 2013). This phenomenon gradually increases as mitosis progresses into metaphase, 
where chromatin reaches its highest compaction. At this point, chromosomes completely abolish their 
interphase characteristics and acquire a spiral conformation of high compaction to go through mitosis 
(Gibcus et al., 2018; Naumova et al., 2013). The termination of mitosis and re-entry into interphase is 
accompanied by rapid re-establishment of genomic organization into TADs and A/B compartments, 
preserving cellular identity of the parental cells and, thus, cellular functions (Gibcus et al., 2018; 
Naumova et al., 2013). It is not yet fully determined which are the driving forces and the parental 
inheritable features that drive this re-establishment of genomic organization, despite the fact that various 
mechanisms have been proposed (Campos et al., 2014). The idea of mitotic bookmarking, for example, 
suggests that several proteins are associated with chromosomes during mitosis, acting as architectural 
buoys responsible for orchestrating the high-order structure of the interphase chromosomes (Festuccia 
et al., 2017). Taken together, chromatin organization seems an integral part of genomic organization and 
homeostatic cellular function.   
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Figure 2.2. The development of chromosome conformation capture studies. 
A series of innovative advances led to the development of the genome-wide conformation techniques. The insight 
acquired from the numerous studies taking advantaging of these methods highlighted the importance of the 
genomic interactions in the facilitation of the various cellular processes. Adapted from (De Wit, 2012). 
 
 2.2 The crosstalk between 3D genome organization and transcription  
 
The knowledge obtained from Hi-C studies revealed some of the structural events that dictate 
the organization of the genome, but the link between structure and function is still missing. Disease- and 
trait-associated genetic variants identified in large-scale GWAS studies are located with a very high 
incidence (~93%) in non-coding regions (Maurano et al., 2012; Schaub et al., 2012). Understanding the 
interplay between chromatin organization and its impact on transcription will possibly enable us to 
characterize the drivers of various pathophysiological states. Point mutations, double-strand breaks, 
duplications, translocations and inversions are typical drivers for various diseases and the mode of action 
could be through alterations of the chromatin high-order structure (Krijger and De Laat, 2016). For 
example, altering the extremities of a TAD or eliminating a TAD boundary could potentially disrupt the 
cell’s specific genomic interactions or create aberrant ones that result in misexpression of a gene or 
cluster of genes and the development of pathophysiological phenotypes. 
Despite the plethora of studies investigating multiple layers to disentangle the functionality of 
these architectural elements and their associated protein factors orchestrating chromatin organization, 
the field is far from reaching a unified scenario. Whether TADs and TAD boundaries are important for 
transcriptional activity, whether loops are a result of de novo formation or pre-exist, and whether loss of 
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these elements could promote malignancy are among the questions frequently raised (Schoenfelder and 
Fraser, 2019). The reality is that during the past decades and with all the innovative technological and 
experimental advances, remarkable studies form various groups presented convergent and (more 
frequently) divergent findings.  
The initiation of transcription requires dynamic looping of distal regulatory elements, such as 
enhancers, to their cognate promoters. Frequently, these elements are many kilobases apart and 
separated by various regulatory elements and genes. Thus, only the proposed model of a partitioned 
genome with chromatin looping could explain such coordinated crosstalk. The organization of the 
genomic into TADs, TAD boundaries and CTCF loops, and their influence on transcriptional regulation 
fit this model. The advent of CRISPR/Cas9 methodology offered a chance to genetically modify these 
elements in various ways and study the impact on the transcriptional rate. Genomic loci hosting 
developmental genes require strict control to coordinate their spatiotemporal induction, and this is 
mediated through a precise crosstalk between transcription factors and the regulatory elements. Due to 
this fact, these loci were extensively used in the studies of genome architecture. The SHH locus is 
organized in a tissue invariant and conserved Mbp-longTAD (Rosenbloom et al., 2013) comprised of 
multiple enhancers responsible for the expression of SHH in a developmental stage- and tissue-specific 
manner.  Interestingly, during mouse limb development, Shh is regulated by the ZRS enhancer, which 
is found almost 960 kbp away from the gene, bypassing several others in closer proximity (Lettice et 
al., 2003), (Lettice et al., 2014). Point mutations in the ZRS enhancer suffice to disrupt SHH expression 
and result in limb malformations (Anderson et al., 2012). These distant regulatory elements translocate 
into close proximity to drive limb bud expression of SHH (Williamson et al., 2016) and reporter genes 
inserted in the SHH TAD are efficiently expressed in an SHH-similar pattern in the limb under the 
control of ZRS enhancer (Symmons et al., 2014), (Ruf et al., 2011). 
As mentioned before, in order to understand the rules governing 3D genome organization and 
its impact on transcription many studies modified architectural elements in the Shh locus. The findings 
obtained from the Shh locus, as well as from other model developmental loci, resulted in convergent and 
divergent conclusions highlighting that the characterization of a universal description of3D genomic 
organization is a complex task. The following lines provide a brief summary of studies that modified 
the most important regulatory elements and the impact (if any) in the expression of the respective genes: 
Genomic distance: Large deletions of the genomic interspace between SHH and ZRS -but 
without disrupting the TAD- did not affectZRS-driven expression of SHH in the developing limb 
showing that this interaction is not distance-dependent (Williamson et al., 2019), (Symmons et al., 
2016). This result contrasts with the deletion of the region between Hoxd13 and its limb specific 
enhancer that resulted in loss of expression (Fabre et al., 2017). The differences in these results might 
be explained by sequence composition, plasticity of the locus and abundance of structural and regulatory 
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elements. Furthermore, higher resolution Hi-C maps might reveal further segregation of the deleted 
region in sub-TADs or other cryptic regulatory elements. 
CTCF sites and orientation: Disruption of a number of CTCF sites surrounding the SHH locus 
altered the boundaries of the TAD, albeit not generating a completely new TAD. Despite altered TAD 
margins, the expression of SHH was not affected and all embryos were born without obvious phenotypes 
(Williamson et al., 2019). Depletion of CTCF sites in the HOXA locus altered its TAD boundary, 
activating an otherwise silenced downstream gene (Narendra et al., 2015). Additionally, the orientation 
of the flanking CTCF motifs represents an important property of CTCF binding and loop formation (Rao 
et al., 2014; Vietri Rudan et al., 2015), as it was shown that a convergent orientation of CTCF motifs 
holds true for >65% of loops formed between two CTCF-bound sites (de Wit et al., 2015). Disruption 
of this orientation is sufficient to disrupt loop formation or to mediate the formation of differential loops, 
thus reshuffling local architecture and altering transcription levels of the surrounding genes (Guo et al., 
2015; de Wit et al., 2015). 
Disruption of a TAD boundary: Genetic modifications of TAD boundaries mimicking human 
diseases that lead to either complete loss of the boundary and rewiring of TADs led to misexpression of 
the surrounding genes and recapitulated patient phenotypes in mice (Fabre et al., 2017), (Lupiáñez et 
al., 2015), (Laugsch et al., 2019). Altering the size of the boundary without affecting the integrity of the 
TADs or the crosstalk between the nearby genes with the respective enhancers seems to not affect 
transcriptional output (Despang et al., 2019; Ghavi-Helm et al., 2019; Lupiáñez et al., 2015; Williamson 
et al., 2019). The technical variations in these experimental procedures explain some of the discrepancies 
observed, however it seems that complete loss of the boundary and formation of new TADs is critical 
to observe alterations in the transcriptional status of adjacent genes by introducing new interactions 
between enhancers and gene promoters.  
Loss of architectural proteins: Despite the wealth of studies regarding chromatin architecture 
and the respective architectural proteins, the influence of these proteins in transcriptional regulation is 
still not fully delineated. CTCF and cohesin are of the most extensively studied molecules and were 
suggested to be the main mediators of 3D genome structure and formation of chromatin loops. Full 
knockout of either the CTCF (Moore et al., 2012) or any of the cohesin (Singh and Gerton, 2015) 
molecules leads to embryonic lethality, highlighting how essential these molecules are for basic cellular 
functions. Recently, a “degron” system was introduced to study such essential proteins, taking advantage 
of a conditional and reversible degradation of targeted proteins using a ubiquitin-ligase system 
responding to the plant hormone, auxin (Nishimura et al., 2009). Two independent studies induced a 
complete auxin-mediated degradation of CTCF, resulting in loss of genomic insulation in more than 
80% of TAD boundaries and elimination of CTCF-mediated chromatin loops, illustrating the importance 
of CTCF binding at TAD boundaries (Nora et al., 2017), (Kubo et al., 2017). Similar auxin-mediated 
experiments were designed to target cohesin and condensin complexes. Auxin-mediated degradation of 
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the cohesin RAD21 (Rao et al., 2017) or SCC1 (Wutz et al., 2017) and a liver-specific, tamoxifen-
induced knockout of the cohesin loading factor Nipbl (Schwarzer et al., 2017), resulted in elimination 
of all CTCF loops, despite CTCF occupancy at its binding sites remaining unchanged. Interestingly, 
both CTCF and cohesin removal did not completely abolished high-order genomic organization. 
Notably, A and B compartmentalization remains largely unaffected, with only minor reduction in the 
strength of compartmentalization upon CTCF degradation (Nora et al., 2017). Compartmentalization of 
active and repressed chromatin was even enhanced upon cohesin removal, with better-defined and well-
separated A and B compartments. These results suggest that the segregation of chromatin into A and B 
compartments is an independent process that involves different factors, compared to the genome 
organization into TADs and CTCF loops. 
The aforementioned studies against these architectural proteins raised once more the same 
question. Since the loss of architectural proteins leads to striking collapse of architectural features, are 
there any functional consequences in the cell, particularly in the regulation of transcription? Although it 
has been long suggested that the looping mediated by CTCF/cohesin is the main mechanism for bringing 
enhancers and promoters in close proximity to initiate transcription, the removal of these important 
architectural proteins had only a minor effect on gene expression levels. Specifically only prolonged 
auxin-mediated degradation of CTCF resulted in bulk changes in gene expression, whereas one day of 
auxin treatment affected only a small number of genes (Nora et al., 2017). Similarly, RAD21 depletion 
led to a minor upregulation of a subset of genes positioned next to super enhancers while the majority 
of the genes remained largely unaffected (Rao et al., 2017). Thus, it seems that the absence of these 
proteins and the subsequent loss of TADs and loops is not sufficient to significantly alter the 
transcriptional landscape of RAD21-depleted cells. It might be that the structural organization of 
chromatin had already influenced the establishment of the transcriptional landscape before degradation 
took place and facilitated the increase in local concentration of transcription factors maintaining the 
established transcriptional profile even in the absence of these structural factors. Another explanation 
could be that the limited timeframe of the degradation is simply is not long enough to induce extensive 
transcriptional changes. 
Despite accumulation of data, it is still difficult to establish a universal mechanism that dictates 
chromatin organization and its downstream coordination of the various transcriptional programs. 
Possibly, the rules governing the dynamics of chromatin during cellular processes are highly context- 
and pathway-dependent, rendering the scenario of a universal mechanism unlikely. Since the genomic 
organization field is relatively young and the methodology still developinig, the produced data need 
careful interpretation. 
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2.3 Cellular senescence: A complex cellular mechanism in the defense against 
tumour as a suitable model of 3D genome organization 
 
Frequently, senescence is conceptually compared to aging, but in reality, senescence and aging 
represent two related but distinct biological processes that develop both separately or simultaneously 
and occur at different scales. Accumulating evidence renders cellular senescence as one of the major 
drivers of accelerated aging and age-related disease. In parallel, there are many reports showing that 
cellular senescence is more pronounced in the later stages of life as a result of telomere exhaustion, 
accumulation of DNA lesions, imbalanced homeostasis through a number of diverse stressors that could 
force cells to enter senescence. Interestingly, the emergence of both senescence and aging, are 
accompanied by extensive alterations in the 3D genome structure and the levels of various architectural 
proteins. Thus, both these two biological processes represent a suitable model to study genome 
architecture in order to delineate some of its underlying rules and the impact of various architectural 
changes on its initiation, progression and establishment in cells. 
 
2.3 Cellular senescence is a diverse cellular program with multiple stimuli and 
signaling pathways 
 
The first description of cellular senescence emerged in the 60’s, with the seminal work of 
Hayflick and (L. HAYFLICK and Wistnr, 1961), when they noticed that cultured primary cells only 
have a finite number of division in vitro, although they are still viable and metabolically active. This 
was the first report of one particular type of cellular senescence, termed replicative senescence. 
Numerous studies up to date reported a wide spectrum of metabolic and genotoxic stressors, known as 
potential senescence-inducers (Figure 2.3). The best studied examples include telomere attrition (Cesare 
and Karlseder, 2012; D’Adda Di Fagagna et al., 2003), DNA damage (D’Adda Di Fagagna, 2008), 
accumulation of reactive oxygen species (Davalli et al., 2016) and aberrant activation of oncogenic 
pathways (Lee and Schmitt, 2019). Despite differences in senescence type and phenotype diversity, the 
various stressors induce the most prevalent feature - irreversible cell cycle arrest. This confers resistance 
to oncogenic transformation, thus rendering cellular senescence a potent tumour-suppressor mechanism 
by permanently withdrawing pre-malignant/damaged cells from the cell cycle (Campisi, 2013). Later 
reports referred to cellular senescence beyond the tumour suppression context in wound healing 
(Demaria et al., 2014), (Meyer et al., 2016), (Chiche et al., 2017) and embryonic development (Muñoz-
Espín et al., 2013), (Storer et al., 2013). The diversity of inducing stimuli and resulting phenotypes 
makes identification of a universal pathway in the induction of senescent a very difficult task. However, 
some basic pathways described involve the action of the tumour suppressors [46]. Although these are 
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not the sole acting pathways, the p16INK4a/pRB and the p53/p21 pathways (acting synergistically in many 
cases [47]) are responsible for the induction and the maintenance of many different senescence types. 
p16INK4a is a cyclin-dependent kinase that acts as an inhibitor of cyclin D-dependent kinases 
CDK4 and CDK6, controlling the G1-S phase transition  (Beach et al., 1993; Khleif et al., 1996). 
p16INK4a is encoded by the CDKN2A locus, which is also in close proximity to CDKN2B, responsible for 
the expression of INK4a family member, p15INK4b. Furthermore, alternative splicing of the CDKN2A 
results in the production of p14arf suggesting that this chromosomal locus evolved as defense against 
tumourigenesis. The inhibitory action of p16INK4a towards cell cycle-associated proteins prompt the 
activation of RB tumour suppressors, which in turn selectively inhibit the S-phase-promoting E2F 
family genes leading to a stable exit from the cell cycle (Harbour and Dean, 2000). Absence of p16 
(Jarrard et al., 1999) or pRB (Sage et al., 2003) is sufficient to bypass senescence and mutations in these 
genes are frequently encountered in malignant human tumours. On the contrary, ectopic expression of 
p16INK4a  (McConnell et al., 1998) or Rb (Bennett et al., 1998) efficiently remove the cells from the cell 
cycle and induce a senescence-associated program. The role of p21 in senescence and tumour 
suppression remains unclear and controversial. In consistence with p16, p21 is also a cyclin dependent 
kinase capable of inhibiting CDK complexes and regulating the progression of the cell cycle (Afshari et 
al., 1996; Dimri et al., 1996). The ability to control cell cycle and the fact that during persistent DNA 
damage p21 is often activated by p53, led to p21 as a potential mediator of senescence. Similarly to p16, 
enforced expression of p21 induces cell cycle arrest (Khleif et al., 1996; Sang et al., 2008). Interestingly, 
the involvement of p21 in the context of senescence was described in two fascinating studies that drifted 
away from the ordinary focus of the field. Namely, p21, and not the p53 or p16 branches, seems to be 
the effector pathway in the induction of senescence in the developing embryonic tissues, and absence of 
p21 leads to developmental abnormalities (Muñoz-Espín et al., 2013; Storer et al., 2013). The activation 
of p21 in embryonic tissues is mediated through the SMAD/TGFβ signaling. In fact, activation of the 
SMAD/TGFβ pathway was observed in senescent cells and was previously associated with increased 
expression of p21 and cell cycle arrest (Acosta et al., 2013; Datto et al., 1995). Interestingly the 
SMAD/TGFβ pathway represents a second leg in the senescence associated secretory phenotype (SASP) 
during Ras-induced senescence driven by NOTCH1 activation (Acosta et al., 2013; Hoare et al., 2016), 
that effectively expands the senescence phenotype by enhancing expression of p21 in neighboring cells. 
Collectively this interplay with p21 and SMAD/TGFβ suggests a positive feedback loop to reinforce 
p21-mediated senescence at least in a subset of senescence types. 
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Figure 2.3. The diversity of cellular senescence 
Multiple stimuli have been described in the induction of senescence. These different stimuli leads to homeostatic 
imbalance that eventually is encountered with cell cycle arrest. Persistent and accumulated senescence in turn 
could detrimentally affect the normal cellular function and promote aging-related disorders and cancer 
development. Adapted from (McHugh, 2017). 
 
2.4 Senescence-associated biomarkers 
 
One of the important obstacles in the definition of senescence is the absence of reliable and 
universal senescence markers. The absence of such markers makes identification of senescent cells a 
challenging task, especially in vivo. A wealth of senescence studies over the last years, have provided 
adequate insight to designate a panel of phenotypical and molecular characteristics (Salama et al., 2014). 
Since senescence is by definition a programmed block of proliferation, growth arrest is the most 
common feature in the diverse senescent contexts and represents a pivotal marker to define senescent 
cells (Salama et al., 2014) with various proliferation assays commercially available. Likewise, 
unresponsiveness to mitogen stimulation for re-entering the cell cycle is generally an acceptable marker 
of senescent cells. Visualization of blue staining through β-galactosidase assay derived from the 
senescence-mediated activation of acidic lysosomal b-galactosidase represents the  “gold standard” for 
the identification of senescent cells (Dimri et al., 1995). Similarly, the recently described Sentragor 
(Evangelou et al., 2017) reacts with and stains blue the cytoplasmic lipofuscin granules that accumulate 
gradually during progression of senescence. However, efficiency varies due to various factors like the 
accessibility of the respective cell/tissue, the complexity of the assay and the cross-reactivity with other 
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than senescence cellular processes. Morphological changes are also indicative of senescence, as 
senescent cells generally enlarge, flatten and acquire a non-defined shape with abundant stress granules 
compared to the proliferating ones (Campisi, 2013). Fluorescence microscopy could be also used to 
identify markers of senescence through visualization of distinct features organized in the nuclei of 
senescent cells.  The senescence associate heterochromatic foci (SAHF, reviewed in 2.6 in more detail) 
represents an example of such markers as it describes the formation of discrete foci, enriched with local 
heterochromatin-associated protein factors that reinforce the repression of proliferating genes in the 
nuclei of the oncogene-induced senescent cells.  Moreover, telomere-dysfunction induced foci (TIF) and 
telomere-associated DNA damage foci (TAF) form in the nuclei of senescent cells due to telomere 
shortening and accumulation of DNA damage. Finally, the co-localization of p53 or pRB with 
characteristic DNA damage biomarkers was observed in the nuclei of senescent cells and termed “DNA 
segments with chromatin alterations reinforcing senescence” (DNA-SCARS). However, these 
phenotypical characteristics are far from universal as they were described in certain stresses while they 
are completely absent from other ones. 
A different approach to detect senescent cells is through assessment of expression levels of 
specific molecular markers such as protein factors involved in the signaling cascades shared with high 
frequency in the majority of the different senescent types. As it was mentioned before, the most 
frequently deployed pathways are the p16INK4a and the p21. The main concerns using these protein 
factors are that 1) they are not universally expressed in all senescent types; 2) they are expressed both 
in in vivo and in vitro in non-senescent cells (ironically even in cancer cells); 3) the available antibodies 
are not very efficient especially when destined for vivo applications. An intriguing epigenetic biomarker 
of senescence is based on the DNA methylation status of six specific CpG islands. Surprisingly, the 
genes hosting these six CpG islands had little functional relevance due to the low expression levels in 
most samples tested. Still the levels of methylation, either hyper- or hypo-methylated was predictive for 
both the state (proliferating or senescence) and the approximate passage number in a cell-independent 
fashion (Koch et al., 2012). 
 
2.5 Features of cellular senescence 
 
One of the major properties of senescence acting as an anti-tumour mechanism is the ability of 
senescent cells to interact with their microenvironment. Senescent cells actively communicate with their 
neighboring cells by secreting a variety of molecules, a phenotype collectively termed as senescence-
associated secretory phenotype (SASP) (Coppé et al., 2008) and represents one of the most fascinating 
features of senescence (Figure 2.4). The SASP repertoire includes a large number of pro-inflammatory 
cytokines, chemokines, growth factors and proteases. The secretory pathway engaged in the induction 
of SASP is highly stimuli- and cell type-dependent (Lecot et al., 2016). Despite the long-standing studies 
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from various groups, it is still debatable whether SASP actually confers beneficial effects in the 
coordinated defense against the aberrant proliferation, or the initial burst of persistent accumulation of 
the secreted molecules could eventually lead to more aggressive tumour (Coppé et al., 2010). 
The paracrine properties of the SASP seem important for both the establishment of senescence 
and its role as a tumour suppressor mechanism. The ability of senescent cells to communicate with 
neighboring cells represents a potential stress signaling mechanism, which ensures that neighboring cells 
will be “primed” for defense against a particular stress (Coppé et al., 2010). At least a subset of these 
SASP factors was shown to reinforce the spread and the maintenance of oncogene-induced senescence 
through a signaling cascade that eventually activates senescence-associated pathways (Acosta et al., 
2008; Coppé et al., 2008; Kuilman et al., 2008). Beyond tumour suppression, SASP possesses further 
beneficial effects such as the preparation of the damage tissue for repair and acceleration of wound 
healing (Coppé et al., 2010). It was shown that senescent fibroblasts and endothelial cells transiently 
accumulate in the sites of wounding where they express an early SASP factor, PDGF-AA (Demaria et 
al., 2014). PDGF-AA mediates myofibroblast differentiation and enables optimal wound closure. It was 
shown that myofibroblast differentiation progresses through the expression and accumulation of a 
matricellular protein CCN1 (Kim et al., 2013). CCN1 was also linked to a p53- and p16-dependent 
accumulation of senescent cells in the optimal wound closure and the alleviation of fibrosis in the 
cutaneous wound healing (Jun and Lau, 2010).  In fact, the alleviation of fibrosis depends on an 
additional fascinating feature of senescence. Since senescent cells are capable of secreting a large 
repertoire of inflammatory agents, it offers the ability of a delicate interplay with the immune system. 
This is of a great importance as it leads to immune-surveillance and subsequent clearance of senescent 
and tumour cells (Xue et al., 2007). In fact immune-clearance was also important to diminish both liver 
and muscle fibrosis (Demaria et al., 2014; Jun and Lau, 2010).  
Despite the beneficial aspects of SASP, the secretion of this very diverse repertoire of factors is 
not devoid of deleterious consequences. Persistent accumulation of senescent cells and chronic 
inflammation driven by extensive SASP activation could potentially lead to aging-related diseases and 
to a more aggressive tumour-development (Coppé et al., 2010). The immune-clearance of senescent 
cells is not without cost, as recruitment of inflammatory cells to the sites of accumulated senescence 
leads to degradation also of the surrounding healthy tissue (Childs et al., 2015). The loss of healthy 
tissue and the resulting exhaustion of stem-cell renewal due to the increasing tissue-regeneration need 
leads to aging-associated phenotypes. Paradoxically, while senescence was described as a tumour-
suppressive mechanism, increasing evidence suggests that SASP represents a prominent driver of 
tumour development and the link between inflammation and cancer has been long established. Multiple 
SASP factors have been described to increase their concentration leading to destabilization of cellular 
homeostasis and activation of cancer-related signaling cascades (Childs et al., 2015). Furthermore, 
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declining healthy tissue integrity facilitates tumour progression by increasing the invasion and 
metastasis (Childs et al., 2015).  
 
 
Figure 2.4. The bright and the dark side of cellular senescence.  
Cellular senescence has been implicated in various cellular functions beyond the tumour suppressive mechanism. 
The extensive secretion of the SASP factors in turn promotes detrimental consequences to the cellular homeostasis 
and contributes to the emergence of age-related diseases. Adapted from (Lecot, 2016) 
 
Despite accumulating knowledge, the complex nature of senescence raises various questions: 
Does senescence represent a useful molecular mechanism in the defense against cancer and disease? Do 
its beneficial effects outcompete the detrimental ones so as to consider senescence as a true homeostatic 
mechanism? Interestingly, senescence has been characterized as one of the hallmarks of organismal 
aging (López-Otín et al., 2013) and increasing evidence links senescence (mainly via the SASP) with 
cancer development (Childs et al., 2015). This causal link between senescence and aging has been 
mainly due to studies showing that clearance of senescence cells is sufficient to increase the  lifespan 
and ameliorate disease-associated phenotypes (Baker et al., 2011; Chang et al., 2016; Jeon et al., 2017). 
Progeroid mice with a hypomorphic BubR1 (a mitotic checkpoint protein background) were shown to 
increase healthy lifespan through selective elimination of senescent cells (Baker et al., 2011). BubR1 
progeroid mice were carrying an INK-ATTAC transgene comprised of a p16Ink4-specific promoter and 
a membrane-bound myristoylated FK506-binding protein–caspase 8 (FKBP–Casp8) fusion protein. The 
activation of the p16Ink4 promoter using a synthetic drug, AP201187 (Baker et al., 2011) drove 
dimerization of FKBP–Casp8, which targeted p16-expressing cells for apoptosis. Taking into account 
that p16 is one of the most reliable biomarkers of senescent cells, administration of AP201187 and 
subsequent expression of the caspase selectively eliminated only the p16-expressing senescent, but not 
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non-senescent cells (Baker et al., 2011). Clearance of senescent cells attenuated progression of age-
related disorders, tumour formation and increased healthy lifespan. Similar results were obtained in 
earlier studies using Cdkn2a-depleted genetic background mice (Baker et al., 2008).  
These studies suggested that clearance of senescent cells positively influences organismal 
homeostasis and inspired senolytic drugs-development to specifically target senescent cells and alleviate 
senescence-mediated progression of age-related diseases. Reports focusing on senolytic drug 
development arose from cancer studies, taking advantage of pathways shared between cancer and 
senescence. The initial attempts of pharmacologically eliminating senescent cells were based on the 
upregulation of pro-apoptotic B cell lymphoma 2 protein family members. This pathway is frequently 
upregulated in various cancer types and two therapeutic agents have been developed (ABT263, 
ABT737) (van Delft et al., 2006; Tse et al., 2008). Later reports proposed these two drugs as senolytic 
drugs to effectively clear senescent cells both in vitro and in vivo. Likewise, drugs developed to target 
the expression of p53 drove senescent cells into apoptosis alleviating the pathophysiology of 
osteoarthritis [82] and increasing the healthy lifespan of either naturally aged mice or in an accelarated 
aging mice model [83]. 
 
2.6 The interplay between 3D genome architecture and senescence/aging 
 
One of the underrated features of the work over the last decades to understand senescence is the 
potential contribution of dynamic alterations in 3D genome structure and epigenetic states towards the 
induction of cellular senescence and vice versa (Figure 2.5). Evidence of the influential contribution of 
3D structure in senescence was presented mainly through telomeric attrition and the DNA damage 
through double stand breaks. These genomic aberrations were sufficient to activate senescence pathways 
and lead to cell cycle arrest. In parallel, various chromatin alterations were shown to associate with 
accelerated aging and aging-associated disorders. Since growing evidence suggest senescence as one of 
the major drivers of age-relates diseases, the dynamics of genome architecture prior, during, and after 
induction of senescence represent an explored filed that attracts the attention of scientific community. 
Despite emergence of sporadic reports, the rules governing the organization of genome organization 
upon senescence and the key factors involved in this still remained elusive.  
The first description of the interplay between the 3D structure and senescence came by Narita 
et al back in 2003 (Narita et al., 2003). Using oncogene induced senescence triggered by Ras activation, 
they showed a discrete DNA formation in the nuclei of senescent cells, visualized as punctuated DNA 
foci originating from DAPI-dense staining in fluorescent microscopy (Narita et al., 2003). These DAPI-
dense foci were termed as “senescence-associated heterochromatin foci” (SAHF) as they were enriched 
with constitutive heterochromatin marks such as H3K9me3 and HP1a (Narita et al., 2003), and 
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facultative heterochromatin markers such as H3K27me3 (Chandra et al., 2012) and macro H2A (Zhang 
et al., 2005). Interestingly staining of the H3K9me3 and H3K27me, prominent histone marks of 
constitutive and facultative heterochromatin respectively, develop a very defined SAHF appearance. In 
immunofluorescence stainings, SAHF foci are organized as concentric rings of H3K9me3 in the core, 
and H3K27me3 in the surrounding of the ring. The formation of these heterochromatic rings during 
senescence, suggests that the transition from the proliferating into the senescence state is also 
accompanied by dynamic re-arrangements of high-order structure (Chandra and Narita, 2013). In fact, 
it was shown that this nuclear accumulation of repressive histones is not a genome-wide spreading of 
heterochromatin (Mikkelsen et al., 2007), but rather a re-arrangement of the existing histone pattern 
(Chandra et al., 2012).  
The description of SAHF formation during senescence was a fascinating finding but still, the 
link between SAHF and the events triggering senescence was missing. Whether this very dynamic re-
organization of chromatin dictates the events leading to senescence or is a downstream effect is still not 
clear. Notably, it was shown that the rearrangement of the histone marks during the transition from 
proliferating to senescence is closely linked to the switch of the transcriptional program governing each 
state. Genes involved in cell cycle progression and DNA replication, as those of the E2F family that 
regulate the S-phase of the cell cycle, are embedded into SAHF (Chandra et al., 2012). The increase of 
heterochromatic histones on proliferating genes coincides with their simultaneous dissociation from key 
senescent factors in order to activate their transcription, as was shown for the p16INK4a locus (Agger et 
al., 2009; Barradas et al., 2009). Interestingly, deletion of p16 or its downstream target pRB inhibits the 
formation of SAHF (Narita, 2007). On the other hand, enforced expression of p16 is sufficient to activate 
expression of RB, SAHF formation and down-regulation of cell cycle-specific E2F genes (Narita, 2007). 
Altogether, this suggests a positive feedback loop between chromatin organization and orchestration of 
transcriptional programs governing senescence. 
Interestingly, redistribution or fluctuation of histone marks and respective histone modifiers 
were documented in both aging and aging syndromes across species. Aged fibroblasts resulted in 
reduced H3 and H4 biogenesis and protein levels due to chronic DNA damage from telomere shortening 
(O’Sullivan et al., 2010). Similarly to SAHF, redistribution of histone marks especially of H3K9me3 
and H3K27me was also reported to premature aging diseases (Sun et al., 2018). In the Werner syndrome, 
mutations in the WRN gene, an helicase involved in DNA repair, leads to premature aging (Zhang et al., 
2015). WRN interacts with H3K9me3-methyltransferases SUV39H1 and HP1a – and depleted 
interaction in Werner patients leads to decreased levels of H3K9me3 and subsequent heterochromatic 
loss (Saksouk et al., 2015). In the Hutchinson-Gilford progeria syndrome (HGPS), an LMNA-deficient 
progeroid syndrome (Eriksson et al., 2003; De Sandre-Giovannoli et al., 2003), a heterochromatic loss 
due to decreased H3K9me3, H3K27me3 and their respective HP1a and EZH2 methyltransferases, was 
also observed (Dechat et al., 2008; Jackson et al., 2006; Shumaker et al., 2006). Intriguingly, all these 
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heterochromatin-associated factors gradually decrease during human lifetime leading to a progressive 
heterochromatic loss. Generally, heterochromatic loss leads to genomic instability, accumulation of 
DNA lesions and aberrant proliferation of cancer-related genes. Taken together, redistribution of 
epigenetic marks seems to play a pivotal role in senescence, aging and aging-related diseases. 
Nuclear lamina plays a prominent role in the organization of the genome as they tethers DNA 
to the nuclear periphery. It was shown that this attachment is not organized randomly, but specific 
genomic regions of the genome preferentially interact with the nuclear lamina, termed Lamin-associated 
domains (LADs) (Guelen et al., 2008; Pickersgill et al., 2006). LADs possess increased levels of 
heterochromatic marks and are responsible to keep genome integrity by keeping the silenced chromatin 
compacted in the nuclear periphery (van Steensel and Belmont, 2017). The changes in the cell 
morphology with enlarged nucleus observed in both HGPS and senescence, is a result of disrupted 
laminar integrity. LMNB1 is used as a molecular biomarker robustly down-regulated and degraded 
through autophagy as cells enter senescence (Freund et al., 2012; Shimi et al., 2011). Upon senescence 
entry, these heterochromatic regions become detached from the nuclear laminar due the loss of LMNB1 
thus resulting in a general re-arrangement of the chromatin, which partially dictates formation of SAHF 
(Chandra et al., 2012). It seems that LMNB1 is necessary for the formation of SAHF but not sufficient, 
as enforced depletion of LMNB1 does recapitulate SAHF (Chandra et al., 2012). The depleted nuclear 
lamina-integrity explains some of the observed phenotypes similar to senescence in the pathophysiology 
of HGPS. Absence of LMNA during HGPS leads to abnormal cellular morphology, accumulation of 
DNA damage and re-distribution of heterochromatin from the periphery to the interior similarly to the 
OIS. Interesting apart from LMNA, decrease LMNB1 levels are also observed in HGPS. Collectively, 
genomic alterations observed in senescence and aging are also induced by the weakening of nuclear 
lamina. 
The advent of 3C-based technologies enabled two research groups to investigate the interplay 
between chromatin structure, cellular senescence and aging. Particularly, they performed Hi-C using 
distinct types of senescence and attempted to shed light in the dynamic alterations of 3D chromatin 
structure changes observed by microscopy and chromatin immunoprecipitation. Notably, Chandra and 
colleagues (Chandra et al., 2012) took advantage of RAF1-oncogene induced senescence that generates 
a homogeneous senescence population with pronounced SAHF formation (around 86% SAHF-positive 
cells). By obtaining such a large number of SAHF-positive cells, they were able to focus on the most 
prominent senescent-associated feature related to genome architecture. Interestingly, the increased 
compaction seen during formation of SAHF was not apparent in their Hi-C data, as they observed a 
significant loss of genomic interactions within individual TADs and loss of local insulation. The 
sequence composition of the regions losing insulation is associated with high LMNB1 occupancy and 
low GC content, features that seem quite important in local de-compaction. Notably regions with 
LMNB1 occupancy and low GC content were highly predictive of the loss of local interactions across 
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the genome and the increase of distal ones. The latter finding and the observation that these regions were 




Figure 2.5. Chromatin architecture is strongly linked with the senescence profile.  
Re-distribution of the chromatin in the nucleus of senescent cells formation of the SAHF foci. A coordinated 
crosstalk of the chromatin fiber with the lamina ensures the compaction of the heterochromatin in discrete foci in 
the nucleus to selectively repress genes associate with the proliferating stage. Adapted from (Chandra, 2015). 
 
A later study by Criscione and colleagues (Criscione et al., 2016), published results convergent 
and divergent to that by Chandra et al regarding the chromatin organization of the senescent state. It is 
important to mention that they obtained “deep” senescence by culturing human diploid fibroblast (HFD) 
cells until replicative exhaustion and they harvested them for Hi-C after an additional four months. Thus, 
this type of senescence varies considerably from the senescence type that Chandra et al used that relies 
in short-term activation of RAF. In contrast to Chandra observation, the produced Hi-C of the deep-
senescent cells showed a genome-wide decrease of long-range interactions and gain of short-range ones. 
Nevertheless, the changes in the interaction landscape were also associated with genomic features like 
enrichment in promoter sequences, high GC content and LAD-regions. One possible explanation for the 
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observed discrepancy is that the chosen time-points represent distinct phases in the induction of 
senescence. The early time-point possibly represents early events after the induction of senescence, 
whereas culturing the senescent cells for many months highlights the events governing the maintenance 
and the adaptation of the cells to the senescent state. 
Despite differences in the local connectivity observed by the two groups, there were features of 
the high-order structure shared in the two datasets. Despite changing insulation within and among TADs 
during transition to the senescence state, the vast majority of TADs remain invariable between growing 
and senescent cells. This is not surprising as TADs are highly conserved across cell types as different as 
stem cells and their downstream derived cell lineages (Dixon et al., 2012, 2015). Even though the 
absence of changes in TAD boundaries could imply a static scheme in the interplay of chromatin and 
senescence, this is not actually precise. There is significant switching of numerous TADs between the 
active A compartment and the repressed B compartment and vice versa. In fact, this 
compartmentalization switch of TADs explains, at least in part, the transcriptional switch correlated to 
either growing or senescent state. Indeed, around 20% of these TADs encompass genes associated with 
cellular proliferation, p16 upregulated pathways and chromatin architecture. Interestingly a high 
percentage of genes related to growing or senescent state were in stable A compartment, thus their 
regulation does not seem to be dependent on the compartmentalization 
Taken together, despite discrepancies, the generation of Hi-C data from growing and oncogene-
/deep replicative-induced senescence pinpoint dynamic changes in genomic organization. However, 
there are some caveats centered in these experimental setup. Namely, in the Chandra study they took 
advantage of a non-physiological system as they employed oncogene-induced senescence, which 
induces rapid senescence and thus rapid alterations in the organization of the genomic structure. 
Similarly, SAHF that represents an explicit manifestation of chromatin alterations has only been 
identified in oncogene-induced senescence and has not been observed in any other physiological in vitro 
or in vivo to date. On the other hand, in the Criscione study they used replicative senescence, which 
represents a physiological system to study senescence. The drawback of this study lies in the fact that 
they performed Hi-C after four months of the timepoint they defined as the entry into senescence. 
Therefore, they drew an interaction landscape in cells that already went through all the necessary 
homeostatic adjustments to adapt in the senescent state. Hence, they could not investigate the dynamic 
events of an ongoing transition from the proliferating to the senescent state and define how dynamic 
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2.7 High mobility group proteins: abundant nuclear protein in the organization pf 
the genome 
 
The high mobility group box (HMGB) proteins constitute a family of very abundant and 
ubiquitously expressed non-histone proteins that bind to the minor groove of DNA and influence 
multiple processes such as transcription, replication, recombination, DNA repair and genomic stability 
(Štros, 2010). They belong to the superfamily of the high mobility group (HMG) proteins, which 
subdivide into three distinct structural families: the HMGA (HMG-AT-hook-family), HMGN (HMG 
nucleosome binding family) and HMGB (the HMG-box) (Reeves, 2010) . Members of each family are 
abundantly and ubiquitously expressed across eukaryotic cells, exhibiting different structures and 
unique DNA and chromatin binding motifs. HMGBs named after their high electrophoretic mobility in 
triton-urea gels due to their high content of positively and negatively charged residues (Goodwin et al., 
2000). The HMGB proteins are the most abundant of the HMGs superfamily and consists of four 
members: HMGB1-3 share an 80% identity containing two HMG boxes and a long acidic tail and differ 
mainly in the length of the acidic tail (Figure 2.6). HMGB4 (~21 kDa) is less well-studied and carries 
two HMG boxes, but lacks an acidic tail. The vast of majority of HMGBs is localized in the nucleus, 
but the high occurrence of lysine residues in their protein sequence render them susceptible to 
acetylation and drives their translocation to the cytoplasm. Interestingly, in many instances, cells 
actively secrete HMGBs in the extracellular space and it was shown at least for HMGB1 that this can 
be critical for the proinflammatory response (Davalos et al., 2013). 
The structure of HMGB proteins is highly conserved in higher eukaryotes. HMGB1-3 are ~25 
kDa proteins consisted of two L-shaped HMG boxes (each one around 80 aa) arranged in tandem and 
of a long acidic tail in its carboxyl-end. HMGB1-3 share an 80% identity and differ mainly in the length 
of the acidic tail which differentiates to some extend the unique functions of each protein. Each HMGB-
box is comprised of three positively charged α-helices, which serve the DNA binding capacity with 
limited or no sequence specificity. Notably, they bind into the minor groove of non-B-type DNA 
structures with high affinity and distort DNA by bending, looping or unwinding. The other main feature 
of HMGBs, the negatively charged acidic tail, resides in the carboxy-terminus and consists of an array 
of glutamic and aspartic residues (up to 30). The acidic tail interacts with the binding surface of the 
HMG-boxes and modulates the binding affinity and functional properties of HMGBs. The length and 
the sequence of the acidic tail was proposed to result in different biological functions for each protein 
and is thought to enhance transcriptional activity explaining why HMGB4 acts as a repressor in the testis 
(Catena et al., 2009). Strikingly, and in a sharp contrast with the rest of HMGBs, HMGB1 contains a 
cytokine activity domain lying in the B-box and a RAGE receptor-binding domain explaining why 
HMGB1 is the only characterized secreted factor capable of interacting with surface receptors to 
contribute to inflammation. 
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HMGBs bind DNA with minimal sequence preference in a “hit-and-run” fashion making the 
interaction, albeit efficient to enhance the transcriptional output. The transient nature of this interaction 
and the incompatibility of these proteins with commonly used fixatives (Teves et al., 2016) renders the 
capture of their actual binding sites genome-wide challenging. Three mechanisms have been proposed 
for the control of the transcription by HMGBs (Štros, 2010). The first one suggests that HMGBs binds 
to relevant to transcription factor sites and distorts chromatin to make it accessible for the respective 
transcription factors. The second one suggests that minimal transcription factors binding acts as docking 
points attracting HMGBs, which in turn distort chromatin and promote bulk binding of the respective 
transcription factors. The final model involves formation of a protein complex between HMGBs and 
transcription factors and chromatin bending follows (Štros, 2010). 
Although in vitro experiments in cultured cells show functional redundancy between HMGB1 
and HMGB2 (Bianchi and Agresti, 2005; Štros et al., 2009), in mice loss of HMGB1 cannot be 
substituted by HMGB2 suggesting functional diversity to multicellular organisms (Calogero et al., 1999; 
Ronfani et al., 2001). The functional diversity of HMGBs, despite their high sequence and structural 
similarities, is also made evident by their different expression in adult tissues. Although all four HMGB 
members are highly abundant during embryogenesis, they differentiate their expression in adult tissues. 
HMGB1 is still abundantly expressed in the majority of adult tissues, while HMGB2 is restricted to 
lymphoid organs and testes. HMGB3 is also down-regulated after embryonic development and sustains 
expression in hematopoietic stem cells, primitive progenitor cells, and differentiating erythroid cells in 
the adult mouse cells, where it controls differentiation of myeloid and B-cells (Nemeth et al., 2003, 
2005). Finally, HMGB4 is also present in some stages of embryonic development and is only present in 
adult testes, alongside HMGB2, where it acts as a potent transcriptional repressor (Catena et al., 2009). 
The importance of these abundant proteins is reflected on the severe phenotypes their absence 
lead to in knockout mouse models.  HMGB1-knockout mice suffer from severe hypoglycemia and die 
after one day of birth, while intraperitoneal injection of glucose can only sustain them alive for a couple 
of weeks underlining the essential role of HMGB1. HMGB2-knockout mice are still viable, but male 
mice have reduced fertility due to germ cell degeneration and immotile spermatozoa, in line with the 
restricted presence of this protein in the adult testes (Ronfani et al., 2001). Finally, HMGB3-knockout 
fail to produce efficiently myeloid and B-cell due to overproduction of erythrocytes (Nemeth et al., 
2005). These mice do not possess overt phenotypes as the overproduction of erythrocytes compensates 
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2.8 HMGBs in the induction of senescence 
 
As mentioned before, the 3D structure of chromatin is tightly linked with the events leading to 
senescence regardless of it being a cause or a consequence. There is sparse information for the role of 
the HMG proteins in the context of senescence. Interestingly, initial reports showed that HMGA proteins 
are necessary and sufficient for both the induction of RAS oncogenic senescence and SAHF formation 
(Narita et al., 2006). In congruency with their role as architectural proteins, the nuclear signal of HMGA 
proteins in immunofluorescence stainings specifically co-localized with HP1a, marking chromatin 
organization in SAHF. Although HMGAs were linked to transcriptional enhancement, it seems that their 
selective binding to the SAHF facilitates spreading of heterochromatin and repression of E2F cell cycle 
genes to maintain proliferative arrest. 
There are also studies focusing on the role of HMGBs in the induction of senescence. The sub-
cellular localization and the presence of HMGBs in the extracellular milieu seems to play multiple roles 
in the induction of senescence both in a cell-autonomous and in a non-cell autonomous fashion. In sharp 
contrast to HMGAs, HMGBs were shown to switch off their transcriptional activity and selectively 
translocate out of the nucleus robustly decreasing their levels. A striking feature of this translocation to 
the extracellular milieu is that HMGB1 can selectively bind to inflammatory receptors, acting as SASP 
factor, enhancing the expression of other inflammatory factors. Senescent cells induced by four different 
stimuli (replicative exhaustion, p16 overexpression, X-irradiation, RAS overexpression) led to the p53-
dependent release of HMGB1 in the extracellular space as part of the SASP program (Davalos et al., 
2013). The p53-dependency of HMGB1 release highlights the contribution of HMGB1, since p53 is one 
of the most prominent protein factor employed in senescence induction (Rufini et al., 2013). The idea 
that HMGB1 functions as a SASP factor was also reinforced by the ability of HMGB1 to bind RAGE 
and TLR receptors and launch a proinflammatory transcriptional cascade controlled by these receptors 
(Ellerman et al., 2007).  
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Figure 2.6. Schematic representation of HMGB1 functional domain.  
HMGBs are very similar in the protein sequence and their respective functional domains. HMGB1-3 possess the 
two boxes responsible for the DNA binding ability and the acidic tail in the carboxyl terminus. Cytokine activity 
and a RAGE-binding domains are uniquely found in the HMGB1 and render this protein as a SASP factor. Adapted 
from (Watanabe 2017) 
 
Much like HMGB1, HMGB2 also actively dynamically decreases its nuclear levels upon entry 
into senescence (Aird et al., 2016). The effect of HMGB2 nuclear eviction in individual cells and its 
potential paracrine effects as a SASP factor remain understudied. Despite the high sequence similarity 
of the two proteins, HMGB2 does not possess a cytokine-like domain and there is no described role of 
HMGB2 as a direct ligand in pro-inflammatory receptors up to date. The only contribution to SASP 
assigned to HMGB2 is through its main role as a chromatin factor and transcriptional regulator. Notably 
it was proposed that while HMGB2 significantly reduces its levels during senescence, any residual 
protein selectively bind SASP genes and promote their transcriptional activation (Aird et al., 2016). 
Although this is an interesting finding, the strength of the ChIP-seq peaks and the low abundance of 
HMGBs in senescence cells suggest that further investigation into this HMGB2 function is required. 
Further investigation into the role of HMGB2 is needed to fully understand its role in the induction of 
senescence, especially as an architectural factor. 
The link of HMGBs to senescence could be postulated through the fact that overexpression of 
these proteins was found in various human tumours like including breast carcinoma, melanoma, 
gastrointestinal stromal tumours, colon carcinomas and acute myeloblastic leukemia (Štros, 2010). 
Considering the role of senescence as tumour-suppressive mechanism and the loss of HMGBs upon the 
entry into senescence, it could be inferred that nuclear HMGB levels could act as a rheostat of cellular 
proliferation. Whether this could be mediated by their main role as architectural proteins or by any of 
their other roles is still unclear. Interestingly HMGB1 expression levels are regulated by p53 and the 
two proteins physically interact in cell nuclei, where HMGB1 promotes phosphorylation and 
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subsequentactivation of p53 (Krynetskaia et al., 2008). Finally, an anti-apoptotic role was assigned to 
HMGB1 through its interaction with, and modulation of the levels of pro-apoptotic factor BCL-2 
(Krynetskaia et al., 2008). Bypass of apoptosis is a prerequisite for tumour development, thus, 
overexpression of HMGB1 could modulate resistance to tumour development. Further investigation 
needed to elucidate whether the ab nucleo role of HMGBs as architectural factors could orchestrate a 
tumour-associated transcriptional repertoire and lead to aberrant proliferation 
Taken together, HMGBs are versatile proteins capable of translocating from their main sub-
compartment (nucleus) into the cytoplasmic and extracellular milieu affecting diverse cellular pathways. 
Although, the vast majority of HMGBs are localized in the nucleus, fluctuations of their levels could 
initiate different signaling cascades and affect cell homeostasis. Similarly, it seems that there exists a 
correlation betweem HMGBs nuclear levels and the proliferation capacity of cells. While it was already 
shown that HMGB levels decrease considerably upon senescence, the actual mechanism and the 
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2.9 The aim of this study 
 
The role of chromatin architecture in the orchestration of the cellular functions and their 
potential implication in various pathophysiological situations brought the chromatin architecture studies 
to the forefront of modern molecular biology. This PhD thesis attempts to shed some light to the complex 
topic of chromatin organization and describe some of the rules governing organization of transcription 
and its subsequent effect on cellular homeostasis. To this end, I exploited cellular senescence, a 
physiological process in mammals where primary cells progressively switch from a hyperactive and 
proliferating state to a more metabolically-muted and proliferative arrested one. It is already established 
that this dynamic and coordinated switch is accompanied by major changes in multiple transcriptional 
pathways. Despite the fact that various studies showed that chromatin organization changes dictate the 
transcriptional fate of the growing and senescence states, there were still large gaps on how 3D 
chromatin structure affects the onset and the maintenance of cellular senescence. This represents the 
main question of this work focusing on how genome-wide chromatin organization is linked to each of 
these diverse cellular states and whether changes in this organization suffice for driving the different 
transcriptional programs. 
I specified the main question on the role of the abundant architectural proteins in the nucleus of 
the proliferating cells, HMGBs. The main reason for this is that, while it was already shown that these 
abundant proteins are actively evicted from nuclei during the transition into senescence, their role as 
architectural proteins in this context was completely unexplored. The few previous reports for HMGBs 
in senescence is focusing more in their role as SASP factors in the extracellular space rather than as 
transcriptional and architectural regulators in their main compartment of action. Thus, the second 
question of our study of this work is concluded on how the architectural proteins shape the organization 
of chromatin in proliferating cells and impacts on the transcription and how their eviction alters the 
structure and the senescent transcriptional output. Towards this aim, we are going to identify other 
architectural proteins that function in synergistically with HMGBs 
Finally, despite the fact senescence represents model that we integrate our basic research for 
chromatin dynamics we are willing to contribute to the field of cellular senescence, which is extensively 
studied yet not completely understood. Senescence is linked to age-related diseases and more permissive 
tumour development, and despite the remarkable studies, a number of different challenges render 
senescence as open field for studying. 
 Results 
3. Results 
3.1 Chapter I – HMGB2 Loss upon Senescence Entry Disrupts Genomic 
Organization and Induces CTCF Clustering across Cell Types  
 
This project was conceived and coordinated by Dr. A. Zirkel, Dr. M. Nikolic and Dr. A. Papantonis. 
The manuscript was written by Dr. A. Papantonis. I was involved in the majority of the experimental 
procedures and I undertook the revisions to successfully publish this manuscript. 
My contribution for this manuscript includes the following experimental procedures 
 Culturing the IMR90’s and HUVECs to replicative senescence and performing the senescence-
associated assays. 
 Preparing the samples and performing the Western blots, qRT-PCRs and immunofluorescence 
stainings 
 Knock-down of HMGB2 and downstream applications (RT-PCR, Western blots, 
Immunofluorescence stainings) 
 Optimizing and performing Chip-seq targeting CTCF, HMGB1 and HMGB2 
 Co-immunoprecipitation of HMGB2 followed by Western blot 
 Hi-chip targeting the interacting sites bound by CTCF 
 Rescue experiment with use of piggy-bac expression and the downstream applications 
(Immunofluorescence, Western Blots) 
 
The following figures and tables were summarized and prepared by A.Z, M.N and A.P using data 
resulted from my experimental procedures: 
 Figure 3.1.1D: Characterization of the protein levels of multiple proteins shows gradual changes 
in 5 different passages from proliferative to the senescent state 
 Figure 3.1.3C: Immunostainings of HMGB1 and HMGB2 in proliferative and senescent 
IMR90’s and HUVECs show the nuclear decrease of these proteins the entry of senescence, a 
phenotype that is tightly linked with increased nuclear size 
 Figure 3.1.3D: Immunostainings of HMGB1 and HMGB2 in proliferative and senescent 
IMR90’s and HUVECs show the nuclear decrease of these proteins the entry of senescence 
 Figure 3.1.3E: Immunostainings of HMGB1 and P21 in proliferative and senescent IMR90’s 
and HUVECs show the correlation of HMGB2 decrease and p21 increase upon the entry of 
senescence 
 Figure 3.1.5A-D: Identification of HMGB2 binding sites genome-wide. HMGB2 is mostly 
bound on gene promoters and gene-bodies and is associated with active transcription. HUVECs 
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and IMR90s share a small number of overlapping peaks, a finding that is in line specific 
epigenetic state of each cell type  
 Figure 3.1.5E: Mapping of HMGB2 binding sites over the Hi-C maps generated by A.Z and 
M.N, show the binding profiles HNGB2 in respect to TADs, TAD boundaries and CTCF. 
 Figure 3.1.5G: Correlation of the differentially expressed genes with the alterations observed in 
TAD level and HMGB2 binding sites upon the entry of senescence 
 Figure 3.1.5F-H: Mapping of the HMGB2 binding sites over the Hi-maps and correlation with 
the TADs margins and CTCF binding shows that HMGB2 demarcates TAD boundaries and the 
insulation is lost upon the entry of senescence 
 Figure 3.1.6D: HMGB2-depleted nuclei drive the formation of CTCF clustering in both 
HMGB2-knockown and senescent cells 
 Figure 3.1.7A-B: HMGB2 and CTCF alignment in respect to the generated Hi-C maps identifies 
the loops mediated by these proteins and the collapse of these loops upon the entry of senescence 
 Figure 3.1.7E: Hi-chip for the interacting regions bound by CTCF reveals the interplay between 
CTCF and HMGB2 in the formation of loops 
 Figure 3.1.7F: CTCF Chip-RT-PCR reveals that the absence of HMGB2 does not affect the 
binding profile of CTCF in the existing sites and do not form new ones, thus it suggests that the 
CTCF clustering is a result of CTCF co-localization 
 Figure 3.1.7G: Re-introducing HMGB2 with the expression vector decreases the formation of 
CTCF foci and highlights the tight link between HMGB2 loss and CTCF clustering upon 
senescence 
 Figure 3.1.7I: Expression profiles of architectural and senescence-associated factors in cancer 
cells upon HMGB2 knockdown 
 Figure 3.1.S1B: Differential expression profiles of architectural and senescence-associated 
factors comparing senescent over proliferative MSCs 
 Figure 3.1.S1H: Timecourse expression profiles of architectural and senescence-associated 
factors comparing senescent over proliferative HUVECs 
 Figure 3.1.S2G: Chip-seq targeting H3K27ac and H3K27me3 shows differential binding 
profiles in proliferative and senescent HUVECs 
 Figure 3.1.S7: The impact of HMGB2 in the organization of the proliferative genome and the 
associated transcriptional pathways 
 Figure 3.1.S8: The positioning ofHMGB2 in respect to TAD boundaries 
 Figure 3.1.S9A: knockdown of HMGB2 does affect the levels of CTCF and HMGB1 and does 
not suffice for the emergence of p21 and positive B-galactosidase staining 
 Figure 3.1.S9E: Knockdown of HMGB2 promotes accumulation of the heterochromatic marker 
HP1a 
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 Figure 3.1.S9F: Nuclei depleted by HMGB2 either in senescent cells or in knockdown cells 
promoted the formation of chromatin-bound CTCF clustering 
 Figure 3.1.S9K-L: CTCF Co-Immunoprecipitation shows absence of interaction between 
HMGB2 and CTCF. RAD21 a known CTCF protein partner used as a control 
 Figure 3.1.S9M: HMGB2 Co-Immunoprecipitation identifies the protein partners of HMGB2. 
GO terms analysis was used to characterize the pathways they are involved 
 Figure 3.1.S9N: CTCF Chip-qPCR demonstrates that the CTCF clustering is not a result of de 
novo CTCF binding to HMGB2 sites or to neo-CTCF sites  
 Figure 3.1.S10F: Hi-Chip demonstrates when the insulation of HMGB2 is lost, CTCF is able to 
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Processes like cell senescence are characterized by complex events giving rise to heterogeneous 
cell populations. However, the early molecular events driving this cascade remain elusive. We 
hypothesized that senescence entry is triggered by an early disruption of the cells’ three-dimensional 
(3D) genome organization. To test this, we combined Hi-C, single-cell and population transcriptomics, 
imaging, and in silico modeling of three distinct cells types entering senescence. Genes involved in DNA 
conformation maintenance are suppressed upon senescence entry across all cell types. We show that 
nuclear depletion of the abundant HMGB2 protein occurs early on the path to senescence, and coincides 
with the dramatic spatial clustering of CTCF. Knocking-down HMGB2 suffices for senescence-induced 
CTCF clustering and for loop reshuffling, while ectopically-expressing HMGB2 rescues these effects. 









Since the original description of in vitro replicative senescence (Hayflick, 1965), in vivo 
implications in development, wound healing, organismal ageing, and disease have been uncovered (van 
Deursen, 2014). In addition, clearance of senescent cells in mice was shown to improve health- and 
lifespan (de Keizer, 2017). Senescence entry is a result of integrated autocrine and paracrine signaling 
in the population (Acosta et al., 2013; Davalos et al., 2013; Hoare & Narita, 2016) triggering replicative 
arrest, gene expression changes, secretory activity, and chromatin reorganization (Rai & Adams, 2013). 
Telomere shortening (Herbig et al., 2004), reorganization of heterochromatin and the lamina (Narita et 
al., 2006; Sadaie et al., 2013; Shah et al., 2013; Swanson et al., 2013; Zhang et al., 2005), activation of 
transposable elements (De Cecco et al., 2013), or epigenetic changes on histones and the primary DNA 
sequence have been observed (Cruickshanks et al., 2013; Franzen et al., 2017; Neyret-Kahn et al., 2013). 
Still, despite some of these events sufficing for replicative arrest, early events signaling senescence entry 
remain elusive. 
Thus, senescence is an attractive model for studying the structure-to-function relationship of 
chromosomes. This is now feasible due to the advent of Hi-C technology that captures spatial 
interactions within and between chromosomes (Belton et al., 2012). As a result of Hi-C studies, we now 
understand that chromosomes are partitioned into active A- and inactive B-compartments at the Mbp-
scale, and into consecutive topologically-associating domains (TADs) at the sub-Mbp scale. TADs 
harbor chromatin loops that tend to interact with one another more frequently than with loops in other 
TADs (Dixon et al., 2012). This higher-order organization is tightly linked to gene expression regulation, 
but also to cell cycle progression (Naumova et al., 2013).  
For senescence, Hi-C has only been applied to fibroblasts undergoing oncogene-induced 
senescence (OIS) or maintained long-term in “deep” senescence, both constituting end-point states. In 
OIS, interaction loss within heterochromatin and lamin-associated regions was observed, and in a next 
step clustering of heterochromatic stretches to form senescence-associated heterochromatic foci 
(SAHFs; Chandra et al., 2015). In “deep” senescence, shorter-range interactions are favored over longer-
range ones, thus compacting chromosome arms, while centromeres decondense (Criscione et al., 2016). 
Therefore, whether spatial genome reorganization triggers replicative senescence entry remains 
unaddressed. 
We used three human primary cell types from individual donors – umbilical vein endothelial 
cells (HUVEC), fetal lung fibroblasts (IMR90), and mesenchymal stromal cells (MSC) – to identify a 
shared regulatory backbone instructing replicative arrest. We combined genomics, super-resolution 
microscopy and single-cell sequencing to discover that proteins of the high mobility group B (HMGB) 
family are implicated in regulating specific TAD boundaries, as well as in the spatial clustering of 
CTCF-bound chromatin. HMGBs are abundant nuclear proteins with characteristic HMG-box DNA-
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binding domains; they are known to distort DNA via unwinding, bending or looping (Stros, 2010). This 
renders them important for transcription, nucleosome remodeling, genome integrity, and recombination 
(Bonaldi et al., 2002; Laurent et al., 2010; Redmond et al., 2015; Lee et al., 2010; Little et al., 2013; 
Polanska et al., 2012). Critically, HMGBs are depleted from cell nuclei in senescent and ageing tissues 
(Abraham et al., 2013; Aird et al., 2016; Davalos et al., 2013; Ly et al., 2000; Taniguchi et al., 2009), 
and markedly overexpressed across cancer types (http://www.cbioportal.org/). Despite their 
physiological relevance, the binding and roles of HMGBs on chromatin remain enigmatic, but this work 
sheds new light onto their connection to the proliferative capacity, 3D genome folding, and 




A shared regulatory backbone for senescence entry across cell types 
We hypothesized that different lineages share a common regulatory backbone controlling entry 
into replicative senescence. To test this, we obtained three distinct primary human cell types from 
individual donors/isolations: HUVEC (mesodermal) from three single donors, two isolates of IMR90 
(endodermal), and MSC (multipotent) from five donors. As the path to senescence is characterized by 
heterogeneity (Smith & Whitney, 1980), we used phenotypic and molecular markers to define the 
passage at which ~65% of cells in each population had entered senescence. Cells staining positive for 
β-galactosidase, showing significantly reduced proliferation, and specific methylation changes at six 
senescence-predictive CpGs (Franzen et al., 2017) were deemed senescent (Figures 1A and S1A,B). 
Note here that one HUVEC and one MSC donor displayed a limited number of population doublings 
until senescence and, despite their convergent gene expression profiles, were excluded from further 
analyses. This highlights the idiosyncratic nature of cellular ageing due to donor-specific features. 
Total RNA from proliferating and senescent populations from all cell types and donors was 
collected, depleted of rRNA, poly(A)+-enriched (except for HUVEC), and sequenced to >50 million 
read pairs each. Following mapping to the genome (hg19), read counts were normalized in silico to 
control for differences in transcript abundance as a result of senescence entry (Risso et al., 2014; Figure 
3.1.S1C). Differential gene expression analysis revealed different numbers of up-/down-regulated genes 
in each cell type (±0.6 log2 fold-change), which nonetheless showed converging gene ontology (GO) 
profiles (Figure 3.1.S1D,E). 153 upregulated genes, mostly involved in cell growth, p53 responses, and 
ECM reorganization, were shared by all cell types (Figure 3.1.S1F). On the other hand, the 206 shared 
downregulated genes associated with cell cycle regulation, replication, DNA metabolism, but critically 
also with DNA conformation, chromatin organization, and DNA packaging (Figure 3.1.1B). The latter 
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terms are due to genes like HMGB1/B2, TOP2A, NCAPD/-G/-H, or ASF1, and aligned with our 
hypothesis on 3D chromatin reorganization upon senescence entry.  
We validated gene expression changes by comparison to available data from senescent IMR90 
(Rai et al., 2014; Figure 3.1.S1G), and by time-course RT-qPCR on selected targets (Figure 3.1.S1H). 
We also isolated and analyzed nascent RNA from proliferative/senescent IMR90 via "factory” RNA-
seq (Melnik et al., 2016) to show that most regulation occurs at the level of transcription (Figures 1C 
and S1I). Due to their ability to bend DNA in vitro, their reduced expression in senescent and ageing 
tissue in vivo, and their unknown roles on chromatin, we focused on HMGB1/B2 and verified their 
suppression at the protein level in both IMR90 and HUVEC (Figure 3.1.1D).Single-cell mRNA 
profiling of senescent-entry cells 
Transcriptional heterogeneity is inherent to senescent cell populations (Hernandez-Segura et al., 
2017). To show that HMGB1/B2 are suppressed before known senescence markers appear, we 
performed single-cell mRNA sequencing by analyzing ~8,300 proliferating and ~5,200 senescent 
HUVEC on a 10X Genomics platform. Following multiplexed sequencing, we generated ~30,000 reads 
per cell in either state, and >2,500 individual transcripts were robustly captured per cell. Next, we 
clustered cells from each state based on their individual expression profiles. Unsupervised clustering 
showed proliferating and senescent cells segregating into four clusters (Figure 3.1.2A). Interestingly, 
the three major senescent-cell clusters reflected the relative distributions of HMGB2 and CDKN1A 
(p21) expression: low HMGB2 levels mostly marked cells with medium-to-high CDKN1A levels (i.e. 
replicatively-arrested cells), yet >1,800 cells carried little HMGB2 mRNA without CDKN1A induction. 
Similarly, >2,500 proliferating cells showed robust HMGB1 but already low HMGB2 levels (Figure 
3.1.2B,C). Senescent cells lacking HMGB2 expression were also marked by high levels of the IL6 and 
IL8 SASP genes (Figure 3.1.2B). Importantly, the gene expression profiles previously reported to hold 
key roles in senescence and the cell cycle, like LMNB1, EZH2, PCNA or CCNA2 also differentially 
marked proliferating and senescent subpopulations, but were less informative for clustering (Figure 
3.1.2B).  
Last, we exploited the heterogeneity in HUVEC populations to perform pseudo-time course 
analyses of scRNA-seq data (Haghverdi et al., 2016). We found that the gradual drop in HMGB1/B2 
levels in proliferating HUVEC sufficed for describing 7 states that appear consecutively derived from 
one another (Figure 3.1.2D). On the other hand, the 8 senescent cell-states along the main path display 
variable amounts of HMGB1/B2, and are best described by a rise in CDKN1A levels and by strong IL8 
and CXCL1 SASP-gene expression. Still, subclusters 1 and 4 had HMGB2 suppressed, but HMGB1 
robustly detected (Figure 3.1.2D). This, to our knowledge, first ever transcriptome of single 
replicatively-senescent cells documents how HMGB2 suppression is an early event marking senescence 
entry.  
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Figure 3.1.1. Senescence entry signals suppression of specific pathways. 
(A) Left: β-galactosidase staining of proliferating and senescent HUVEC donors D1 and D2; percent of β-gal 
positive cells are indicated. Middle: MTT assays for D1 and D2 at different passages; cells were deemed senescent 
at passage 20 and 18, respectively (green lines). Right: Spearman’s correlation (R2) between actual and predicted 
HUVEC passage based on the methylation at six CpGs. 
(B) Left: Genes downregulated in senescence across cells types. Right: Pathways associated with shared 
downregulated genes. Nodes (yellow) containing genes involved in DNA conformation, DNA packaging or 
chromatin assembly are highlighted, and selected genes are listed (box). 
(C) CCND2 locus RNA-seq profiles in HUVEC and IMR90. 
(D) HMGB1, HMGB2, CTCF, Lamin B1, Rad21, and p21 western blots at five different passages in HUVEC and 
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HMGB2 depletion precedes p21 activation and induces heterochromatic changes 
To complement scRNA-seq data and examine changes in HMGB1/B2 titers, we turned to 
single-cell immunofluorescence. Super-resolution imaging found the abundant HMGB1/B2 proteins 
localizing in non-DAPI-dense nuclear areas (Figure 3.1.S2A). Widefield microscopy coupled to semi-
automated quantification of fluorescence levels (see STAR Methods) revealed that senescent nuclei 
almost doubled in area across cell types, and larger nuclei were almost invariably β-galactosidase 
positive (Figure 3.1.3A,B). This urged us to stratify all microscopy data according to increasing nuclear 
sizes. This way we could verify that HMGB1/B2 were depleted from essentially all large HUVEC, 
IMR90, or MSC nuclei (Figure 3.1.3C). Although HMGB1/B2 nuclear depletion appeared coordinated 
amongst individual cells (ρ=0.81), p21 upregulation – a hallmark of replicative arrest – correlated rather 
poorly with low HMGB2 titers (ρ=0.35; Figure 3.1.3D,E). This agrees with our scRNA-seq data where 
HUVEC with low HMGB2 titers and no CDKN1A and/or robust HMGB1 levels represent an early state 
on the path to senescence. 
Focusing on size-discretized nuclei, we found that larger and HMGB2-depleted nuclei show 
specific decrease in H3K27me3 levels, the mark characteristic of facultative heterochromatin (see Shah 
et al., 2013), while also displaying increased HP1α levels (marking constitutive heterochromatin, but 
without SAHF formation as in OIS; Narita et al., 2006;  Figure 3.1.S2B). This was concomitant with a 
drop in histone acetylation measured using H3K27ac or H4K16ac as markers (Figure 3.1.S2C,D). 
Finally, increased H3K9-methylation was confirmed in senescent HUVEC and IMR90 via ELISA 
(Figure 3.1.S2E), while the senescent-induced drop in H3K27ac/me3 was in line with changes in 
H3K27ac/me3 ChIP-seq signal (Figure 3.1.S2F,G).  
Senescence entry is marked by changes in 3D chromatin folding 
Population and single-cell data encouraged us to interrogate changes in whole-genome 3D 
folding upon senescence entry via Hi-C. We used HindIII and obtained >300 million read pairs per 
donor and condition, after sequencing two technical replicates from two HUVEC and IMR90 
donors/isolates from, and one MSC donor (Figure 3.1.S3A). After confirming reproducibility between 
Hi-C maps from the same cell type and condition (Figure 3.1.S3B), we merged replicates and could 
now afford ~20-kbp resolution of spatial chromatin interactions in both proliferating and senescent cells 
(higher than that afforded for “deep” senescence; Criscione et al., 2016). Initially, we looked into 
interchromosomal interaction changes between whole chromosomes upon senescence entry; both 
HUVEC and IMR90 chromosomes mostly displayed decreased, cell type-specific, trans-interactions 
(Figure 3.1.S3C).  
We next examined intrachromosomal interactions; two features stand out when comparing Hi-
C interaction maps from proliferating and senescent HUVEC. First, stronger longer-range interactions 
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emerge upon senescence entry; second, apparent insulation, especially between large higher-order 
domains, is seen in senescent cells (Figures 3.1.4A and 3.1.S4A). This holds true across all cell types 
and chromosomes studied (Figure 3.1.S3D and S4A-C). Second, interaction changes between single 
donors/isolates visualized at a 200 kbp-resolution are almost invariably of the same nature (Figure 
3.1.S3E). But, when different cell types are compared, the same chromosomal regions refold in a cell 
type-specific manner upon senescence (Figures 3.1.4B and 3.1.S4F), and this is in line with senescence 
epigenetically reprogramming each cell type.  
In addition, most Hi-C data to date display more changes at the level of A/B compartments than 
at that of TADs (e.g. Criscione et al., 2016; Dixon et al., 2012). However, we observed limited switching 
between A/B compartments (Figures 3.1.4B and 3.1.S5A). We went on to define TADs in our Hi-C 
data from both conditions across cell types. We employed “TADtool” (Kruse et al., 2016) and the 
resolution afforded by our lowest-covered dataset (40-kbp resolution in MSC), while applying similar 
TAD-calling parameters for proliferating or senescent data in each cell type. This analysis returned a 
total of ~3,000 TADs for HUVEC and IMR90, and ~3,500 for MSC in either state. In IMR90 and MSC, 
~50% of TADs remain unchanged upon senescence entry, while ~20% shift at least one of their 
boundaries by ≥80 kbp and ~25% fuse into larger TADs (Figure 3.1.4C). TAD changes were more 
drastic in HUVEC, with 24% TADs shifting boundaries, and 43% fusing into larger ones – in agreement 
with the strong differences seen in HUVEC Hi-C (Figure 3.1.S4A-C). Interaction decay plots revealed 
widespread changes in both longer- and shorter-range interactions upon senescence entry (Figures 
3.1.4D and 3.1.S5B), which differs from what was observed for “deep” senescence (Criscione et al., 
2016; Figure 3.1.S5C,D). 
Finally, we used 3D-DNA FISH (Roukos et al., 2015), with probes targeting three increasingly 
separated regions on the long arm of chr12 to query conformational changes. In senescent HUVEC, 
which are predominantly tetraploid (Figure 3.1.S6A), FISH showed all probes becoming more 
separated from one another upon senescence and assuming less peripheral positioning in the larger 
senescent nuclei (Figure 3.1.S6B-E). In IMR90, which remain diploid, the two most distant probes 
come significantly closer together upon senescence, while the intervening one separates out, and only 
one probe pair shows less peripheral positioning (Figure 3.1.S9A-E). Critically, in both HUVEC and 
IMR90 the FISH data agree with changes seen by Hi-C (i.e. increased probe separation matched by 
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Figure 3.1.2. scRNA-seq highlights early HMGB2 suppression. 
(A) Unsupervised clustering of scRNA-seq data from proliferating or senescent HUVEC. Each dot represents 
one cell, and numbers of cells per cluster is indicated. 
(B) mRNA levels of 14 senescence-regulated genes in proliferating or senescent cells.  
(C) HMGB2 scRNA-seq read counts were plotted against HMGB1 and CDKN1A read counts; median values 
minus one S.D. (dotted lines), Pearson’s correlation coefficients (ρ), and the number of cells in each quadrant are 
indicated.  
(D) Left: Pseudo-time course clustering of scRNA-seq data from proliferating or senescent HUVEC. The main 
path (black line) also breaks into a secondary leg (yellow line). Right: Expression of 6 key genes in the clusters 








Figure 3.1.3. Senescence entry is characterized by HMGB2 nuclear loss. 
(A) Distribution of nuclear sizes in proliferating (grey) or senescent (green) HUVEC, IMR90, and MSC. The total 
number of nuclei measured (N) is indicated. 
(B) Typical images of senescent IMR90 stained for β-galactosidase and DAPI. 
(C) Typical images of proliferating/senescent MSC, IMR90, and HUVEC immunostained for HMGB1/B2 (left). 
Bean plots (right) show changes in HMGB1/B2 levels in cells grouped according to increasing nuclear size. The 
total number of nuclei measured (N). is indicated. 
(D) Typical images of proliferating/senescent HUVEC immunostained for HMGB1/B2. Fluorescence levels were 
used to produce scatter plots; median values minus one S.D. (dashed lines) and Pearson’s correlation coefficients 
(ρ) are indicated. 
(E) As in panel D, but for HMGB2 and p21. 
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Heterochromatic remodeling does not adequately explain 3D genome reorganization 
Genome reorganization in OIS and in “deep” senescence involves formation of characteristic 
SAHFs (Chandra et al., 2015) and strong chromatin compaction, respectively (Criscione et al., 2016). 
Here, senescence entry coincides with a heterochromatic shift (Figure 3.1.S2B), and we asked whether 
this suffices to explain the changes seen by Hi-C (Figure 3.1.S4). As it is not straightforward to 
experimentally decouple HMGB1/B2 loss from heterochromatic changes, we used molecular dynamics 
simulations of 3D chromatin folding. This in silico approach models preferential low-attraction 
interactions of loci on the basis of their chromatin identity (defined using ENCODE ChIP-seq; see STAR 
Methods) that faithfully recapitulate Hi-C interactions (Brackley et al., 2016a). We focused on a 15-
Mbp region on the long arm of chr12. Based on our ChIP-seq data, heterochromatic positions were kept 
the same for both states modelled, but H3K9me3-mediated interaction strength was increased by ~30% 
in the senescent model (consistent with Figure 3.1.S2B-G). Following multiple iterations, average 
interaction profiles only partly recapitulated experimental Hi-C profiles (Figure 3.1.S6F,G). Thus, as 
this strengthened heterochromatic bridging did not sufficiently explain all changes occurring upon 
senescence entry (Figure 3.1.S6H), we went on to explore a potential contribution of HMGB1/B2 in 
chromatin folding. 
HMGB1 and HMGB2 bind non-overlapping active chromatin sites  
Our understanding of the roles of HMGB1/B2 remains incomplete due to the fact that 
formaldehyde crosslinking fails to capture HMG-box factors bound to chromatin (Pallier et al., 2003; 
Redmond et al., 2015; Teves et al., 2016). To circumvent this, we devised a dual-crosslinking approach 
for HMGB1/B2 ChIP-seq (see STAR Methods) and identified 1574 and 1188 robust HMGB2 peaks in 
proliferating HUVEC and IMR90, respectively; we also identified 391 peaks in senescent IMR90 
(Figures 3.1.5A and 3.1.S7A). HMGB2 mostly binds promoters or bodies of active genes associated 
with processes relevant to senescence (e.g. ECM organization, wound healing or mitotic phase 
transition; Figures 3.1.5B and 3.1.S7B). Notably, at least twice as many genes bound by HMGB2 are 
up- rather than downregulated (Figure 3.1.5C). As HUVEC and IMR90 deploy different gene 
expression programs and HMGB2 predominantly associates with active loci, the two cell types only 
share 131 (~10%) HMGB2 peaks. Still, there are eight-fold more up- than downregulated genes 
associated with these 131 peaks, and they are linked to such processes as cell proliferation and cell 
ageing (Figure 3.1.5C).  
Of the 391 HMGB2 peaks found in the senescent IMR90 population, 220 were at positions also 
bound in proliferative cells (and are thus rather the result of heterogeneity than of persistent binding), 
whereas 171 seem to form de novo. These 220 peaks associated with mitotic processes and mRNA 
surveillance (Figure 3.1.5D). Critically, none of the 171 senescence-specific peaks overlapped SASP 
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genes as was proposed for OIS (Aird et al., 2016; Figures S7D). Thus, remodeling of HMGB2-binding 
in replicative senescence does not involve SASP loci. 
Next, to identify transcription factors (TFs) potentially co-bound with HMGB2, we analyzed 
DNase I-hypersensitive footprints under HMGB2 ChIP-seq peaks for known TF motif enrichment. 
Following filtering for well-expressed TFs, this analysis returned a number of candidate TFs that 
included architectural ones, like CTCF, relevant to cell cycle regulation, like E2F-family members and 
FOXP1/2, or involved in proinflammatory signaling, like NFKB2 and RELA (Figure 3.1.S7E). These 
motifs are enriched under HMGB2 peaks from proliferative cells, which implies that loss of HMGB1/B2 
from these positions might either dismantle co-bound complexes (e.g. in the case of E2F factors to hinder 
cell cycle progression) or facilitate assembly of new ones (e.g. in the case of proinflammatory SASP-
related TFs that remain largely inactive in proliferating cells). 
Finally, using the same dual-crosslinking approach, we generated HMGB1 ChIP-seq profiles in 
proliferating HUVEC and IMR90. We identified 810 and 593 HMGB1 peaks, respectively, more than 
30% of which were intergenic, and rarely overlapped HMGB2-bound sites, suggesting that the two 
factors have non-overlapping functions (Figure 3.1.S7F,G). 
Chromatin-bound HMGB2 marks a subset of TAD boundaries 
Using high-resolution Hi-C data from IMR90 (Rao et al., 2014), we found that HMGB2 ChIP-
seq peaks display good correlation to positions of interaction insulation (i.e. at TAD/sub-TAD 
boundaries; Figure 3.1.S8A). Correlation of HMGB2 peaks to TAD extremities from proliferating 
HUVEC and IMR90 showed that they mark TAD boundaries comparably to CTCF, and this 
demarcation markedly weakened for TADs from senescent cells (Figure 3.1.5E). This implies that 
TAD-boundary changes upon senescence entry (see Figure 3.1.4F) are linked to HMGB2 depletion 
from nuclei. In more detail, HMGB2 marks TADs of proliferating cells that both shift their boundaries 
or remain unchanged in senescence – but not of those that fuse. Intriguingly, non-changing TADs have 
both boundaries marked by HMGB2, whereas those that shift a boundary display reciprocal demarcation 
with HMGB2 enriched on one side and CTCF on the other (Figures 5F and S8Β). Also, TADs that lose 
HMGB2 from their boundaries harbor almost twice as many up- than down-regulated genes compared 
to other TAD subgroups, in line with our ChIP-seq data (Figure 3.1.5C,G). Approx. 10% of HMGB2 
peaks fell within 40 kbp of a TAD boundary in proliferating cells, which is significantly more than what 
would be expected by chance (P<0.001, Fisher’s exact test). In order to link HMGB2 boundary-
positioning to spatial reorganization upon senescence entry, we looked at average Hi-C interaction 
profiles around HMGB2 peaks. Interaction insulation at HMGB2-bound boundaries collapsed when 
comparing senescent cells to proliferating cells, and this effect was far less pronounced when 
considering all peaks (Figure 3.1.5H). Of course, since our HUVEC Hi-C afforded higher resolution, 
we repeated all analyses using 20-kbp resolution data. At this resolution, more TAD changes arose 
(Figure 3.1.S8C), more HMB2 peaks resided at TAD boundaries (~16%; Figure 3.1.S8D), but still 
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demarcation of TAD subgroups, gene expression changes therein, and changes around HMGB2-bound 
boundaries were of the same nature (Figure 3.1.S8E-G).  
 
 
Figure 3.1.4. Senescence entry is accompanied by 3D genome reorganization. 
(A) Hi-C contact frequencies along the long arm of chr6 from proliferating and senescent HUVEC at increasing 
resolution.  
(B) Binary increase/decrease in Hi-C contact frequencies between senescent and proliferating HUVEC, IMR90, 
or MSC along a subregion of chr12. Aligned below are graphs showing A- (purple) and B-compartments (green) 
for each cell type and condition. 
(C) The number of TADs (percentages in brackets) that remain unchanged, shift one boundary, fuse into one larger 
TAD, or separate into smaller TADs upon senescence are listed for all cell types. 
(D) Interaction frequency decay as a function of cis-separation between fragments for chr21 in proliferating or 
senescent HUVEC Hi-C data. 
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Figure 3.1.5. HMGB2 chromatin-binding properties. 
(A) HMGB2 ChIP-seq from proliferating/senescent HUVEC and IMR90 along a chr17 locus; CTCF ChIP-seq and 
input profiles are aligned below. 
(B) Left: Percentage of HMGB2 peaks from proliferating/senescent HUVEC and IMR90 overlapping promoters, 
gene bodies, repeats, or intergenic space. The total number of peaks (N) per dataset is indicated. Right: Distribution 
of H3K27ac, H3K27me3, and H2A.Z ChIP-seq signal in the 10 kbp around HUVEC HMGB2 peaks. 
(C) Left: HMGB2 peaks shared between HUVEC and IMR90. Middle: Log2 fold changes of differentially-
expressed genes bound by HMGB2. The total number of genes (N) is indicated. Right: GO terms associated with 
HMGB2-bound upregulated genes in both HUVEC and IMR90.  
(D) As in panel C, but for HMGB2 peaks shared between proliferating and senescent IMR90.  
(E) Distribution of HMGB2 ChIP-seq signal along TADs (±20 kbp) in proliferating/senescent HUVEC or IMR90; 
CTCF and H3K27ac distributions serve as controls. 
(F) As in panel E, but for IMR90 TADs that do not change (left), shift one boundary (middle), or fuse into one 
larger TAD (right). The total number of TADs in each group (N) is indicated. 
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(G) Log2 fold changes of differentially-expressed genes located within the different TAD subsets. The total 
number of genes in each group (N) is indicated. *significantly different to “unchanged”; P<0.01, Wilcoxon-Mann-
Whitney test. 
(H) Normalized Hi-C interaction frequencies (top). or senescence-induced changes Hi-C interactions (bottom). in 
the 0.4 Mbp around all or TAD-boundary HMGB2 peaks from IMR90. 
 
HMGB2 knockdown affects heterochromatin and induces spatial CTCF clustering 
The above analyses are support a role for HMGB2 in reorganizing chromatin topological upon 
senescence entry. To functionally establish this, we knocked-down HMGB2 in HUVEC and IMR90 
using self-delivering siRNAs (as primary cells are difficult to transfect and lipofectamine stresses cells 
and convolutes their phenotypes). This approach strongly depleted the HMGB2 protein (Figure 
3.1.S9A), but unlike previously reported effects for sustained HMGB1 knockdown (Davalos et al., 
2013), the loss of HMGB2 only caused a mild increase in the number of senescent cells in the 72-hour 
treatment window, while also marginally affecting nuclear size, DNA replication, or gene expression 
(Figure 3.1.S9B-D). However, after labeling nascent transcripts in live cells via a short (5-min) EUTP 
pulse and quantifying EU-RNA fluorescence, we uncovered a ~30% drop in nascent RNA levels upon 
HMGB2 knockdown; a similar decrease of ~10% in nascent RNA production was seen in senescent 
IMR90 (Figure 3.1.6A). Also, knocking-down HMGB2 sufficed for inducing HP1α and suppressing 
H3K27me3 levels (Figures 3.1.6B and 3.1.S9E), thus recapitulating the shift between constitutive and 
facultative heterochromatin seen in senescence. These effects highlight that HMGB2 depletion is an 
upstream event affecting both the organization of the genome and its functional output. 
Next, we asked whether HMGB2 depletion also affected the levels and distribution of CTCF in 
primary cells. Super-resolution imaging revealed that in proliferating HUVEC HMGB2 and CTCF foci 
are tightly alternating and interwoven. Upon senescence entry, CTCF is dramatically reorganized in 
large senescence-induced CTCF clusters (SICCs) devoid of HMGB2 signal (Figure 3.1.6C). SICC 
formation was consistently found in senescent HUVEC and IMR90, and HMGB2 knockdown 
phenocopied this despite the smaller nuclear sizes in knockdown-cells (Figures 3.1.6D and 3.1.S9F-
H). Notably, SICCs did not overlap HP1α foci (Figure 3.1.S9I), thus bear no resemblance to SAHFs 
and are specific to replicative senescence. SICC formation was not accompanied by strong cohesin 
reorganization in senescent IMR90, despite extensive colocalization of CTCF and cohesin on chromatin 
(Rao et al., 2014). Still, decreased cohesin levels in SICC-positive cells were recorded (Figure 3.1.S9J). 
Perhaps surprisingly, <200 HMGB2 peaks from HUVEC or IMR90 were proximal to CTCF peaks, and 
co-immunoprecipitation of either CTCF or HMGB2 did not reveal physical interaction between the two 
factors (Figure 3.1.S9K-M). In addition, CTCF binding at both standalone and HMGB2-proximal sites 
remains unchanged between proliferating and senescent cells (Figure 3.1.S9N).  
 To assess the impact of HMGB2 depletion on whole-genome folding, we applied Hi-C to 
control and HMGB2-knockdown HUVEC. This data revealed apparent differences between the two 
states, but, just like in senescence, only limited A/B-compartment remodeling. At 40-kbp resolution, 
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interactions around HMGB2 peaks were particularly disrupted (Figures 3.1.6E and 3.1.S10A). Changes 
to TAD boundaries mirrored precisely those seen in senescent HUVEC (Figures 3.1.6F) and average 
interaction profiles around HMGB2- and/or CTCF-bound positions again recapitulated the effects of 
senescence entry at TAD boundaries (Figure 3.1.S10B,C). 
Towards a molecular mechanism for SICC formation 
Closer inspection of HMGB2 ChIP-seq aligned to high-resolution HUVEC Hi-C (Rao et al., 
2014) revealed loop-like interactions between multiple HMGB2 peaks (Figure 3.1.7A). Thus, we 
inquired whether HMGB2 forms loops similar to CTCF (Rao et al., 2014). We interrogated all pairwise 
cis-interactions involving HMGB2 peaks looking for local Hi-C signal maxima exceeding background. 
We found that ~2,900 and ~5,000 loop structures emanating from HMGB2-bound positions in IMR90 
and HUVEC, respectively, with their average profiles and intensities being directly comparable to those 
of CTCF loops (Figure 3.1.7B). 
 As heterochromatic changes did not fully explain conformation changes observed by Hi-C, we 
revisited modeling of the 15-Mbp region on chr12. Typically, HMGB2 peaks are positioned between 
CTCF loops (Figures 3.1.7A,C) and we hypothesized they might act to insulate further CTCF-CTCF 
interactions. To model this mode-of-action, we devised three in silico scenarios. First, in proliferating 
cells stable looping between convergent CTCF-bound sites was allowed (based on IMR90 loops; Rao 
et al., 2014), but loops across HMGB2 peaks were disallowed. Second, in “senescence model I” 
insulation by HMGB2 was alleviated to mimic its depletion from nuclei. Third, in “senescence model 
II”, additional stochastic CTCF-CTCF interactions are favoured upon HMGB2 depletion. All three 
scenarios were implemented on top of the framework used before (Figure 3.1.S6F-H). Each scenario 
was modeled for 48 iterations, and generated increasingly stronger clustering of CTCF-bound chromatin 
in the absence of HMGB2 (Figure 3.1.7C,D). 
 To validate these models experimentally, we used HiChIP that allows spatial interactions owing 
to a particular TF to be subselected and interrogated independently of all others (Mumbach et al., 2016). 
We pulled-down CTCF and were able to detect ~2,000 and ~1,000 robust CTCF-CTCF loops per 
condition in HUVEC and IMR90, respectively (despite lower complexity in CTCF-HiChIP compared 
to Hi-C libraries; Figure 3.1.S10D). Comparing intra-chromosomal loops between proliferating and 
senescent cells revealed increased loop lengths, with ~40% being unique to each state (Figure 
3.1.S10E). Inspection of multi-Mbp genomic stretches populated by CTCF-CTCF loops, new long-
range CTCF loops develop around positions where HMGB2 binding is lost, just as our in silico models 
predicted. On the other hand, around positions where HMGB2 binding persists or only occurs in 
senescence, local loop depletion was observed (Figures 3.1.7E and 3.1.S10F). Hence, HMGB2 peaks 
indeed function as “insulators” for flanking CTCF-bound sites. However, we ruled out the possibility of 
CTCF binding at HMGB2 sites that contain motifs resembling those cognate for CTCF by assessing its 
binding at these “neoCTCF” sites in senescent and HMGB2-knockdown cells (Figure 3.1.7F). 
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Importantly, in both HUVEC and IMR90, genes within 10 kbp of CTCF loop anchors that reshuffle 
upon senescence entry display significantly stronger expression changes compared to genes within 10 
kbp of static loops (Figure 3.1.S10G).  
Ultimately, to unambiguously link HMGB2 loss to SICC formation, we generated IMR90 
populations carrying either a doxycycline-inducible HMGB2-GFP fusion or GFP alone. The constructs 
were inserted into the genome using a piggybac-based vector. We selected, expanded, and drove cells 
into senescent heterogeneous populations (to average out clonal variation). HMGB2 overexpression was 
induced in senescent cells using doxycycline for 24 h; ~50% of cells in each population expressed GFP 
or the HMGB2-GFP fusion (Figure 3.1.7G). Of those carrying only GFP, >45% showed strong SICC 
formation, while significantly fewer (<20%) of those expressing HMGB2-GFP displayed SICCs 
(Figure 3.1.7G). Thus, the nuclear presence or absence of HMGB2 is sufficient and instructive for 
induction of CTCF clusters upon senescence entry. 
Cancer cell proliferation potency relies on HMGB factors 
HMGB2 proteins are depleted from cell nuclei upon senescence entry and this depletion reduces 
nascent RNA levels globally (Figure 3.1.6A). Conversely, in tumour cells enhanced proliferative 
capacity is accompanied by increased global transcription (Kotsantis et al., 2016). Importantly, unlike 
senescent cells, a large variety of cancer cells display HMGB2 overexpression (Figure 3.1.7H). We 
hypothesized that these higher titers might explain their proliferative potency. As proof-of-principle, we 
used two lung lines for HMGB2 knockdown, and could show that suppressing HMGB2 affects genes 
like HDAC9, RBL1, and TP53 (upregulated), or LMNB1, EZH2, and SUV39H2 (downregulated), but 
not HMGB1 (Figure 3.1.7I). Importantly, this resulted in severe growth arrest of adenocarcinoma cells 
(Figure 3.1.7J), highlighting the potential role of HMGB2 in the maintenance of the proliferative state 
in cancer.  
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Figure3.1.6. HMGB2 knockdown 
alters CTCF and chromatin 
organization. 
(A) Decrease in nascent EU-RNA 
between control (NTC) and 
knockdown (siHMGB2) HUVEC 
or IMR90. *significantly different 
to NTC; P<0.05, Wilcoxon-Mann-
Whitney test. The total number of 
cells (N) analyzed is indicated. 
Average EU-RNA levels reduction 
in knockdown/control is compared 
(below) to that in 
senescent/proliferating cells 
(normalized for the increase in 
nuclear size).  
(B. Concomitant increase in HP1α 
and decrease in H3K27me3 levels 
in HMGB2-knockdown HUVEC. 
*significantly different to NTC; 
P<0.05, Wilcoxon-Mann-Whitney 
test. Typical images of NTC or 
siHMGB2 HUVEC immunostained 
for HMGB2/HP1α (below); the 
total number of cells (N) analyzed 
is indicated. 
(C) Super-resolution images of 
proliferating and senescent 
HUVEC immunostained for 
HMGB2 and CTCF. Insets: 
magnified clusters. 
(D) Typical widefield images of 
control, HMGB2-knockdown or 
senescent HUVEC immunostained 
for HMGB2 and CTCF. 
(E) Hi-C contact frequencies along 
the long arm of chr7 in control and 
HMGB2-knockdown HUVEC. 100 
kbp-resolution maps are aligned to 
A/B compartment plots. Zoom-ins 
are aligned to HMGB2 and CTCF 
ChIP-seq and changed interactions 
around HMGB2 peaks are 
indicated (arrows). 
(F) The number (percentages in 
brackets) of TADs that remain 
unchanged, shift one boundary, 
fuse into one larger TAD, or 
separate into smaller TADs in 
senescent/proliferating or HMGB2-
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Figure 3.1.7. HMGB2 forms loops and deters CTCF clustering. 
(A) CTCF and HMGB2 ChIP-seq from proliferating HUVEC aligned to high-resolution Hi-C (Rao et al., 2014). 
Loops (local Hi-C signal maxima) involving CTCF (C1-3; magenta) or HMGB2 peaks (H1-5; green) are 
demarcated. 
(B) Average Hi-C signal in the 100 kbp around CTCF-CTCF loops (separated by ≥150 kbp) from proliferating 
cells (top) or in senescent versus proliferating cells (bottom)..  
(C) Left: CTCF peaks and loops, and HMGB2, H3K4me1/3, H3K36me3, H3K27me3, and H3K9me3 ChIP-seq 
peaks along 15 Mbp of chr12 used in simulations. Right: Snapshots of single conformations from proliferating or 
senescent-cell models (“I” and “II”). showing chromatin (red) and bound CTCF (green).  
(D) Graphs showing increasingly larger SICC sizes (top). and CTCF molecules per SICC (bottom) with simulation 
time for each of the three models in panel C. 
(E) HiChIP CTCF loops in a 6.5-Mbp region of chr17 from proliferating and senescent IMR90. CTCF and HMGB2 
peaks in proliferating and senescent IMR90 are aligned above. 
(F) Mean ChIP-qPCR enrichment (over input and negative controls; log2 ±S.D., n=2) in different IMR90 
populations with primers targeting CTCF, HMGB2 or putative “neoCTCF” sites. 
(G) Left: Strategy for ectopic HMGB2 expression in IMR90. Middle: Overexpression of endogenous (“endo”). or 
GFP-fusion HMGB2 (“w/GFP”); CTCF and β-tubulin levels provide a control. Right: Typical images of Dox-
induced IMR90 expressing only GFP or HMGB2-GFP (white arrowheads indicate SICCs), and quantification of 
GFP-positive cells carrying SICCs (white) with the number of cells in each group (N) displayed below. 
*significantly different; P<0.01, Fisher’s exact test. 
(H) HMGB2 expression levels across 15 cancer types (http://www.cbioportal.org/); the number of patient samples 
per each type is indicated, and lung adenocarcinoma data highlighted. 
(I) Changes in selected mRNAs levels upon HMGB2 knockdown in H1975 knockdown versus control cells (mean 
fold change ±S.D.; n=2). 
(J) The number of live A549 and H1975 lung adenocarcinoma cells that remain (mean ±S.D.; n=3) in the 4 days 





Proliferating cells have mechanisms in place that preserve their inherent chromatin state and its 
higher-order architecture in conjunction with DNA replication and cell division – and 3D chromatin 
folding gradually dissolves towards mitosis, before being reinstated after cell division concludes 
(Naumova et al., 2013). However, how this maintenance is achieved in proliferatively-arrested cells 
remains unclear. Here we hypothesized that entry into senescence of different cell types is governed by 
a shared regulatory backbone involving an early event of spatial genomic reorganization. We assign this 
presumed event to the downregulation of genes associated with DNA conformation maintenance, of 
which HMGB1/B2 stand out due to their nuclear abundance and inherent ability to bend chromatin 
(Stros, 2010). 
 At least 10% of HMGB-bound loci mark TAD boundaries, often coinciding with active gene 
promoters. This is consistent with active protein-coding and tRNA genes overrepresented at TAD 
boundaries (Dixon et al., 2012) and the notion that transcription acts to partition eukaryotic genomes 
(Rowley et al., 2017). At HMGB-marked TAD boundaries, the change in activity of the underlying 
genes coincides with interaction reshuffling upon senescence entry. Notably, HMGB2 contributes to 
loop formation along human chromosomes, much like CTCF, and this unveils a novel looping factor 
specifically contributing to 3D genome conformation in proliferating primary cells. 
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Unlike manipulations of HMGB1 in fibroblasts (Davalos et al., 2013), HMGB2 loss does not 
suffice for senescence induction given the transient nature of a knockdown experiment. However, its 
suppression recapitulated three key features of senescence entry: It globally reduced transcriptional 
output, yielding as much as 30% less nascent RNA, induced a shift between facultative and constitutive 
heterochromatin, and HMGB2-bound TAD boundaries collapsed as regards interaction insulation. All 
three effects were widespread and constitute prime examples of genomic function following form, 
highlighting how replicative senescence is a suitable and perhaps underappreciated model for studying 
this relationship in human chromosomes. 
Senescent cells are also characterized by the dramatic clustering of CTCF foci into SICCs. In 
proliferating cells, HMGB2-bound positions seem to insulate flanking CTCF peaks from forming long-
range interactions with one another; this is alleviated upon senescence entry. Notably, SICC formation 
is reminiscent of “phase separation” (Hnisz et al., 2017), but proved reversible upon reintroduction of 
HMGB2, which should perhaps be expected for an early event on the path to senescence. Another 
notable feature is that HMGB1/B2 have been detected bound to mitotic chromatin (Pallier et al., 2003) 
in a manner similar to another HMGB-box factor, Sox2 (Teves et al., 2016). This opens up the possibility 
of mitotic bookmarking by HMGB2, thus connecting proliferative capacity to topological demarcation 
and looping. Although further work is needed, such bookmarking could explain the inability of lung 
adenocarcinoma cells to propagate in the persistent absence of HMGB2. We propose that deregulation 
of higher-order chromatin organization via the nuclear depletion of HMGB2 constitutes a deterministic 
primer for the ensuing senescent program across cell types, and HMGB2 itself acts as a rheostat of 
topological insulation, the depletion of which reversibly affects global transcription competency and 
heterochromatin organization.  
 
3.1.5 Materials and Methods 
 
Primary human cell lines and senescence markers 
HUVECs from single, apparently healthy, donors (passage 2; Lonza Inc.) were continuously passaged 
to replicative exhaustion in complete Endopan-2 supplemented with 2% FBS under 5% CO¬₂. Cells 
were constantly seeded at ~10,000 cells/cm2, except late passages that were seeded at ~20,000 
cells/cm2. Single IMR90 isolates (I90-10 and -79, passage 5; Coriell Biorepository) were continuously 
passaged to replicative exhaustion in MEM (M4655, Sigma-Aldrich) supplemented with non-essential 
amino acids and 20% FBS under 5% CO¬₂. Mesenchymal stromal cells (MSCs) were isolated at the 
Aachen Medical School, and cultured to senescence as previously described (Franzen et al., 2017). Cell 
proliferation was monitored by MTT assays at different passages. In brief, ~5,000 cells are seeded in 
96-well format plates in quadruplicates. On the next day, the medium is replaced with 100 µl fresh 
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medium plus 10 µl of a 12 µM MTT stock solution (Invitrogen), and cells are incubated at 37°C for 4 
h. Subsequently, all but 25 μl of the medium is removed from the wells, and formazan dissolved in 50 
μl DMSO, mixed thoroughly and incubated at 37°C for 10 min. Samples are then mixed again and 
absorbance read at 530 nm. Measurements are taken at 24, 48 and 72 h post-seeding, background 
subtracted, and normalized to the 24 h time point. Senescence-associated β-galactosidase assay (Cell 
Signaling) was performed according to the manufacturer’s instructions to evaluate the fraction of 
senescent cells at different passages. Finally, DNA methylation at six selected CpG islands (Franzen et 
al., 2017) was measured by isolating genomic DNA at the different cell states and performing targeted 
pyrosequencing (Cygenia GmbH). 
Immunofluorescence and image analysis 
Cells were grown on coverslips from the stage indicated; they were fixed in 4% PFA/PBS for 15 min at 
room temperature. After washing once in PBS, cells were permeabilized with 0.5% Triton-X/PBS for 5 
min at room temperature. Blocking with 1% BSA/PBS for 1h was followed by incubation with the 
indicated primary antibodies for 1-2 h. Cells were washed twice with PBS for 5 min before incubating 
with secondary antibodies for 1 h at room temperature. Nuclei were stained with DAPI (Sigma-Aldrich) 
for 5 min, washed, and coverslips mounted onto slides in Prolong Gold Antifade (Invitrogen).. For image 
acquisition, a widefield Leica DMI 6000B with a HCX PL APO 63x/1.40 (Oil) objective was used; 
confocal and super-resolution images were acquired on a Leica TCS SP8 gSTED microscope with a 
100x/1.40 (Oil) STED Orange objective. Deconvolution of super-resolution images was performed 
using the Huygens software from Scientific Volume Imaging. Note that for the immunostainings of pre-
extracted nuclei (Figure 3.1. S9F), cells grown on overspills were incubated in CSK buffer (10 mM 
HEPES pH 7.9, 300 mM sucrose, 100 mM Nacl, 3 mM MgCl2) for 1 min at room temperature, and then 
in CSK+0.5% Triton X-100 for 1 min at room temperature before fixation as described above. 
Genome-wide chromosome conformation capture (Hi-C) and analysis 
For Hi-C studies, 25-35 million proliferating/senescent HUVEC were crosslinked by adding 1% PFA 
(Electron Microscopy Sciences) for 10 min at room temperature with subsequent quenching (125 mM 
glycine), and gently scraped off the plates on ice. Then, Hi-C was performed as previously described 
(Belton et al., 2012) under conditions where nuclei remained largely intact. In brief, cells were lysed (10 
mM Tris-HCl pH 8.0, 10 mM NaCl, 0.4% NP40, 1x protease inhibitor cocktail) twice for 20 min on ice, 
washed with 1x NEBuffer 2 twice, and distributed into 4-5 tubes. Following SDS treatment (0.1%). for 
10 min at 65°C and quenching with Triton-X for 15 min at 37°C, chromatin was digested with 600 units 
of HindIII overnight at 37°C under constant agitation. Next day, digestion was extended for another 
hour with an additional 600 units of HindIII for 1-2 hours. DNA overhangs were filled-in using a biotin-
dCTP containing mix (1.5µl dATP, 1.5 µl dGTP, 1.5 µl dTTP, 37.7 µl biotin-dCTP, each 10 mM stock; 
Invitrogen) in the presence of 1.5 µl 50 U/µl Klenow (NEB) for 45min at 37°C, and all enzymes are 
inactivated by adding 86 µl 10% SDS to all tubes and incubating for 30min at 65°C. Next, each 
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individual mixture was transferred into a 15 ml tube, incubated for 10-20min on ice to quench SDS, and 
a mixture containing 745 µl of 10% Triton-X, 745 µl 10x ligation buffer (500 mM Tris-HCl pH 7.5, 100 
mM MgCl2, 100 mM DTT), 80 µl of a 10 mg/ml BSA stock, 80 µl of 100 mM ATP and 5.96 ml milliQ 
water is added to each tube, and blunt-end ligation initiated by adding 15 µl of 5 U/µl T4 DNA ligase 
(Invitrogen) and incubated for 6 hours at 16°C. Crosslinks were then reversed and proteins degraded by 
adding 35 µl of 15mg/ml proteinase K and incubated overnight at 65°C. Next day, an additional 35 µl 
of proteinase K was added for 2 hours at 65°C, mixtures were cooled to room temperature, transferred 
to 50-ml tubes, and DNA was extracted twice with phenol:chloroform (pH 8.0) and ethanol precipitated. 
The resulting pellets were dissolved in 450 µl 1x TE, transferred to 1.7ml tubes, DNA was re-extracted 
twice, precipitated, pellets were washed once in 70% ethanol, air-dried, and resuspended in 25 µl 1x TE. 
Subsequently, three tubes, each with ~5 µg of the Hi-C template, were incubated for 2 h at 12°C in the 
presence of 1 µl 10 mg/ml BSA, 10 µl 10x NEBuffer 2, 1 µl 10 mM dATP, 1 µl 10 mM dGTP (for NcoI 
samples dCTP was used instead) and 5 units of T4 DNA polymerase (NEB). in a total volume of 100 µl 
to remove biotin-16-dCTP at non-ligated DNA ends. Reactions were stopped by adding 2 µl of 0.5 M 
EDTA pH 8.0, and the DNA was subsequently purified by phenol extraction and ethanol precipitation. 
DNA pellets were resuspended and pooled in a total of 100µl of milliQ water, and residual salts were 
removed via Amicon 30K columns via three washing steps (1x 200 µl and 2x 100 µl milliQ water). 
Finally, DNA was sheared to a size of 300-600 bp on a Bioruptor Plus (Diagenode; 2x 10 cycles of 30 
sec on and 30 sec off, at the highest power setting).  
 For IMR90 and MSC cells, the procedure was slightly modified to follow the in situ Hi-C 
protocol (Rao et al., 2014).. Approx. 20 million cells were lysed twice in 900 µl lysis buffer (10 mM 
Tris-HCl pH 8.0, 10 mM NaCl, 0.4% NP-40, 1x protease inhibitor cocktail) for 15 min on ice, nuclei 
were pelleted and washed once in 1x NEBuffer 2, distributed into 4 tubes, resuspended in 200 µl 0.5% 
SDS/NEBuffer 2, and incubated for 10 min at 62°C. After repelleting, SDS-treated nuclei were 
resuspended in 150µl 1% Triton-X/NEBuffer 2, and digested overnight using 400 units of HindIII at 
37°C with constant agitation. Next day, another 400 units of HindIII were added for another 1-2 h at 
37°C. Following heat inactivation for 20 min at 62°C, nuclei were pelleted by centrifugation and 
resuspend in 256 µl NEBuffer 2. DNA ends were then biotinylated by adding 50 µl of a biotin-dCTP-
Klenow mix (37.5µl of 0.4 mM biotin-dCTP, 1.5µl of 10 mM dTTP, dATP, and dGTP, and 1.5µl of 50 
U/μl Klenow). to each tube and incubating for 1 h at 37°C. Subsequently, 900 µl of ligation mix (603 
µl H2O, 240 µl 5x Invitrogen ligation buffer, 30 µl of 10% Triton-X, 12 µl of 10 mg/ml BSA, and 15 
µl ligase) was added to each sample, mixed, and incubated for 6 h at 16°C; tubes were inverted 
frequently. Nuclei were next pelleted and a volume of 900 µl was removed. Following reversal of 
crosslinking and proteinase K addition, DNA is phenol:chloroform extracted and ethanol precipitated; 
all subsequent steps were performed as described above. 
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 Hi-C DNA was used as template for adding sequencing linkers via 10 PCR cycles. Then, Hi-C 
libraries were sequenced to generate at least 400 million paired-end reads (50-75 bp in length) per each 
donor/condition on a HiSeq4000 platform (Illumina). Raw reads were mapped to the human reference 
genome (hg19) iteratively (to ensure maximum recovery of uniquely mapped pairs). using BWA (Li & 
Durbin, 2010), duplicates were removed (http://picard.sourceforge.net/), and the output converted into 
BEDPE format. Next, custom R scripts were used to bin the genome into non-overlapping bins (typically 
10-kbp ones), assign reads to bins, remove read pairs not representing valid interactions, and to 
normalize read counts to library size. Finally, the HiTC Bioconductor package was used to annotate, 
correct matrices for biases in genomic features (Servant et al., 2012), and visualize 2D heat maps at 
different resolutions. In addition, we applied a composite, uniform, correction to Hi-C maps from 
senescent HUVEC due to their tetraploidy; the scaling factor was calculated by adjusting for the ratio 
of 2n versus 4n cells in the two HUVEC populations (as recorded using DNA FISH; Figure 3.1. S6A), 
as well as the shift in cis-/trans-contact ratio (expecting the tetraploid cells will have a small bias in 
favour of cis-interactions. The final factors used were 0.961x for D1, and 0.641x for D2, and were 
applied before data merging. For subtracted Hi-C maps, we determined bins under a particular cutoff 
(typically 5 rpm) and set them to 0, while all others were set to 1; then, matrices were subtracted to give 
a binary appreciation of the interaction changes between the different states. For plotting insulation 
heatmaps, normalized interactions values in the twenty 20-kbp bins around each HMGB1/B2 peak were 
added up, normalized to the median value in each bin and plotted. All R scripts used here are available 
on request, and all HMGB2-HMGB2 loops identified are listed in Table S1. Note that the visualization 
of high-resolution Hi-C data (from Rao et al., 2014) was via the “3D Genome Browser” interface 
(http://promoter.bx.psu.edu/hi-c/). 
RNA isolation, sequencing, and analysis 
Cell of different types/conditions were harvested in Trizol LS (Life Technologies) and total RNA was 
isolated and DNase I-treated using the Direct-zol RNA miniprep kit (Zymo Research). Following, 
rRNA-depletion using the RiboZero Gold kit (Illumina), barcoded cDNA libraries were generated using 
the TruSeq RNA library kit (Illumina) with (IMR90, MSC) or without selection on poly(dT) beads 
(HUVEC); in addition some IMR90 and MSC libraries were spiked using a synthetic ERCC Spike-In 
mix (Thermo Fischer Scientific) to facilitate normalization. The resulting libraries were paired-end 
sequenced to at least 50 million read pairs on a HiSeq4000 platform (Illumina)., and raw reads were 
mapped to the human reference genome (hg19) and analyzed via the QuickNGS pipeline (Wagle et al., 
2015) to obtain read counts. Then, read counts from different single-donors/conditions were normalized 
using the RUVSeq package (Risso et al., 2014). Please note that, in our hands, normalization using either 
synthetic spike-in controls or the intrinsic “top quantile“ function of the RUVseq package is essentially 
interchangeable. Finally, for analysis of nascent RNA in IMR90 the “factory RNA-seq“ approach was 
applied on ~5 million proliferating or senescent cells (Melnik et al., 2016), RNA was isolated and 
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sequenced as above, and intronic read counts were obtained and differentially analyzed for the two 
conditions using the iRNAseq package (Madsen et al., 2015). All box/bean plots were plotted using the 
BoxPlotR tool online (http://shiny.chemgrid.org/boxplotr/), and GO term/pathway enrichment analyses 
using Metascape (http://metascape.org/gp/index.html; Tripathi et al., 2015). Differentially-regulated 
genes per each cell type are listed in Table S2. 
3D-DNA FISH and high-throughput imaging  
A three color DNA FISH was performed using the BAC probes RP11-347B21, RP11-296G9 and RP11-
781M19 (Chori BACPAC) fluorescently labeled with Alexa-488 dUTP, Alexa 568 dUTP and Alexa 
647 dUTP, respectively by nick translation. Briefly, HUVEC and IMR90 cells grown and fixed on 
coverslips were permeabilized in 0.5% saponin /0.5% tritonX100/PBS for 20 minutes and incubated in 
0.1N HCl for 15 minutes. Following a 30-min incubation in 50% formamide/2X SSC, samples were 
denatured with the labelled BACs at 85°C for 5 min, and hybridized at 37°C overnight. Three washing 
steps with 1xSSC and 0.1x SSC were performed before mounting of coverslips with Vectashield 
containing DAPI onto glass slides. Images were acquired with an Opera Phenix High Content Screening 
System (PerkinElmer)., equipped with four laser lines (405 nm, 488 nm, 568 nm, and 640 nm) and two 
16-bit CMOS cameras. Images for 3D and radial distances were acquired in confocal mode using a 40X 
water objective lens (NA 1.1). For each sample, 13 z-planes separated by 0.5 µm were obtained for a 
total number of at least 108 fields, on a minimum of 1500 cells per condition. For cell cycle staging by 
DAPI content analysis, cells were imaged using a 20X water objective lens (NA 1.0) in wide-field mode. 
For each sample, 3 z-planes separated by 1 µm were obtained for a total number of 72 fields, on a 
minimum of 3500 cells per condition.  
Molecular dynamics simulations  
Polymer simulations in Figure 3.1. S6 were performed according to a predictive scheme developed 
previously (Brackley et al., 2016a; Brackley et al., 2016b). First, the target region (chr12: 60,000,000-
75,000,000; hg19) was divided into 3-kbp windows, each represented by a polymer “bead“. Protein 
complexes are also represented by simple spheres, which interact attractively with specific beads on the 
polymer. These are determined using IMR90 ChIP-seq data for H3K4me3, H3K36me3, H3K27me3, 
and H3K9me3 (ENCODE, 2012). We accordingly specified three types of changing bridging proteins 
and polymer beads. The first type of protein, denoted “active“, interacts with polymer beads marked by 
H3K4me1/3 and H3K36me3 (binding strongly to the enhancer-/promoter-associated marks, and weakly 
to the H3K36me3 regions); the second type, denoted “repressed“, interacts with beads marked by 
H3K27me3; the third type, denoted “heterochromatin“, interacts with beads marked by H3K9me3. Since 
polymer beads cover 3-kbp, it was possible for a bead to cover regions in different states, and so interact 
with more than one type of protein; beads not carrying any mark do not interact attractively with any 
bridging proteins. The dynamics of the diffusing polymer and of the protein complexes are simulated 
using LAMMPS (Plimpton, 1995) in “Langevin Dynamics“ mode; the position of each bead is 
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determined by an equation that describes the potential for interactions between all elements in the 
system. These potentials include: spring bonds between adjacent beads along the polymer (finite 
extensible non-linear elastic bonds), angle interactions between triplets of adjacent polymer beads 
(giving the polymer bending rigidity), steric interactions between all beads to prevent them from 
overlapping (Weeks-Chandler-Anderson potential), and attractive interactions between protein spheres 
and polymer beads (shifted truncated Lennard-Jones potential). We performed 48 independent 
simulations of this 5000-bead polymer with 167 active, 109 H3K27me3-binding, and 165 H3K9me3-
binding proteins (these protein numbers were chosen such that the ratio of binding sites to proteins is as 
previously found to give an optimal prediction of Hi-C data; Brackley et al., 2016b). The system extends 
120-bead diameters (σ), the persistence length of the polymer is 4-σ, and we use interaction energies of 
5.5 kBT and 2 kBT for the strong and weak Lennard-Jones interactions, respectively (with a cut-off of 
1.8-σ). Each 3-kbp polymer bead has a 30-nm diameter, and each simulation is run for the equivalent of 
76 sec. These simulations modelled proliferating cells; to model senescent cells a further set of 48 
simulations were performed where we increased the number of H3K9me3-binding proteins by 30% to 
220.  
            For the CTCF clustering simulations in Figure 3.1.7, in addition to protein bridges, we also 
included additional spring interactions between pairs of CTCF sites such that permanent loops form. We 
used HUVEC ChIP-seq data for H3K4me3, H3K36me3, H3K27me3, and H3K9me3 (ENCODE, 2012) 
as above to label beads as binding for “active“, “repressed“ or “heterochromatin“ proteins. In each of 
48 independent simulations, pairs of convergent CTCF sites are stochastically chosen to form loops 
depending on the ChIP-seq signal strength in HUVEC data – in this way, a different set of convergent 
CTCF sites could be looped in each simulation, allowing for cell-to-cell variation. Operating on the 
hypothesis that CTCF looping is disrupted by the high mobility group proteins, in the case of 
proliferating cells we switched off any CTCF loops which enclosed HMBG2 binding sites or for which 
an HMGB2 sites was adjacent to the CTCF site; additionally we switched off protein-bridge binding to 
beads adjacent to all HMGB2 and CTCF sites. As before the number of heterochromatin binding bridges 
was 30% higher in the senescent cell simulations. Another possible mechanism for CTCF clustering in 
senescence is that in these cells there are multimeric interactions between CTCFs (i.e., more than 
pairwise binding, either directly between CTCF proteins or mediated by another protein); to model this 
scenario we perform a set of simulations as above, but which also include a direct attractive interaction 
between all CTCF sites (i.e., fixed-spring interactions between convergent pairs, plus short range 
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ChIP-seq and analysis 
For each batch of ChIP experiments approx. 25 million cells, cultured to >80% confluence in 15-cm 
dishes, were crosslinked in 15 mM EGS/PBS (ethylene glycol bis(succinimidyl succinate); Thermo) for 
20 min at room temperature, followed by fixation for 40 min at 4°C in 1% PFA. From this point onwards, 
cells were processed via the ChIP-IT High Sensitivity kit (Active motif) as per manufacturer’s 
instructions. Chromatin was sheared to 200-500 bp fragments on a Bioruptor Plus (Diagenode; 2x 9 
cycles of 30 sec on and 30 sec off, at the highest power setting), and immuno-precipitation was carried 
out by adding 4 μg of the appropriate antiserum (HMGB1: PCRP-HMGB1-4F10-s, DSHB; HMGB2: 
ab 67282, Abcam; CTCF: 61311, Active motif) to approx. 30 μg of chromatin and incubating on a 
rotator overnight at 4°C in the presence of protease inhibitors. Following addition of protein A/G agarose 
beads and washing, DNA was purified using the ChIP DNA Clean & Concentrator kit (Zymo Research) 
and used in qPCR or next-generation sequencing on a HiSeq4000 platform (Illumina). Where ChIP-seq 
was performed, at least 35 million reads were obtained and the respective “input“ sample was also 
sequenced. Raw sequencing reads (typically 100 bp-long) were mapped to the reference human genome 
(hg19). using BWA (Li & Durbin, 2010), and the resulting .BAM files were processed via the MACS2 
software (Zhang et al., 2008) to identify signal enrichment over input. Thresholded HMGB1/B2 ChIP-
seq peaks per each cell type are listed in Table S1, and oligonucleotides used as primers in ChIP-qPCR 
listed in Table 3.1.S4. The .BAM files were also used in ngs.plot (Shen et al., 2014) for plotting ChIP-
seq coverage over particular genomic positions for different conditions/cell types. Finally, transcription 
factor recognition motif enrichments within DHS footprints under HMGB1/B2 ChIP-seq peaks were 
calculated using the Regulatory Genomics Toolbox (Gusmao et al., 2014).. Note that for the 
H3K27ac/me3 ChIP-seq, crosslinking was with 1% PFA for 10 min at room temperature, rabbit 
polyclonal antisera were used (H3K27me3: C15410069, H3K27ac: C15410174; Diagenode), and 
preparations were spiked with chromatin prepared from Drosophila S2 cells as described (Orlando et 
al., 2014). 
CTCF-HiChIP and analysis 
For HiChIP (Mumbach et al., 2016) ~30 million proliferating or senescent IMR90 and HUVEC were 
crosslinked in 1% PFA for 10 min at room temperature with subsequent quenching (125 mM glycine), 
and gently scraped off the plates on ice. Then, the in situ Hi-C protocol described above was applied 
until the ligation step, and followed by CTCF-bound chromatin immunoprecipitation. Briefly, cells were 
lysed twice (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.4% NP-40, 1x protease inhibitor cocktail) for 15 
min on ice, nuclei were pelleted and washed once in 1x NEBuffer 2, distributed into 3 tubes, treated 
with SDS, and incubated for 10 min at 62°C. Chromatin was digested using HindIII (for IMR90). or 
NcoI (for HUVEC) at 37°C. Following heat inactivation, DNA ends were biotinylated by a biotin-dCTP-
Klenow mix and incubated for 1 h at 37°C. Subsequently, ligation was performed for 6 h at 16°C, during 
which tubes were frequently inverted. Nuclei were next pelleted, and 260 μl of shearing buffer (0,1% 
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SDS, 1 mM EDTA, 10 mM Tris-HCl pH 8.0) was used to resuspend the pellet. Sonication was 
performed using a Bioruptor (Diagenode; 2x 6 cycles of 30 sec on/30 sec off, at a low power setting). 
Immunoprecipitation was carried out by adding 4 μg of the appropriate antiserum (α-CTCF; 61311, 
Αctive motif) to approximately 30 μg of biotinylated chromatin before incubating on a rotating platform 
overnight at 4°C, in the presence of protease inhibitors. Following addition of protein-G magnetic beads 
(Active motif)., DNA was purified using the Chip DNA Clean concentrator kit (Zymo Research). 
HiChIP DNA was used as template for adding Illumina sequencing linkers via 12 PCR cycles, and 
libraries were sequenced to generate >150 million paired-end reads (75-100 bp in length) per condition 
on a HiSeq4000 platform (Illumina). Raw reads were processed and loops identified using “hichipper” 
(Lareau et al., 2018). 
Protein extraction and western blotting 
For assessing protein abundance at the different cell states, approx. 4×106 cells were gently scraped off 
15-cm dishes, and pelleted for 5 min at 600 x g. The supernatant was discarded, and the pellet 
resuspended in 100 μl of ice-cold RIPA lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM 
EDTA pH 8.0, 1 mM EGTA pH 8.0, 1% NP-40, 1% sodium deoxycholate) containing 1x protease 
inhibitor cocktail (Roche)., incubated for 20 min on ice, and centrifuged for 15 min at >20,000 x g to 
pellet cell debris and collect the supernatant. The concentration of the nuclear extracts was determined 
using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific), before extracts were aliquoted and 
stored at -70°C to be used for western blotting. Resolved proteins were detected using the antisera and 
dilutions listed in the Key Resources Table. 
EdU and EU labeling of nucleic acids 
Nascent DNA synthesis was monitored by EdU incorporation and subsequent labelling with the Click-
iT® chemistry (Click-iT EdU Imaging Kit; Invitrogen). In brief, cells were incubated in 10 µM EdU for 
7 h, fixed using 3.7% PFA/PBS for 15 min at room temperature, permeabilized, and labeled as per 
manufacturer’s instructions. Similarly, nascent RNA synthesis was monitored by incorporating EU in 
transcripts by incubating cells in 1 mM of 5-ethynyl uridine for exactly 5 min at 37°C. Cells were then 
fixed, permeabilized, and labeled via Click-iT chemistry as above. Before imaging on a widefield Leica 
microscope as described above, cells were also immunostained for HMGB2, stained with DAPI, and 
mounted onto glass slides. 
Single-cell mRNA sequencing and analysis 
Freshly-frozen early- (p. 4) and late-passage HUVEC (p. 16) were thawed, washed once in warm PBS, 
and subjected immediately to encapsulation in oil droplets. Each droplet contained beads carrying 
barcoded oligos for cDNA synthesis that allow both cell barcoding and unique transcript identification 
on a Chromium 10X Genomics platform as  per manufacturer’s instructions. This way 8,323 early- and 
5,269 late-passage cells were processed (with a 0.8% chance of capturing a cell duplet). Samples from 
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each condition were pooled and sequenced separately in two HiSeq2500 lanes each (Illumina) yielding 
~30,000 reads per early- and ~47,000 reads per late-passage cell. This accounts for a >50% sequencing 
saturation, and returned >2,500 and >3,000 robustly captured transcripts for early- and late-passage 
cells, respectively. Raw sequencing data were processed and visualized using default settings in the Cell 
Ranger suite provided by the manufacturer. 
siRNA-mediated HMGB2 knock-down 
HUVEC or IMR90 were seeded at 20,000 cells/cm2 the day before transfection. An Accell-siRNA pool 
(Dharmacon) against HMGB2, plus a non-targeting control (NTC; fluorescencently-tagged to allow 
transfection efficiency to be monitored for each experiment), were added to the cells at a final 
concentration of 1 µM. Knock-down efficiency and its downstream effects were evaluated at 72 h after 
transfection using RT-qPCR and/or immunofluorescence assays. For HUVEC Hi-C, cells were seeded 
the same way but in 2x15cm plates per condition. The cells were crosslinked at 72h post transfection 
and processed as described for IMR90 and MSC Hi-C. Due to the lower cell number (~5 million cells) 
permeabilized nuclei were kept in a single tube for downstream processes. 
SICC rescue experiments 
Doxicycline-inducible overexpression IMR90 cells were generated using PiggyBac transposition. The 
HMGB2 ORF was TOPO-cloned from cDNA (Invitrogen). Following validation by Sanger sequencing, 
it was subcloned into the DOX-inducible KA0717 expression vector to generate an HMGB2-GFP 
fusion. The construct was co-transfected into IMR90 together with transactivator and transposase-
encoding vectors (KA0637 and SBI Biosciences #PB200PA-1, respectively) at a DNA mass ratio of 
10:1:3 using Fugene HD (PRomega) as per manufacturer’s instructions. Stable, transgene-positive, 
proliferating IMR90 were selected using 250 μg/ml G418 (Sigma Aldrich), and driven into replicative 
senescence. HMGB2-GFP expression was induced using doxycycline for >6 h, and IMR90 carrying the 
empty GFP vector served as a control (for more details see Rao et al., 2016).  
Quantification and statistical analyses 
Image analyses 
For immunofluorescence image analysis, the NuclearParticleDetector2D of the “MiToBo“ software 
(from version 1.4.3; available at (http://www2.informatik.uni-halle.de/agprbio/mitobo/). was used. 
Measurements of nuclear immunofluorescence signal were automatically generated using a mask drawn 
on DAPI staining to define nuclear bounds. Background subtractions were then used to precisely 
determine the mean intensity per area of each immunodetected protein. All primary antibodies used here 
are listed in the Key Resources Table. For STED microscopy only, the 2C Pack STED 775 IR-R- 
(1:2000; 2-0032-052-6, Abberior) secondary antibodies were used. 
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For 3D-DNA FISH, image analysis was performed using the Harmony software (version 4.4, 
PerkinElmer) and custom-made scripts. Segmentation of nuclei was performed via algorithm B in 
maximum-projection images using the DAPI channel. Any cell in the periphery of the image was 
excluded from further analysis. In each individual nucleus, FISH spots were identified in all three 
channels using the spot detection algorithm C. Distances between all different spots of all different 
channels were calculated in 2D using custom-made building blocks, while the z-plane having the 
maximum pixel intensity of each spot was identified. Single cell information was then exported as text 
files and custom R scripts were used to calculate Euclidean distances between the different spots in 3D. 
In order to only select intrachromosomal distances between the three probes, the minimum distance of 
each spot (each allele) to other fluorescently labelled alleles was identified and plotted. For data analysis, 
only cells with equal spot number in all three channels were selected, and at least 1000 cells per condition 
were analyzed. Distances between spot pairs were plotted as box plots with 5-95% whiskers in GraphPad 
and significances determined by a Mann-Whitney U test. For determination of radial distances of each 
spot to the nuclear center and border, custom scripts were built based on previous analyses (Shachar et 
al., 2015). DNA content analysis was performed and plotted as previously described (Roukos et al., 
2015).  
Statistical tests 
P-values associated with Student’s t-tests and Fischer’s exact tests were calculated using GraphPad 
(http://graphpad.com/)., those associated with the Wilcoxon-Mann-Whitney test using the EDISON-
WMW tool (Marx et al., 2016), while Pearson’s correlation coefficients (ρ) using the function embedded 
in MS Excel (Microsoft). Unless otherwise stated, P-values <0.01 were deemed significant.  
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Figure 3.1.S1. Senescence entry determination and RNA-seq data analysis (related to Figure 3.1.1). 
(A) Left: β-galactosidase staining of proliferating and senescent IMR90 from two individual isolates (D1 and D2). 
Middle: MTT proliferation assays over 72 hours for single-donor IMR90 at different passages; D1 cells in passage 
28, and D2 cells in passage 35 were deemed as senescent (green curves). Right: Plot showing the correlation (R2) 
between actual and predicted passage number based on the methylation levels of six CpGs measured by 
pyrosequencing. 
(B) Left: β-galactosidase staining of proliferating and senescent MSC from a single donor (D1). Middle: changes 
in mRNA levels of selected genes were assessed by RT-qPCR. Genes down- (green) or up-regulated (orange) in 
senescent versus proliferating cells are shown (mean fold change ±S.D.; n=3). Right: Plot showing the correlation 
(R2) between actual and predicted passage number based on the methylation levels of six CpGs measured by 
pyrosequencing (from. 
(C) Raw RNA-seq data from all donors and across all three cell types were normalized in silico using the RUVseq 
package. Left: Box plots show the fluctuation of mRNA expression levels in proliferating (grey) and senescent cell 
populations (green) per each donor, before (“raw“; grey outline) and after normalization (“norm“; black outline). 
Right: Principal component analysis (PCA) plots for each RNA-seq data set in proliferating (grey) and senescent 
cells (green) per each donor, before (grey outline) and after normalization (black outline). Note that MSC-D1 
RNA-seq has twice as many reads as those for D2-4, and thus clusters further away. 
(D) Plots showing differentially expressed mRNAs (±0.6-log2 fold change or more; Padj<0.05) after RNA-seq data 
normalization for IMR90 mRNA, IMR90 factory RNA, HUVEC, and MSC from two single donors (with the 
exception of four donors used for MSC). The number of up- (orange) and down-regulated genes (green) is shown 
in each plot. 
(E) Gene ontology (GO) and pathway enrichment analysis for the up- (top) or down-regulated genes (bottom) from 
each cell type/condition; common GO terms/pathways are displayed in bold. 
(F) Shared stimulated GO terms/pathways in senescence. Left: Venn diagram showing genes up-regulated across 
all cells types. Right: 153 shared up-regulated genes associate with the pathways displayed in the drawn color-
coded network.  
(G) Overlap of suppressed genes seen in our and in publicly-available IMR90 RNA-seq data (from Rai et al., 
2014). Left: Venn diagram showing genes down-regulated in both datasets. Right: 789 shared down-regulated 
genes associate with the GO terms/pathways shown in the bar plot. 
(H) Validation of gene expression changes in two HUVEC donors using RT-qPCR. Relative fold changes in 
mRNA levels of selected genes from successively passaged cells (“pro“ to “sen“) are shown (mean fold change 
±S.E.M.; n=2). Changes in HMGB1 (pink) and HMGB2 levels (magenta) are highlighted. 
(I) Overlap of suppressed (left) or induced (right) genes seen in poly(A)+ and factory RNA-seq data from two 
IMR90 isolates. Venn diagram showing genes up-/down-regulated in both datasets; 424 shared down- and 450 up-
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Figure 3.1.S2. Senescence-induced nuclear changes studied at the single-cell level (related to Figure 3.1.3) 
(A) Super-resolution imaging of HMGB1/B2 nuclear distribution. gSTED images of a representative proliferating 
HUVEC nucleus immunostained for HMGB2 (top row) and HMGB1 (bottom row).  
(B) Widefield images of representative proliferating (top row) and senescent (bottom row) HUVEC, IMR90, and 
MSC single-donor cells immunostained for H3K27me3 and HP1α. Below: Bean plots show changes in H3K27me3 
and HP1α levels in proliferating (grey) or senescent IMR90 (green) grouped according to increasing nuclear size 
(from left to right: nuclei smaller than the mean of proliferating cells; between the mean and 1.5x that of 
proliferating cells; between 1.5x and 2x the mean of proliferating cells; larger than 2x the mean size of proliferating 
cells). The total numbers of nuclei measured (N) per group are indicated below each bean plot. 
(C) As in panel B, but for IMR90 immunostained for H3K9me3 and H3K27ac. 
(D) As in panel B, but for IMR90 immunostained for H3K16ac. 
(E) Bar graphs showing normalized levels (±S.D.; n=4) of post-transcriptional histone modifications (PTM) in 
proliferating (grey) or senescent (green) IMR90 and HUVEC. *: significantly different mean; P<0.01, unpaired, 
two-tailed, Student’s t-test. 
(F) Box plots showing total (log) signal under H3K27ac (left) and H3K27me3 ChIP-seq peaks (right) from 
proliferating (grey) and senescent (green) HUVEC. *: significantly different; P<0.01, Wilcoxon-Mann-Whitney 
test. The total numbers of peaks analyzed (N) per condition are indicated below. 
(G) Representative browser views showing H3K27ac and H3K27me3 ChIP-seq data from proliferating (grey) and 









Figure 3.1.S3. Hi-C data generated from proliferating and senescent cells (related to Figure 3.1.4). 
(A) Table showing (from left to right) the total number of read pairs generated for each Hi-C library, the per cent 
of reads mapped, the number of read pairs remaining after binning (in 10-kbp bins) and processing, and the ratio 
of cis:trans interactions in the final contact matrices.  
(B) Heatmap showing correlation values between Hi-C replicas for chromosomes 12 (black squares) and 2 (blue 
squares) calculated using HiCRep (Yang et al., 2017) and 40-kbp resolution data.  
(C) Heatmaps showing increase/decrease (red/blue) in normalized interchromosomal interactions between 
individual chromosomes from HUVEC and IMR90 data.  
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(D) Hi-C heatmaps showing interaction frequencies along the long arm of chromosome 6 (ideogram) in 
proliferating and senescent IMR90 and MSC at 100-, 40-, and 10-kbp resolution. 
(E) Heatmaps show binary increase/decrease (log; red/blue) in normalized Hi-C contact frequency along 
chromosome 7 (ideogram) for HUVEC and IMR90 from two individual donors/isolates (D1 and D2) at 200-kbp 
resolution. 
(F) As in panel E, but for the long arm of chromosomes 20 and 13 (ideogram) from senescent versus proliferating 
HUVEC, IMR90, and MSC at 200-kbp resolution. 
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Figure 3.1.S4. Hi-C contact maps from proliferating and senescent cells (related to Figure 3.1.4). 
Hi-C heatmaps showing contact frequencies along the long arms of chromosomes 3, 5, 8, and X (ideograms) from 
proliferating/senescent HUVEC (A), IMR90 (B), and MSC (C) at 40-kbp resolution. 
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Figure 3.1.S5. Changes in chromosome-wide interactions upon senescence entry and comparison to Hi-C 
data from “deep“ senescence (related to Figure 3.1.4). 
(A) Graphs showing switching between A (purple) and B compartments (green) along chromosomes 6, 8, and X 
in proliferating (top row) and senescent (bottom row) HUVEC, IMR90, and MSC. 
(B) Line plots showing normalized Hi-C contact frequency (log) with distance along chromosomes 6, 8, 11, and 
16 from proliferating (grey line) and senescent (green line) HUVEC, IMR0, and MSC. 
(C) Hi-C heatmaps showing interaction frequencies along the long arm of chromosomes 3, 5, and 8 (ideograms) 
from proliferating/senescent IMR90 (top) and WI-38 (bottom) at 40-kbp resolution. 
(D) Heatmaps show increase/decrease (log; red/blue) in normalized Hi-C interaction frequency along the long arm 
of chr5 (ideogram) from senescent versus proliferating IMR90 and WI-38 cells. Graphs showing switching 
between A (purple) and B compartments (green) along the long arm of chr5 in proliferating (top row) and 
senescent (bottom row) IMR90, and WI-38 are aligned below.  
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Figure 3.1.S6. 3D-DNA FISH and modeling of genomic organization in senescence (related to Figure 3.1.4). 
(A) Plots showing the distribution of DAPI intensity in proliferating and senescent HUVEC (left) and IMR90 
nuclei (right) as revealed by high throughput 3D-DNA FISH image analysis. Note the bimodal distribution of 
senescent HUVEC nuclear sizes that allowed us to group them into smaller and larger ones. Insets: Pie charts show 
the percent of diploid (2n) or tetraploid (4n) nuclei in each population. 
(B) Box plots showing the normalized radial positions (0 = central to the nucleus; 1 = peripheral) of the three 
BACs (green, red, blue) used as probes in 3D-DNA FISH in proliferating (“pro“) or senescent (“sen“) HUVEC 
and IMR90. *: significantly different; P<0.05, Wilcoxon-Mann-Whitney test. 
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(C) Heatmaps show binary increase/decrease (red/blue) in normalized Hi-C contact frequencies along a 30-Mbp 
subregion chromosome 12 (ideogram) in HUVEC and IMR90 at 200-kbp resolution. The relative positions of the 
BAC clones used as DNA FISH probes (green, red, and blue), and their interactions are indicated. Bottom: a zoom-
in on the changing Hi-C interactions between each BAC probe pair in a 1-Mbp space. 
(D) Representative images of HUVEC (left) and IMR90 nuclei (right) hybridized with the three BAC probes 
(colours as in panel A). Bar: 6 μm. 
(E) Box plots showing the shift in measured 3D-distances in proliferating (grey) and senescent (green) HUVEC 
and IMR90, and their respective changes in Hi-C interaction frequencies (magenta ovals) for each probe pair 
(bottom). Note how HUVEC senescent cells are grouped according to their nuclear size (S, small; L, large) like in 
panel A. *: significantly different; P<0.01, Wilcoxon-Mann-Whitney test. 
(F) Comparison of in silico (“simulation“) and experimental contact heatmaps (“Hi-C“) for the 15-Mbp subregion 
of chromosome 12 (ideogram) used in simulations in both the proliferative and senescent state. The positions of 
CTCF, H3K4me1/3, H3K36me3, H3K27me3, and H3K9me3 ChIP-seq peaks are also aligned below. 
(G) Snapshots of individual simulation runs using the parameters from the proliferating-cell model; the chromatin 
fiber (green) and CTCF proteins (spheres) are shown. Magnification: a subregion of the simulated system is 
shown, in the absence of the chromatin fiber, to visualize active (red), inactive (blue) and heterochromatic (black) 
protein clusters. 
(H) Heatmaps show increase/decrease (red/blue) in normalized Hi-C interaction frequencies in the 15-Mbp 
modelled subregion of chromosome 12 at 100-kbp resolution. Representative regions where contact changes are 
similar (rectangles i- ii and iv-v) or differ (rectangle iii) are demarcated. Below: plot showing the changes in 
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Figure 3.1.S7. Analysis of HMGB1/B2 chromatin-binding properties (related to Figure 3.1.5). 
(A) Genome browser view of HMGB2 ChIP-seq profiles from proliferating HUVEC and proliferating/ senescent 
IMR90 along a subregion of chromosome 8 (ideogram); CTCF ChIP-seq profiles and Refseq gene models are also 
aligned below.  
(B) Gene ontology (GO) and pathway enrichment analysis for the up- (top) or down-regulated genes (bottom) 
bound by HMGB2 in HUVEC or IMR90. 
(C) HMGB2 ChIP-qPCR (±S.D.; n=3) was used to interrogate changes in binding between proliferating (grey) 
and senescent cell populations (green). HMGB2 peaks are grouped into those positioned at TAD boundaries and 
those internal to TADs; CTCF-bound sites and SASP genes serve as controls.  
(D) Browser views showing representative HMGB2 peaks from proliferating (grey) and replicatively-senescent 
IMR90 (green) or from proliferating (light purple) and oncogene-induced senescent WI-38 (dark purple). Top 
row: HMGB2 peaks lost in RS, but are not at all picked up in OIS; bottom left: an HMGB2 peak persisting upon 
RS, but again not picked up in OIS; bottom right: two OIS-specific HMGB2 peaks at the SASP genes IL8 and 
CXCL1 are not present in RS, despite activation of both loci. 
(E) Heat maps showing known transcription factor (TF) binding motif enrichment (log scale) within the DNase-
hypersensitive sites (DHS) under HMGB2 peaks in IMR90 (left) or HUVEC (top right); TFs up-/down-regulated 
upon senescence are colored orange and green, respectively. Enriched GO terms/pathways of up- or down-
regulated TFs co-bound by HMGB2 are shown (bottom right).  
(F) A browser view of HMGB2/B1 ChIP-seq profiles from proliferating HUVEC along a subregion of 
chromosome 17; CTCF ChIP-seq and 5-kbp resolution Hi-C data (Rao et al., 2014) are aligned below. 
(G) Venn diagram showing the overlap between HMGB2 (grey) and HMGB1 peaks (purple) detected in 
proliferating HUVEC and IMR90. 
(H) Bar plots showing the percent of HMGB1 ChIP-seq peaks from HUVEC and IMR90 overlapping gene 
promoters (orange), gene bodies (blue), repeats (white), or intergenic regions (grey). The total number of peaks 
(N) per dataset is displayed below.  
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Figure 3.1.S8. Relative positioning of HMGB2 in respect to TAD boundaries (related to Figure 3.1.5 and 
S6). 
(A) Genome browser views of HMGB2 ChIP-seq profiles from proliferating HUVEC and proliferating/ senescent 
IMR90 along the indicated regions of chromosomes 6, 11, and 13. 5-kbp resolution IMR90 Hi-C data (Rao et al., 
2014), and CTCF ChIP-seq, proliferating/senescent RNA-seq profiles, and Refseq gene models are aligned above 
and below, respectively. 
(B) Meta-plots showing the distribution of HMGB2 (grey) and CTCF ChIP-seq signal (black) along HUVEC 
TADs (±20 kbp) that do not change (left), shift one boundary by >80 kbp (middle), or fuse into one larger TAD 
(right). TADs identified using 40- or 20-kbp Hi-C data and the total numbers of TADs in each group (N) are 
shown. 
(C) The number of TADs (percentages in brackets) that remain unchanged, shift one boundary by >80 kbp, fuse 
into one larger TAD, or separate into smaller TADs upon senescence are listed for the two resolution studied here. 
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(D) Pie charts showing the percent of HMGB2 (light grey) and CTCF (dark grey) that overlap HUVEC TAD 
boundaries called at 40- (orange dashed line) and 20-kbp resolution (solid line). 
(E) Bean plots showing (log2) fold changes in mRNA levels of differentially-expressed genes contained within 
TADs with unchanged, shifting boundaries or fusing, or at boundaries that lose HMGB2 upon senescence entry. 
The total numbers of up-/down-regulated genes (N) are shown. *: significantly different; P<0.01, Wilcoxon-Mann-
Whitney test. 
(F) Graphs showing switching between A/B compartments along a 2-Mbp subregion of chromosome 12 in 
proliferating (left) and senescent (right) HUVEC at 10-kbp resolution. 
(G) Top: Heatmaps showing normalized interaction frequencies in the 0.4 Mbp around all HMGB2 peaks or around 
those at TAD boundaries in proliferating HUVEC. Bottom: Heatmaps showing changes in interaction frequencies 
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Figure 3.1.S9. Effects of HMGB2 knock-down on primary human cells (related to Figure 3.1.6). 
(A) Top: Typical images of proliferating HUVEC treated with self-delivering, fluorescently-labeled, non-targeting 
siRNAs (“redNTC“) for 24 h. Bottom left: Box plots showing HMGB2 levels immuno-detected in control (“NTC“) 
or knock-down HUVEC (“siHMGB2“) treated with different siRNA titers. *: significantly different; P<0.01, 
Wilcoxon-Mann-Whitney test. Bottom right: Western blots of HMGB1, HMGB2, CTCF, and p21 in NTC and 
knock-down HUVEC; tubulin levels provide a control. 
(B) Top: Typical images of control (“NTC“) and knock-down HUVEC (“siHMGB2“) stained for HMGB2 and β-
galactosidase activity; percent of β-gal positive cells are indicated. Bottom: Box plots showing distribution in 
nuclear size for untreated, NTC, or siHMGB2 HUVEC (top) and IMR90 (bottom). 
(C) Top: Typical images of proliferating (left) and senescent IMR90 (right) grown in the presence of EdU (green) 
for 7 h; DAPI staining was used to visualize nuclei. Bottom: Table showing percentages of EdU-negative and EdU-
positive cells in NTC- or siHMGB2-treated HUVEC/IMR90; the percentages recorded in proliferating/senescent 
IMR90 serve as a control. 
(D) Scatter plot showing differentially-expressed mRNAs (at least ±0.3-log2 fold change; P<0.05) after RNA-seq 
data normalization for knock-down (“siHMGB2“) versus control HUVEC (“NTC“) from two replicates. Genes 
most up- (orange) or down-regulated (green) are indicated. 
(E) Widefield images of representative control (top), and HMGB2-knockdown HUVEC nuclei (bottom) 
immunostained for HMGB2 and HP1α. 
(F) Representative wide-field images of proliferating (top row), control (second row from top), knock-down (third 
row from top), senescent (penultimate row), or senescent and pre-extracted with CSK IMR90 (bottom row) 
immunostained for HMGB2 and CTCF. 
(G) gSTED images of proliferating, senescent, or siHMGB2 IMR90 and HUVEC immunostained for HMGB2 
(left column) and CTCF (middle column); characteristic regions are magnified (inset). Line scans (far right) 
provide profiles of CTCF (green curve) and HMGB2 fluorescence (red curve) across a 10-15 μm section indicated 
in the “merge“ panel (yellow line) with SICCs are indicated (arrows). 
(H) Confocal imaging of representative proliferating (top row) and senescent (bottom row) IMR90 and HUVEC 
cells immunostained for HMGB1/B2 and CTCF. 
(I) Representative wide-field images of proliferating (left) and senescent IMR90 (right) showing no overlap 
between immunostainings for HP1α and CTCF foci. 
(J) Left: Representative wide-field images of proliferating (top row) and senescent IMR90 (bottom row) 
immunostained for SMC1A and CTCF. Right: Box plots showing SMC1A levels immunodetected in proliferating 
(grey), senescent (blue), and SICC-positive senescent IMR90 (green). Bar: 4 μm. 
(K) Line plot showing distribution of CTCF ChIP-seq signal in the 40 kbp around HMGB2 peaks from 
proliferating HUVEC and IMR90 (grey) or senescent IMR90 (green). The number of overlapping peaks (N) per 
cell types is indicated. 
(L) Representative western blot of Rad21 and HMGB2 in co-immunoprecipitation experiments with CTCF; 
control co-IPs using non-specific IgG antisera provide a control.  
(M) Volcano plot showing mass-spectrometry data for the relative enrichment of proteins interacting with HMGB2 
(orange dots; N=67) versus IgG controls (grey dots denote contaminants) using P-value <0.05 and fold change 
(log2) >1 as cutoffs. The 10 most enriched GO terms associated with HMGB2 interaction partners are listed (right). 
(N) CTCF ChIP-qPCR (±S.D.; n=3) reveals little change in binding between proliferating (grey) and senescent 
IMR90 (green). CTCF peaks are grouped into those overlapping (“HMGB2+CTCF“) or not overlapping HMGB2-
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Figure 3.1.S10. Disruption of higher-order organization upon HMGB2 knock-down (related to Figure 3.1.7). 
(A) Hi-C heatmaps showing interaction frequencies along the long arm of chromosomes 11 and X (ideograms) in 
control (“NTC“) and knock-down (“siHMGB2“) HUVEC at 100- (left), and zoom-ins at 40-kbp resolution (right). 
Low-resolution maps are aligned to A/B compartment plots. Zoom-in maps are aligned to HMGB2 and CTCF 
ChIP-seq data, and two regions with changing interactions around HMGB2 peaks are indicated (arrows). 
(B) Left column: Heatmaps showing normalized Hi-C interaction frequencies (at 20-kbp resolution) in the 0.4 Mbp 
around HMGB2, CTCF, and Rad21 peaks in proliferating or NTC HUVEC positioned at TAD boundaries. Right 
column: Heatmaps showing changes in contact frequency in the same 0.4 Mbp upon senescence entry or HMGB2 
knock-down. Rad21/HMGB2 heatmaps refer to data from IMR90 (grey square). The number of peaks (N) used in 
each heatmap is indicated. 
(C) As in panel B, but for all HMGB2, CTCF or Rad21 ChIP-seq peaks. 
(D) Table showing (left to right) the total number of read pairs generated for each HiChIP library, the per cent of 
reads mapped, the number of interaction pairs and read pairs that map to them, and the final number of CTCF-
CTCF loops called in cis. 
(E) Bar plots showing the percentage of all CTCF-CTCF loops detected by HiChIP that do not change (“static“), 
change only on one end (“one anchor static“) or are only seen in proliferating or senescent HUVEC and IMR90 
(“unique“). The number of loops detected per cell type and condition (N), and their median length (blue) are 
indicated below the graph. 
(F) CTCF-CTCF loops detected using HiChIP along representative region of different chromosomes. CTCF 
(black) and HMGB2 peak positions from proliferating (grey) and senescent HUVEC/IMR90 (green) are shown 
aligned to Refseq gene models, and CTCF loops (colour-coded for intensity; PETs). 
(G) Bean plots showing changes in mRNA levels of genes (log2 fold-change) with 10-kbp of CTCF loops that do 
not change (“static“) or change only on one end (“one anchor static“). The number of genes associated with each 






Page | 85  
 
Supplemental Tables 
Table 3.1.S4 (related to Figures 3.1.5 and 3.1.7). List of primers used in HMGB2/CTCF ChIP-qPCR 
experiments. 
Location (hg19) Primer pair ID Forward primer   Reverse primer 
HMGB2 primers    
chr10: 92671441-
92671590 
#1 ATGCGGGTTTACCATGCAGA GGCCGAGAGCCATAAAGACA 
chr1: 205091401-
205091550 
#2 TCAGACTCCGCAGGAAAGGT AAGTACGCGCCTTGGTGAG 
chr1: 205091401-
205091550 
#2 TCAGACTCCGCAGGAAAGGT AAGTACGCGCCTTGGTGAG 
chr15: 39890983-
39891451 
#4 CATACAATAAAGGTGGTGCCAG TTCAGGAGCTTAATACTGGAGGC 
chr20: 43229526-
43229628 
#8 GACACGCTCAATAGGCTGAGT GGGCTCTTATCCTTTCCCGA 
chr7: 135242558-
135242707 
#9 GCCTTTTGTACGCCTGGGA ACCTGAGCGAAGCCTGAAC 
chr10: 12085032-
12085261 
#11 TGAGTGCCATTCACTTAACAGC GCTGGTAGTGGCTACCTTACG 
chr1: 54304149-
54304338 
#12 TCTGGCGACCAAACGGTCC ATTCCTCCTACTTCCTCTCAGGG 
chr1: 71546764-
71546943  
#13 CCTGACTCGCGCCTACTACT CTGGACAACAACGTACAAGCTG 
chr3: 197676616-
197677150 
#3 TCAGTGCGAAGCCGATTTCC AACATCTTTCGACTCCGCCC 
chr3: 197676616-
197677150 
#3 TCAGTGCGAAGCCGATTTCC AACATCTTTCGACTCCGCCC 
chr12: 110841451-
110841950 
#5 GGTCCATCGGGTCCACAC CACCTGAAAAGGACCACGAC 
chr12: 110841451-
110841950 
#5 GGTCCATCGGGTCCACAC CACCTGAAAAGGACCACGAC 
chr14: 89290652-
89291101 
#6 CCAGGGGCAGGTGTCTAACT GCTTGCCTAAACTTGGTTGGA 
chr14: 89290652-
89291101 
#6 CCAGGGGCAGGTGTCTAACT GCTTGCCTAAACTTGGTTGGA 
chr4: 145598489-
145598788 
#7 TCTCTGGAGCCAAGGACAGA ACAACACCTCGATTTCCCCT 
chr17: 45000353-
45000542 
#10 CCTTCTCCGATCTCGCAACC CCTTCCGGTTTCCGGCTTC 
CTCF primers    
chr12: 58934310-
58934609 
CTCF_1 CTGGGGTTGAGGGATGCAAA AAGTGCAGTAGTGAACCAGCA 
chr2: 231024897-
231025196 
CTCF_2 ATCTTCCTCCCCTTCAAAGCC CTCCAGAGACGGAAAGGAATTG 
chr2: 113587071-
113587195 
IL1B ACTACCAGTCCTGACTCCCT GCCACCGAAGACTATCCTCC 
chr7: 22770135-
22771841 
IL6 TG  CAATAACCACCCCTGACC      AGCTGCGCAGAATGAGATG 
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IL8 GTGTCCTCCACAGAATGTTGG TCCAGCTATGCTAAAGCGCA 
chr12: 58934310-
58934609 
CTCF_1 CTGGGGTTGAGGGATGCAAA AAGTGCAGTAGTGAACCAGCA 
chr2: 231024897-
231025196 
CTCF_2 ATCTTCCTCCCCTTCAAAGCC CTCCAGAGACGGAAAGGAATTG 
chr19: 4139796-
4140095 
CTCF_4 AGAAGATTTCCGGCAGAGGAG CCTGGTTTCTCAGCTCCCATT 
chr1: 203141394-
203141693 
CTCF_5 GGTAAGCATCCTGGGCACTC AGGGGGAGACAGAGAGTCAG 
chr11: 73336782-
73337081 
CTCF_6 GGAAGTAATGCCTCTCGCCT CTCCATCTGGCTCTTCTGCT 
chr1: 23823644-
23823893 
CTCF_7 AACAGTTCGAGTGGTCAGGG AGTGGTTGTGTTGACCCAGT 
chr6: 136965421-
136965570 
HMGB/CTCF _10 CCTGTAGGACACACCACAAGG TGCTGTTTTCCCTGATTCCCA 
chr10: 92671441-
92671590 
HMGB/CTCF _4 ATGCGGGTTTACCATGCAGA GGCCGAGAGCCATAAAGACA 
chr19: 1848761-
1848910 
HMGB/CTCF _5 GGGCCCGCTATTACTCATTTG CCAGGTTTAAGGCCACCTCC 
chr1: 205091401-
205091550 
HMGB/CTCF _6 TCAGACTCCGCAGGAAAGGT AAGTACGCGCCTTGGTGAG 
chr11: 66206561-
66206710 
HMGB/CTCF _7 ATCTGCTGCACACGGTGATA ACAGCATGTGAGGAACAGAGAG 
chr2: 74619201-
74619350 
HMGB/CTCF _9 GGGAAGCCGATTAGGACCAT TGCAAATAAGTCCTCCAGCCC 
chr5: 142078622-
142078921 
HMGB/CTCF_11 TGGACTGCACTTTCCACTACC AAGCCTTGCAGACTCCCATC 
chr10: 92671421-
92671670  
HMGB/CTCF_14 ATGCGGGTTTACCATGCAGA GGCCGAGAGCCATAAAGACA 
chr13:27825572-
27826096 
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3.2 Chapter II –HMGB1 as a rheostat of chromatin topology and RNA homeostasis on the 
path to senescence  
 
This project was conceived and coordinated by Dr. A. Zirkel, Dr. M. Nikolic and Dr. A. Papantonis. The 
manuscript was written by Dr. A. Papantonis. I was involved in the majority of the experimental procedures 
and I fully undertook the project after the departure of by Dr. A. Zirkel, Dr. M. Nikolic. 
My contribution for this manuscript includes the following experimental procedures 
 Culturing the IMR90’s and HUVECs to replicative senescence and performing the senescence-associated 
assays. 
 Preparing the samples and performing the Western blots, qRT-PCRs and immunofluorescence stainings 
 Knock-down of HMGB1 and downstream applications (RT-PCR, Western blots, Immunofluorescence 
stainings) 
 Optimizing and performing the Chip-seq targeting CTCF, HMGB1 and HMGB2 
 Co-immunoprecipitation of HMGB1 followed by Western blot or mass-spectrometry 
 
The following figures and tables were summarized and prepared by A.Z, M.N and A.P using data resulted 
from my experimental procedures: 
 Figure 3.2.1C: Characterization of the protein levels of multiple protein in 4 different passages from 
proliferative to the senescent state 
 Figure 3.2: Identification of HMGB1 binding sites and mapping in respect to the Hi-C maps generated by 
A.Z and M.N 
 Figure 3.4A: The interactive proteome of HMGB1 is consisted of multiple RNA binding proteins 
 Figure 3.5A-D: Knockdown of HMGB1 is linked with senescence-associated GO terms 
 Figure 3.5E-F: HMGB1 is a bona fide RNA binding protein controlling the splicing events in multiple 
genes associated with senescence 
 Figure 3.S3: HMGB1 binding sites are associated with the binding motifs of senescence associated protein 
factors surrounding genes relevant to senescence 
 Figure 3.S5F: Comparison of HMGB1 binding sites and the differential expression analysis of RNAseq 
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Spatial organization and gene expression of mammalian chromosomes are maintained and 
regulated in conjunction with cell cycle progression. This link is perturbed once cells enter senescence. The 
highly abundant HMGB1 protein, known to associate with bent and looped DNA, is actively depleted from 
senescent cell nuclei to act as an extracellular proinflammatory stimulus. Despite its physiological 
importance, we still lack understanding of the positioning and functional roles of HMGB1 on chromatin in 
vivo. To address this, we mapped HMGB1 binding genome-wide in different primary cells using a tailored 
protocol. We then integrated ChIP-seq and Hi-C data with a knot theory approach to uncover HMGB1 
demarcation at the boundaries of particular topologically-associating domains (TADs). These TADs harbor 
genes involved in the key proinflammatory leg of the senescent transcriptional program. Moreover, we used 
sCLIP and siRNA-mediated knockdown to show that HMGB1 is a bona fide RNA- binding protein also 
affecting splicing choices. Together, our findings highlight a broader than hitherto assumed role for 
HMGB1 in chromatin homeostasis connected to cell cycle potency, and allow us to postulate a “rheostat” 
model for HMGB function with implications in cancer biology. 
 
Keywords: 3D chromatin folding; replicative senescence; chromatin loop; RNA binding; splicing; single 












The high-mobility group box 1 (HMGB1) protein, a member of the highly conserved non-histone 
DNA binding HMG protein family, was named after its characteristically rapid electrophoretic mobility 
(Štros, 2010). HMGB1, together with histone H1, are the next most abundant proteins after core histones, 
with one HMGB1 molecule for every ~10 nucleosomes (Thomas and Stott, 2012). Despite its documented 
abundance in cell nuclei, HMGB1 (also known as an “alarmin”) has been predominantly studied in vivo as 
an extracellular signaling molecule (Lohani and Rajeswari, 2016; Bianchi et al, 2017). HMGB1 is actively 
secreted by activated monocytes and macrophages to signal tissue damage, and passively released by 
necrotic and damaged cells. Once received by cells, HMGB1 molecules can be recognized with high 
affinity by RAGE receptors to potently signal inflammation (Scaffidi et al, 2002; Bonaldi et al, 2003; 
Orlova et al, 2007). In cells entering senescence, HMGB1 relocalizes from the nucleus to the cytoplasm 
and is then secreted to stimulate NF-κB activity via Toll-like receptor signaling. This relocalization and 
secretion controls and contributes to the senescence-associated secretory phenotype (SASP) of mammalian 
cells, representing a major paracrine contributor both in vitro and in vivo (Salminen et al, 2012; Acosta et 
al, 2013; Davalos et al, 2013). 
Within proliferating cell nuclei, HMGB1 is thought to bind DNA in a nonspecific manner via its 
two HMGB-box domains, and to bend and contort the double helix – a mode of action that facilitates 
recruitment of various DNA-binding factors, like p53 (Štros et al, 2004; Štros, 2010; Rowell et al, 2012). 
HMGB1 has been studied in detail for its contribution to DNA repair (Ito et al, 2015; Mukherjee et al, 
2016), V(D)J recombination (Little et al, 2013; Zagelbaum et al, 2016) or chromatin assembly (Bonaldi et 
al, 2002), but not so much for its transcriptional role (Calogero et al, 2009). Notably, cells lacking HMGB1 
also contain reduced numbers of nucleosomes, rendering chromatin more susceptible to DNA damage, 
spurious transcription, and inflammatory activation (Giavara et al, 2005; El Gazzar et al, 2009; Celona et 
al, 2011; De Toma et al, 2014). 
HMGB1 associates with its cognate DNA sites with characteristically high “on”/“off” rates, and 
its acidic tail is important for stabilizing binding (Pallier et al, 2003; Ueda et al, 2004; Štros, 2010; Blair et 
al, 2016). However, it is now understood that HMG-box DNA-binding domains are particularly sensitive 
to commonly-used fixatives, like formaldehyde; thus, capturing them on chromatin can be challenging 
(Pallier et al, 2003; Teves et al, 2016). As a result, there exist no genome-wide datasets describing HMGB 
binding repertoires in primary mammalian cells (see http://chip-atlas.org), and our appreciation of their on-
chromatin roles remains vague. To address this, we employed here a tailored dual-crosslinking approach 
previously used to map HMGB2 binding genome-wide (Zirkel et al, 2018). We can now show that HMGB1 
binding in proliferating primary endothelial and lung fibroblast cells is far from nonspecific, while also 
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C) data from proliferating and senescent cells, HMGB1-bound positions demarcate the boundaries of a 
considerable and specific fraction of topologically-associating domains (TADs; Dixon et al, 2012; Nora et 
al, 2017). This topological contribution is eliminated upon senescence entry, and knockdown experiments 
show that HMGB1 directly controls the expression of genes central to the senescent transcriptional 
program. Critically, as HMGB1 was proposed to also constitute a bona fide RNA-binding protein (Castello 
et al, 2016), we used sCLIP (Kargapolova et al, 2017) to show it does also influence RNA splicing. In 
summary, we use senescence as a model to comprehensively characterize the multifaceted in nucleo roles 
of HMGB1 and show how these converge to underpin transition into replicative arrest by linking chromatin 
homeostasis with cell cycle progression – a link with far-reaching implications for the attenuation of 




HMGB1 nuclear loss marks senescence entry coinciding with chromatin changes 
 
To investigate the in nucleo roles of HMGB1 across cellular contexts we used primary human 
umbilical vein endothelial cells (HUVECs) and fetal lung fibroblasts (IMR90) that are of distinct 
developmental origins and have disparate gene expression programs. We defined an early-passage 
proliferative state and a late-passage senescent state by combining β-galactosidase staining, cell cycle 
staging by FACS, and MTT proliferation assays (Figure 3.2.1A). Next, we used RNAseq data from 
proliferating and senescent HUVEC and IMR90 (from two different biological donors/isolates) to look into 
changing mRNA levels of chromatin-associated factors. Changes that were convergent between the two 
cell types involved genes encoding lamin B1, various histones, centrosomal proteins, cohesin and 
condensin complexes, as well as HMG family proteins, most of which were consistently suppressed upon 
senescence entry, also at the protein level (Figure 3.2.1B,C; Davalos et al, 2013; Shah et al, 2013; Rai et 
al, 2014; Zirkel et al, 2018). Here, we chose to focus on HMGB1 due to its high nuclear abundance (Thomas 
and Stott, 2012; Figure 3.2.1D) and key role in SASP induction (Davalos et al, 2013), but mostly due to 
its still elusive on- chromatin functions, especially as regards spatial chromatin folding. 
HMGB1 immunodetection in early- and late-passage cells documented a >50% decrease in its total nuclear 
levels in senescence-entry cell populations of HUVECs or IMR90 (Figure 3.2.1E). However, HMGB1 
nuclear depletion was most dramatic in the enlarged nuclei of senescent cells of either cell type, while 
smaller nuclei remained largely unaffected. FACS-sorting IMR90 based on light scattering allowed 
enrichment for cell populations with enlarged nuclei (i.e., ~70% of cells had larger than average nuclei, 
with >35% being >1.5-fold larger than the average nucleus of a proliferating cell; Figure 3.2.S1A). This 
showed that, within such heterogeneous populations, enlarged nuclei almost invariably represent senescent 
cells lacking HMGB1 and concomitantly exhibiting a drop in H3K27me3 levels that mark facultative 
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showed that it is those larger cells that secrete HMGB1, but not HMGB2, into their growth medium to 




Figure 3.2.1. Senescence entry affects chromatin-binding factors in primary human cells. 
(A) Proliferating and senescent IMR90 and HUVECs were tested for β-galactosidase activity (left), cell cycle 
progression via FACS (middle), and proliferation rates via MTT assays (right). 
(B)  Heatmaps show gene expression levels (FPKM; left) and fold-change upon senescence (log2; right) of selected 
genes encoding chromatin-associated factors. 
(C)  Western blots show changing protein levels in IMR90 and HUVECs on the path to senescence. 
(D) Super-resolution (gSTED) imaging of HMGB1 distribution in proliferating HUVEC nuclei. Bar: 2μm. 
(E)  Representative immunofluorescence images of IMR90 and HUVECs show reduced HMGB1 levels in enlarged 
senescent nuclei (left), and bean plots quantify this reduction (right; N indicates the number of cells analyzed per 
each condition/cell type). Bars: 5 μm. 
 
 
Regulated HMGB1 nascent transcription in single cells 
 
Since senescence entry is idiosyncratic to each individual cell and occurs asynchronously in a given 
cell population, it is important to obtain a single-cell understanding of the transcriptional changes linked to 
the nuclear loss of HMGB1. To this end, we developed a new protocol for single-cell sequencing of nascent 
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of their long poly(A) tails (See et al, 2018). To capture nascent RNA, we decided to add poly(A) tails to 
any RNA associated with an active site of transcription. We employed the previously- introduced “factory” 
RNA-seq protocol (Caudron-Herger et al, 2015) as a basis for isolating intact nuclei rich in nascent 
transcripts from both proliferating and senescent HUVEC. We next removed most chromatin not attached 
to active transcription sites, and polyadenylated nascent transcripts in situ, before a standard library 
preparation via a 10X Genomics platform (overview in Figure 3.2.S2A). Using this new approach, and 
despite low rates of non-duplet capturing (see Methods for more details), we obtained >550 single nuclei 
with an average of 1,650 transcripts in each nucleus, >55% of which represented introns or intron-exon 
junctions. Unsupervised t-SNE clustering of single-nucleus transcriptomes grouped all senescent cells in a 
single cluster, while subdividing the larger proliferating HUVEC population into three clusters (Figure 
3.2.S2B). Reassuringly, genes differentially-expressed amongst proliferating and senescent clusters 
associated with GO terms relevant to senescence entry and SASP induction (Figure 3.2.S2C). 
Mapping nascent RNA levels of individual gene loci onto those clusters, showed that HMGB1 and 
HMGB2 are actively repressed not only in senescent cells, but also in numerous proliferating cells; the 
senescence-induced HMGA1/A2 loci strongly produce nascent RNA in senescent cells, but are markedly 
upregulated also in proliferating cells showing lower HMGB1/B2 transcription (e.g., in cells of the blue 
cluster; Figure 3.2.S2B). As expected, SASP-related genes like IL4R and MMP14 show strong 
transcription in cells repressing HMGB1/B2, while the p21-encoding locus, CDKN1A, has most nascent 
RNA detected in the senescent cluster (Figure 3.2.S2D). Notably, correlating HMGB1 and HMGB2 levels 
in senescent cells confirms that switching off the latter locus is an early event on the path to senescence (as 
recently proposed; Zirkel et al, 2018), and this trend is already obvious in proliferating cells (Figure 
3.2.S2E). Similarly, correlating HMGB1 levels with those of CDKN1A, HMGBA1 or IL4R, all of which 
are activated upon senescence entry, we observed that their hyperactivation mostly occurs in those cells 
where HMGB1 nascent RNA production is diminished (Figure 3.2.S2E). 
 
HMGB1 binds active chromatin loci in a cell type-specific manner 
 
Capturing HMGB proteins bound to chromatin has proven challenging, because their tandem 
HMG- box DNA-binding domains are not compatible with standard formaldehyde fixation (Pallier et al, 
2003; Belmont et al, 2015; Teves et al, 2016). Here, we employed a tailored fixation strategy in ChIP assays 
to efficiently capture HMGB1 bound to its cognate sites genome-wide in both proliferating HUVECs and 
IMR90 (Figures 3.2.2A and 3.2.S3A; see Methods for details). HMGB1 ChIP-seq peaks were 
predominantly found at the promoters and gene bodies of active genes (>75% and >65% of 810 and 593 
peaks in HUVECs and IMR90, respectively; Figure 3.2.2B), overlapping regions marked by H3K27ac and 
oftentimes H2A.Z (Figure 2.2.2C). HMGB1 peaks were often found clustering along chromosomes of 
proliferating cells (Figure 3.2.S3B), but as HMGB1 mostly binds active loci, and HUVECs have a gene 
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It is noteworthy that none of these peaks mark SASP-related genes, despite HMGB1’s role in 
proinflammatory stimulation. 
De novo motif discovery in accessible “footprints” within DNase I-hypersensitive sites (derived 
from ENCODE data) overlapping HMGB1 peaks revealed rather specific CG-rich motifs, which do not 
however converge into a single consensus sequence (Figure 3.2.S3D). We also surveyed these same 
accessible footprints for known transcription factor (TF) motifs to infer possible co-binding complexes or 
complexes that might replace HMGB1 on senescent chromatin. We found that HMGB1 binding sites are 
significantly enriched for E2F-family motifs, which are notably down-regulated upon senescence entry. 
Also, motifs for senescence-activated corepressors (e.g., REST and HEY2) and for the architectural 
ZBTB7B protein that is important for inflammatory gene activation (Nikopoulou et al, 2018) are also 
enriched therein (Figure 3.2.S3E). Last, we combined RNA-seq with HMGB1 ChIP-seq data to catalogue 
differentially-expressed genes in either cell type that are directly regulated upon HMGB1 loss in 
senescence. In both HUVECs and IMR90 we find >2-fold more up- rather than downregulated genes bound 
by HMGB1 (Figure 3.2.S3F). These senescence-induced genes are involved in ECM organization, 
regulation of apoptosis, as well as with NOTCH-/TGFβ-signalling that is now understood to represent a 
second “wave” of paracrine signalling in senescent cells (Hoare et al, 2017). On the other hand, 
downregulated genes in both cell types converge to cell growth and cell cycle regulation (Figure 3.2.S3F). 
Together, this data demonstrates how HMGB1 nuclear eviction regulates a critical leg of the program 











Figure 3.2.2. HMGB1 binds active genes and demarcates a subset of TAD boundaries. 
(A) Genome browser views showing HMGB1 ChIP-seq signal at the KMT2A promoter in HUVEC and IMR90 
(black); input tracks (grey) provide a negative control. 
(B)  Bar graphs show the genomic distribution of HMGB1 binding peaks in HUVEC and IMR90. The number of 





Page | 95  
 
(C)  Line plots show the distribution of H3K27ac (magenta), H3K27me3 (light blue), H2A.Z (green), and CTCF 
ChIP-seq signal (grey) in the 10 kbp around all HUVEC HMGB1 peaks. 
(D) Exemplary Hi-C heatmap for a sub region of HUVEC chromosome 10 aligned to HMGB1 ChIP-seq shows 
signal peaks (magenta) at TAD boundaries (orange triangles). 
(E)  Pie chart (top) shows the fraction of HUVEC HMGB1 peaks residing at TAD boundaries. Line plots (below) 
show the mean distribution of HMGB1 (green) and CTCF ChIP-seq signal (grey) in the 5 kbp around HMGB1- 
or CTCF-marked boundaries. 
(F)  Line plots show the mean distribution of HMGB1 (green) and CTCF ChIP-seq signal (grey) along all TADs 
±20 kbp from proliferating or senescent HUVECs (left) and IMR90 (right). 
(G) Heatmaps show mean Hi-C signal from proliferating (top row) or senescent/proliferating HUVEC (bottom row) 
in the 0.4 Mbp around all HMGB1 peaks (left) or those at TAD boundaries (right). N indicates the number of 
peaks in each subgroup. 
(H) As in panel C, but for TADs that remain unchanged (top left), shift one boundary (top right), merge together 
(bottom left), or break up upon senescence entry (bottom right). N indicates the number of TADs in each 
subgroup. 
(I)  Heatmaps show focal Hi-C interactions between HMGB1-bound peaks from proliferating HUVEC (left) and 
their loss upon senescence entry (middle); HUVEC CTCF loops provide a positive control (right). Median sizes 




HMGB1 demarcates a particular subset of senescence-regulated TAD boundaries 
 
The boundaries of TADs represent genomic sites of strong local insulation of spatial interactions, and are 
often marked by the presence of CTCF and/or active gene promoters (Dixon et al, 2012; Nora et al, 2017). 
We recently showed that a considerable number of TAD boundaries in proliferating human cells are marked 
by HMGB2, and this demarcation is lost upon senescence entry leading to the formation of senescence-
induced CTCF foci (Zirkel et al, 2018). Based on this, we reasoned that HMGB1 might also function 
similarly Hi-C data from proliferating and senescent HUVEC to investigate this. First, we found that >20% 
of the 810 HMGB1 peaks reside at TAD boundaries (called at 25-kbp resolution; Figure 3.2.2D,E). 
Remarkably, and much unlike HMGB2, we identified TAD boundaries marked by HMGB1, but lacking 
CTCF (and the converse; Figure 3.2.2E). As expected, TADs of senescent nuclei lose this demarcation 
(Figure 3.2.2F), and HMGB1-marked boundaries exhibit an obvious loss of insulation and rearrangement 
of spatial interactions (Figure 3.2.2G). Next, we grouped TADs according to whether or not their 
boundaries change upon senescence entry. We found that the ~1,000 TADs remaining invariant in 
senescence, boundaries are more enriched for CTCF rather than HMGB1 binding. CTCF and HMGB1 
demarcation is comparable in TADs shifting one boundary or collapsing into a larger TAD (~5,500 TADs 
in total; Figure 3.2.2H). Thus, we postulate that the loss of HMGB1 in senescence contributes to the 
remodeling of TADs. Last, we asked whether HMGB1 engages in long-range loop formation; the 810 
HMGB1-bound genomic sites give rise to >600 interchromosomal loops, which appear to collapse upon 
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Spatial TAD co-association reveals functional chromosome compartmentalization 
 
It is now understood that human chromosomes undergo large-scale changes upon replicative arrest 
(Zirkel et al, 2018), which are accentuated in “deep” senescence (Criscione et al, 2016). Looking at TADs 
as building blocks of chromosomes (Sexton and Cavalli, 2015), one can ask how these might spatialuly 
associate to give rise to “meta-TADs” (Fraser et al, 2015) and ultimately to diverse functional topologies. 
To address this question, we employed a bias-free and unsupervised approach based on “topologically-
intrinsic lexicographic ordering” (TiLO; Johnson, 2014), whereby TADs are treated as nodes in a clustered 
spatial network tested for robustness via iterative network slicing (see Figure 3.2.3A and Methods for 
details). By applying this to TADs derived from proliferating and senescent HUVEC Hi-C data, we found 
that there is a marked increase in clusters that include multiple consecutive TADs in senescence, indicative 
of TAD merging (Figure 3.2.3B,C). This is consistent with the observation of general spatial chromatin 
compaction in senescence (Criscione et al, 2016; Zirkel et al, 2018) and with the fact that ~75% of TADs 
merge in senescence (Figure 3.2.2G). However, we also identified individual (“singular”) TADs typically 
positioned between multi-TAD clusters (Figure 3.2.3C, arrows). Strikingly, the boundaries of singular 
TADs were strongly marked by HMGB1, compared to the extremities of clusters comprised of >3 
consecutive TADs (Figure 3.2.3D). To assess the functional impact of this, we investigated expression 
level changes of genes embedded in different cluster types. Both singular TADs and TADs with >3 
consecutive TADs harbor genes significantly more upregulated that those in all other TADs, but singular 
TADs also show significantly more modest gene downregulation (Figure 3.2.3E). Notably, these two 
subsets harbor most of the genes differentially-regulated upon senescence entry. What further discriminates 
these clusters functionally, is the fact that multi-TAD clusters uniquely harbor genes involved in the 
regulation of chromatin organization and conformation, while those unique to singular TADs associate with 
SASP production and its downstream effects (Figure 3.2.3F). Thus, TiLO identifies functional entities that 
involve spatial co-association of multiple TADs in cis, explaining the functional specialization of different 
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Figure 3.2.3 HMGB1 marks individual TADs harboring SASP-related genes. 
(A) Overview of TiLO. TADs in each HUVEC chromosome are treated as nodes in an interacting network and inter-
TAD interaction strength is used to infer network connections. These connections are then sliced and network 
robustness is assessed iteratively; the final network clustering is determined once the minimum number of TAD 
clusters is reached. 
(B)  Bar plots show the number of TADs contained in clusters of 1 or more TADs derived using TiLO on proliferating 
(grey) and senescent HUVEC Hi-C data (green). *: P<0.01; Fisher’s exact test. 
(C)  Illustration of TAD clusters identified using proliferating (left) and senescent HUVEC Hi-C data (right) from 
chromosome 17. Each sphere represents one TAD; the most 5’/3’ TADs are indicated by purple and yellow dots, 
respectively; arrows indicate “singular” TADs. 
(D) Line plots show the mean distribution of HMGB1 (green), CTCF (grey), and H3K27ac ChIP-seq signal (magenta) 
at the extremities of all clustered TADs (±20 kbp; top), of clusters of >3 TADs (middle), or of “singular” TADs 
(bottom; as those indicated in panel C) from proliferating HUVECs. 
(E)  Box plots show the (log2) fold-change in mRNA levels of senescence-regulated genes embedded in the three 
cluster categories from panel D. The median fold-changes in expression and the numbers of genes in each plot are 
also indicated. *: P<0.01; Wilcoxon-Mann-Whitney test. 
(F)  Heatmaps show GO terms/pathways associated with differentially-expressed genes in the three cluster categories 
from panel D. Chromatin organization- and SASP-related GO terms are highlighted (grey rectangles). 
 
 
HMGB1 directly binds and regulates senescence-relevant transcripts 
  
On top of its known ability to bind chromatin, HMGB1 was recently also classified as a bona fide 
RNA- binding protein (Castello et al, 2016; Trendel et al, 2018). Thus, its loss in senescence could also 
affect some aspect of RNA metabolism. Our suspicion was reinforced by cataloguing the proteins that co- 
immunoprecipitate with HMGB1 from proliferating IMR90 using mass spectrometry. This returned a 
diverse range of RNA-binding proteins and splicing regulators, in addition to the expected proteins involved 
in the regulation of chromatin conformation (Figure 3.2.4A). 
To study HMGB1 as a direct RNA binder and regulator, we performed sCLIP (Kargapolova et al, 
2017) in proliferating IMR90 in two well correlated biological replicates (Figure 3.2.S4A-C). These two 
datasets provided a compendium of 1,773 binding peaks on 866 different transcripts (e.g., ASH1L and 
CCNL2; Figure 3.2.4B and Table S1), which reassuringly display <25% overlap to HMGB1-bound genes 
in ChIP-seq. On RNA, HMGB1 was mostly found bound to exons and 5’/3’ UTRs, but also to a substantial 
number of non-coding RNAs (Figure 3.2.4C). These HMGB1 RNA-binding sites present a hexameric 5’- 
NMWGRA-3’ (M=A/C, W=A/T, R=A/G) motif, irrespective of the predicted folding of the underlying 
RNA or the exclusion of repeat sequences from the genome build used for motif analysis (Figures 3.2.4D 
and 3.2.S4D). Much like the trend observed in ChIP-seq data, HMGB1 was found bound to ~3-fold more 
transcripts that are up- rather than downregulated upon senescence (Figure 3.2.S4E, left). Upregulated 
transcripts associated with senescence-relevant GO terms like “ECM organization”, “wound healing” and 
“negative regulation of cell proliferation”, while downregulated ones mostly converged on processes like 
RNA splicing, RNA-/miRNA-mediated gene silencing, or histone remodeling and deacetylation (Figure 
3.2.S4E, right). This suggests a feedback loop whereby transcripts encoding RNA regulators are affected 
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We next examined how splicing patterns are altered upon senescence entry by IMR90 using 
Whippet (Sterne-Weiler et al, 2018). We documented significant changes involving ~4,000 transcripts, the 
majority of which concerned the use of alternative transcription start and polyadenylation sites (>80% of 
cases; Figure 3.2.4E). Interestingly, looking at the splicing changes involving 342 HMGB1-bound 
mRNAs, this trend remained invariant (Figure 3.2.4E). Finally, we asked whether transcripts undergoing 
different types of splicing changes are involved in different functional processes. GO term analysis revealed 
that transcripts with alternative TSS usage encoded regulators of ECM organization and growth control, 
whereas those with alternative poly(A)-site usage encoded mostly splicing and RNA processing factors; 
HMGB1-bound transcripts, however, associated with functions from the whole of this spectrum (Figure 
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 Figure 3.2.4. HMGB1 binds specific mRNAs and affects splicing choices. 
(A) Scatter plot (left) shows proteins from proliferating IMR90 co-immunoprecipitating with HMGB1 (orange dots) 
compared to IgG controls. HMGB1 interactors associate with GO terms/pathways illustrated in the network analysis 
(right; node size refelcts the number of proteins it includes). 
(B) Genome browser views showing HMGB1 sCLIP signal (black) along the ASH1L and CCNL2 IMR90 loci; input 
tracks (grey) provide a negative control. *: significantly-enriched peak. 
(C) Bar graphs show genomic distribution of HMGB1 RNA-bound peaks (log2 enrichment) from proliferating 
IMR90. 
(D) Logos show consensus hexameric motifs deduced from all (top) or hairpin-embedded HMGB1 sCLIP peaks 
(bottom) using ssHMM analysis. 
(E) Bar plots show relative occurrence of differential-splicing events in IMR90 undergoing senescence or only for 
those mRNAs bound by HMGB1. The number of bound mRNAs (N) analyzed is indicated. 
(F) Heatmaps show GO terms/pathways associated with differentially-spliced mRNAs from three categories from 
panel E (TSS, poly(A), all other) or with all HMGB1-bound mRNAs (B1 CLIP). 
 
 
HMGB1 depletion underlies induction of the senescence transcriptional program 
 
It was previously demonstrated that transduction of human fibroblasts with shRNAs against 
HMGB1 sufficed to induce senescence (Davalos et al, 2013). To avoid using lentiviral vectors, we first 
treated HUVECs with a pool of self-delivering siRNAs targeting HMGB1. This led to a ~2-fold reduction 
of HMGB1 protein and RNA levels within 72 h (Figure 3.2.S5A), was accompanied by a doubling of β-
gal and p21-positive cells in the knockdown population, but only small changes in nuclear size and BrdU 
incorporation were recorded (Figure S5B-E). We subsequently turned to IMR90, where standard siRNA 
transfections allowed for a >10-fold decrease in HMGB1 levels, while also suppressing or inducing 
expression of known senescence-regulated genes (but only marginally affecting HMGB2; Figure 3.2.5A). 
“Deep” sequencing and analysis of mRNAs from HMGB1-knockdown and control IMR90 revealed ~900 
up- and ~950 downregulated genes (Figure 3.2.5B). GO term and gene set enrichment analyses showed 
that genes that were upregulated associated with the SASP and proinflammatory signalling, whilethose that 
were downregulated with changes in chromatin organization, transcriptional silencing, and the p53 pathway 
(Figure 3.2.5C,D). 
For a more precise understanding for the role of HMGB1 in these processes, we focused on genes 
differentially-regulated upon HMGB1-knockdown that also carried at least one HMGB1 ChIP- seq peak. 
This returned 44 up- and 56 downregulated genes constituting direct HMGB1 targets linked to NF-κB 
activation, and to chromatin organization or non-inflammatory signalling, respectively (Figure 3.2.S5F). 
Nonetheless, this left >850 genes in either category that could not be directly linked to an HMGB1 
chromatin-binding event. To bridge this gap, we repeated the above analysis using sCLIP binding events. 
We found 56 and 97 HMGB1-bound mRNAs up- and downregulated upon HMGB1- knockdown, 
respectively. Consistent to our previous observations, those upregulated could be linked to processes like 
ECM organization and proinflammatory activation, while downregulated ones to non-inflammatory 
signalling and the organization of chromatin (Figure 3.2.S5G). Notably, splicing changes deemed 
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essentially identical to that observed in senescence, with >60% of senescence splicing events also being 
recorded in knockdown cells (Figure 3.2.5E). These mRNAs encode factors linked to senescence-regulated 
processes like cell cycle and cell growth regulation or the p53 pathway (Figure 3.2.5F). Taken together, 
our data are in support of a model whereby HMGB1 acts both at chromatin loci and on RNA transcripts to 





Figure 3.2.5. HMGB1 knockdown induces senescence-specific gene expression changes. 
(A) Immunofluorescence (top) and RT-qPCR analyses (bottom; mean fold-change ±S.D., N=3) confirm HMGB1 
knockdown in IMR90 at the protein and mRNA levels, respectively. Bar: 5 μm. 
(B)  PCA analysis plot (top) of the two control (black) and HMGB1-knockdown replicates (green). Scatter plot 
(bottom) shows genes significantly up- (>0.6 log2-fold change; orange) or downregulated (<-0.6 log2-fold change; 
green) upon HMGB1 knockdown. 
(C)  Bar plots show the most enriched GO terms associated with the gene sets in panel B and their enrichment P-values 
(right). 
(D) Gene set enrichment analysis (GSEA) of gene expression changes in HMGB1-KD IMR90. Normalized enrichment 
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(E)  Bar plots (left) show occurrence of significant splicing events upon senescence (grey) or HMGB1- KD (green). 
Venn diagram (right) shows the overlap of these events. 
(F) Bar plots show the most enriched GO terms associated with the 761 shared differentially-spliced mRNAs in panel 




Unlike its well documented proinflammatory role, the intracellular positioning and gene expression 
control exerted by HMGB1 on mammalian chromosomes is poorly understood. Here, we were able to 
assign a multifaceted role to HMGB1 — as an on-chromatin regulator of active gene loci, and as a bona 
fide RNA-binding protein recognizing a distinct subset of transcripts. As a result, we can deduce the 
following. First, we that the loss of HMGB1 from the nuclei of senescent cells mostly triggers upregulation 
of its previously-bound target loci and mRNAs, suggesting that HMGB1 tends to act a “buffering” factor 
thereon. Second, that ~1/5 of HMGB1-bound positions mark the boundary of a TAD, and many of these 
TADs specifically harbor SASP-related genes induced upon senescence entry. Last, that the loss of 
HMGB1 correlates essentially only with alternative usage of TSS and polyadenylation sites in its bound 
transcripts. These observations come to substantiate a previous hypothesis that low nuclear titers of 
HMGB1 are necessary for the fully-fledged development of the SASP (Davalos et al, 2013). This is because 
there is a need for alleviating the regulatory effects that HMGB1 exerts on active promoters, on mRNAs 
being processed, as well as on TAD boundaries. This is a rather unique example of a regulatory circuit, 
where the programmed deregulation in one cellular compartment (the nucleus) is in direct and quantitative 
crosstalk with the signaling deployed in another (in extracellular space to initiate paracrine activation). 
Thus, the senescent regulatory program has a strong, if not hierarchical, dependency on the nuclear events 
preceding SASP deployment. 
Recently, we characterized the function of the sister protein to HMGB1, HMGB2, for the entry 
into replicative senescence (Zirkel et al, 2018). The loss of HMGB2 is an event preceding the loss of 
HMGB1, and leads to the formation of large senescence-induced CTCF clusters (SICCs). This has an 
apparent effect on the spatial architecture of chromosomes, and concomitantly on gene expression. 
Intriguingly, direct HMGB2 target loci are also typically upregulated when relieved of HMGB2 binding; 
however, this is the only similarity between the functions of HMGB1 and HMGB2. The loss of HMGB1 
does not trigger SICC formation, the same way that the loss of HMGB2 does not trigger immediate 
senescence entry. Also, HMGB1 and HMGB2 bind non-overlapping targets and also demarcate TADs in 
two distinct modes – HMGB2 marks the extremities of TADs that shift one boundary in senescence, while 
HMGB1 is mostly found at the boundaries of TADs that collapse together, in line with the overall 
compaction observed in senescent chromosomes (Criscione et al, 2016; Zirkel et al, 2018). Finally, it is 
important to note that the HMGB1 knockdown does not reduce HMGB2 levels in primary human cells, nor 
does the converse hold true, meaning that the two pathways these related factors control do not really cross 
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Interestingly, the knockdown of HMGB1 in primary lung fibroblasts exhibits differential gene 
expression patterns that are partially inversed in the same cells upon senescence entry (e.g., the negative 
regulation of RNAPII transcription is suppressed in the knockdown, but not in senescence). This hints 
towards a coordinated counter-regulation of HMGB1 effects by the rest of the program of cells entering 
senescence. This can be explained by the fact that the nuclear presence of HMGB1 is linked to favorable 
proautophagic effects that enhance cell survival and limit programmed cell death (Tang et al, 2010). This 
might also be a simple way to explain the strong overexpression of HMGB1 (and often also HMGB2) in 
various cancer types (Li et al, 2014; Zirkel et al, 2018). This overexpression seems to favor increased cell 
proliferation (Li et al, 2014), and it is only reasonable to assume that its targeting might be an effective 
anti-cancer strategy. Here, we used three lung adenocarcinoma lines to show that indeed a simple siRNA-
mediated inhibition of HMGB1 suffices for replicative arrest and cell death. However, we observed that 
the response of each of these three lines correlated inversely to their proliferation rates, suggesting that 
higher rates come with stronger addiction to HMGB1 presence. Moreover, the formation (or strengthening) 
of SICCs in these cancer cells also aligned well with their response to HMGB1 knockdown —i.e., obvious 
SICC emergence signified replicative arrest. 
  
In summary, the above allows to propose a simple model by which HMGB1 titers can be seen as a 
“rheostat” of cell cycle potency of a given cell. Primary proliferating cells maintain normal nuclear HMGB1 
levels, cells entering senescence arrest upon nuclear depletion of HMGB1, while aberrantly proliferating 
cancer cells actively overexpress HMGB1 and are addicted to it for propagation (Figure 3.2.6G). Thus, in 
a next step, elucidating the exact molecular dependencies of cancer cells to HMGB1 (and probably also 
HMGB2) nuclear overrepresentation for proliferation may lead to new ideas for combinatorial cancer 
treatments. 
 
3.2.5 Materials and Methods 
 
Primary cell culture and senescence markers 
 
HUVECs from single, apparently healthy, donors (passage 2; Lonza) were continuously passaged to 
replicative exhaustion in complete Endopan-2 supplemented with 2% FBS under 5% CO2. Cells were 
constantly seeded at ~10,000 cells/cm2, except for late passages when they were seeded at ~20,000 
cells/cm2. Single IMR90 isolates (I90-10 and -79, passage 5; Coriell Biorepository) were continuously 
passaged to replicative exhaustion in MEM (M4655, Sigma-Aldrich) supplemented with non-essential 
amino acids and 20% FBS under 5% CO2. Senescence-associated β-galactosidase assay (Cell Signaling) 
was performed according to the manufacturer’s instructions to evaluate the fraction of positively- stained 
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~5,000 cells are seeded in 96-well format plates in quadruplicates. On the next day, the medium is replaced 
with 100 ml fresh medium plus 10 ml of a 12 mM MTT stock solution (Invitrogen), and cells are incubated 
at 37oC for 4 h. Subsequently, all but 25 mL of the medium is removed from the wells, and formazan 
dissolved in 50 mL DMSO, mixed thoroughly and incubated at 37oC for 10 min. Samples are then mixed 
again and absorbance read at 530 nm. Measurements are taken at 24, 48 and 72 h post-seeding, background 
subtracted, and normalized to the 24 h time point. DNA methylation at six selected CpG islands (Franzen 
et al, 2017) was measured by isolating genomic DNA at different passages and performing targeted 
pyrosequencing (Cygenia GmbH). Finally, nascent DNA synthesis was monitored by EdU incorporation 
and subsequent labelling with Click-iT chemistry (Click-iT EdU Imaging Kit; Invitrogen). In brief, cells 
were incubated in 10 mM EdU for 7 h, fixed using 3.7% PFA/PBS for 15 min at room temperature, 
permeabilized, and labelled as per manufacturer’s instructions, before imaging on a widefield Leica 
microscope. 
 
Immunofluorescence and image analysis 
 
Proliferating and senescent cells were grown on coverslips from the stage indicated and were fixed in 4% 
PFA/PBS for 15 min at room temperature. After washing once in PBS, cells were permeabilized in 0.5% 
Triton-X/PBS for 5 min at room temperature. Blocking with 1% BSA/PBS for 1h was followed by 
incubation with the following primary antibodies for 1-2 h at the indicated dilution: mouse monoclonal 
anti-HMGB1 (1:1000; Abcam ab190377-1F3); rabbit polyclonal anti-HMGB2 (1:1000; Abcam ab67282); 
mouse monoclonal anti-HMGB1/2 (1:1000; Sigma-Aldrich 12248-3D2); rabbit polyclonal anti-CTCF 
(1:500; Active motif 61311); rabbit polyclonal anti-H3K27me3 (1:1000; Diagenode C15410069); mouse 
monoclonal anti-p21 (1:500; Abcam ab184640-GT1032); rabbit polyclonal anti- lamin B1 (1:2000; Abcam 
ab16048); mouse monoclonal anti-β-tubulin (1:1000; Sigma-Aldrich T0198- D66). Following 
immunodetection, cells were washed twice with PBS for 5 min before incubating with secondary antibodies 
for 1 h at room temperature. Nuclei were stained with DAPI (Sigma-Aldrich) for 5 min, washed, and 
coverslips mounted onto slides in Prolong Gold Antifade (Invitrogen). Note thatfor gSTED microscopy 
only, the 2C Pack STED 775 secondary antibodies (1:2000; Abberior 2-0032-052-6) were used. For image 
acquisition, a widefield Leica DMI 6000B with an HCX PL APO 63x/1.40 (Oil) objective was used; 
confocal and super-resolution images were acquired on a Leica TCS SP8 gSTED microscope with a 
100x/1.40 (Oil) STED Orange objective. For immunofluorescence image analysis, the 
NuclearParticleDetector2D of MiToBo (version 1.4.3; available at http://mitobo.informatik.uni- 
halle.de/index.php/Main_Page) was used. Measurements of nuclear immunofluorescence signal were 
automatically generated using a mask drawn on DAPI staining to define nuclear bounds. Background 
subtractions were then implemented to precisely determine the mean intensity per area of each 
immunodetected protein. Deconvolution of super-resolution images was performed using the default 
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Protein extraction and western blotting 
 
For assessing protein abundance at different passages, ~4 x 106 cells were gently scraped off 15-cm dishes, 
and pelleted for 5 min at 600 x g. The supernatant was discarded, and the pellet resuspended in 100 mL of 
ice-cold RIPA lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA 
pH 8.0, 1% NP-40, 1% sodium deoxycholate) containing 1x protease inhibitor cocktail (Roche), incubated 
for 20 min on ice, and centrifuged for 15 min at >20,000 x g to pellet cell debris and collect the supernatant. 
The concentration of the nuclear extracts was determined using the Pierce BCA Protein Assay Kit (Thermo 
Fisher Scientific), before extracts were aliquoted and stored at -70oC to be used for western blotting. 
Resolved proteins were detected using the antisera mentioned above, plus a mouse monoclonal anti-
H3K9me3 (1:200; Active motif 39286). 
 
Chromatin immunoprecipitation (ChIP) sequencing and analysis 
 
For each batch of ChIP experiments ~25 million proliferating cells, cultured to > 80% confluence in 15- 
cm dishes, were crosslinked in 15 mM EGS/PBS (ethylene-glycol-bis-succinimidyl-succinate; Thermo) for 
20 min at room temperature, followed by fixation for 40 min at 4oC in 1%PFA. From this point onward, 
cells were processed via the ChIP-IT High Sensitivity kit (Active motif) as per manufacturer’s instructions. 
In brief, chromatin was sheared to 200-500 bp fragments on a Bioruptor Plus (Diagenode; 2x 9 cycles of 
30 sec on and 30 sec off at the highest power setting), and immunoprecipitation was carried out by adding 
4 mg of a monoclonal HMGB1 antiserum (Developmental Studies Hybridoma Bank; PCRP-HMGB1-
4F10) to ~30 mg of chromatin and rotating overnight at 4oC in the presence of protease inhibitors. 
Following addition of protein A/G agarose beads and washing, DNA was purified using the ChIP DNA 
Clean & Concentrator kit (Zymo Research) and used in next-generation sequencing on a HiSeq4000 
platform (Illumina) to obtain at least 25 million reads were obtained of both sample and its respective 
‘‘input’’. Raw reads (typically 100 bp-long) were mapped to the reference human genome (hg19) using 
BWA (Li and Durbin, 2010), and the resulting .BAM files were processed using Picard tools 
(http://broadinstitute.github.io/picard/) before MACS2 software (Zhang et al, 2008) was used to identify 
signal enrichment over input. Thresholded HMGB1 ChIP-seq peaks per each cell type were annotated using 
Chipseeker (Yu et al, 2015) and are listed in Table S2A; .BAM files were used in ngs.plot (Shen et al, 
2014) for plotting signal coverage over particular genomic positions for different conditions/cell types. 
Finally, transcription factor recognition motif enrichments within DHS footprints under HMGB1 ChIP-seq 
peaks were calculated using the Regulatory Genomics Toolbox (Gusmao et al, 2014). Note that all other 
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Whole-genome chromosome conformation capture (Hi-C) and TiLO analysis 
 
Hi-C data from proliferating and senescent HUVEC were generated previously (Zirkel et al, 2018), and the 
HiTC Bioconductor package was used to annotate, correct data for biases in genomic features (Servant et 
al, 2012), and visualize 2D heatmaps with a maximum resolution of 20-kbp. For plotting insulation 
heatmaps and “loop-o-grams”, normalized interactions values in the twenty 20-kbp bins around each 
HMGB1 peak were added up, normalized to the median value in each matrix and plotted provided the local 
maxima are higher than the third quantile of Hi-C data in the matrix. All R scripts are available on request; 
HMGB1-anchored loops are listed in Table S2B. 
For Topologically-intrinsic Lexicographic Ordering (TiLO), we directly applied an algorithm from 
mathematical knot theory that makes zero assumptions about the structure, shape or number of clusters in 
the data (Johnson, 2014). In brief, topologically-intrinsic ordering was used to permutate the linear order 
of TADs (as a starting organization level in the Hi-C matrices) until a certain “robustly irreducible” 
topological condition is satisfied. Then, the “pinch ratio” algorithm is used (Heisterkamp and Johnson, 
2013) is applied to heuristically slice the network at connections between TADs were local interaction 
minima are, while also considering noise in the matrices. Finally, this analysis returns a list of TADs 
grouped into multiple clusters in cis, also via its built-in measure for network robustness defining the end-
point. 
 
Single-cell nascent RNA sequencing and analysis 
 
Proliferating (p. 4) and senescent HUVEC (p. 16) were washed once in an isotonic near-physiological 
buffer (PB) that maintains the cells’ transcriptional activity and subjected immediately to the first steps of 
the “factory RNA-seq” protocol (Melnik et al, 2016). In more detail, cell nuclei are gently isolated using 
PB+0.4% NP-40, DNase I-treated at 33oC for 25 min to detach most chromatin, pelleted and washed once 
in ice-cold PB, before polyadenylation of nascent RNA as described (Kargapolova et al, 2017). Next, 
~2,500 cells from each state were loaded onto the Chromium 10X Genomics platform for encapsulation in 
oil droplets and generation of barcoded cDNA libraries from individual nuclei as per manufacturer’s 
instructions. Despite the documented 0.8% chance of capturing a cell duplet on this platform, HUVEC 
nuclei are particularly prone to aggregation. As a result, 494 proliferating and 129 senescent single nuclei 
were efficiently captured and processed. Following sequencing on a HiSeq4000 platform (Illumina), and 
mapping to the reference genome (hg38) using STAR (Dobin et al, 2013) and filtering via UMI-tools (Smith 
et al, 2017), ~45,000 and ~60,000 reads were generated per each proliferating or senescent cell, 
respectively. Poor quality cells were excluded (i.e. cells with <300 or >5,000 expressed genes), as were 
genes expressed <10 cells. This returned 1,650 robustly captured transcripts per cell on average, with >55% 
of reads mapping to introns or exon-intron junctions, 575 genes being expressed in at least 25% of all cells, 
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were then processed and visualized using a compilation of ZINB-WaVE (ver. 1.3.4; Risso et al, 2018) and 
Seurat (ver. 2.3.4; Butler et al, 2018) for clustering and t-SNE visualization. ZINB-WaVE was used to 
create a low-dimensional representation of the gene expression matrix, and factors inferred in the ZINB-
WaVE model were added as one of the low-dimensional data representations in the Seurat object in order 
to identify cell subpopulations via a shared nearest neighbour (SNN) modularity optimization-based 
clustering algorithm as applied in the FindClusters function of Seurat. Visualization was performed using 
the t-SNE map by applying the Rtsne function on the ZINB-WaVE output. This map was integrated into 
the Seurat object and used to plot gene expression. For differential gene expression analysis between the 
clusters, we applied a combination of ZINB-WaVE and DESeq2 (Love et al, 2014), where the posterior 
probabilities that counts were generated from the negative binomial count component of the ZINB-WaVE 
model were used as observation-level weights in the estimation of regression parameters in DESeq2 (Van 
den Berge et al, 2018). Differentially-expressed genes identified via this method were filtered using a 
threshold of log2FC>±1 plus P-value<0.05 and are listed in Table S3A. 
 
HMGB1 sCLIP and analysis 
 
sCLIP was performed on ~25 million UV-crosslinked nuclei from proliferating IMR90 as previously 
described (Kargapolova et al, 2017) using the same the monoclonal HMGB1 antiserum (DSHB; PCRP- 
HMGB1-4F10) as for ChIP. Following sequencing of strand-specific libraries on a HiSeq4000 platform 
(Illumina), raw reads were mapped to the human reference genome (hg19). Consistent peaks were identified 
by overlapping intervals of peaks with a P-value <0.05 from 2 biological replicates to obtain 1773 peaks. 
This peak annotation was used to count reads uniquely aligned to each peak region using HTSeq, HMGB1-
bound transcript coordinates were retrieved via Ensembl (GRCh37, ver. 78) and annotated using HOMER 
(http://homer.ucsd.edu), while Gene Ontology analysis was performed using Metascape 
(www.metascape.org). Finally, the final merged peak list was use for de novo motif analysis using ssHMM 
(Heller et al, 2017) and significantly enriched motifs were next compared to existing RBP motifs to predict 
proteins potentially recognizing similar sequences using Tomtom (http://meme- suite.org/tools/tomtom). 
All HMGB1-bound mRNAs are listed in Table S1. 
 
siRNA-mediated HMGB1 knockdown 
 
HUVECs were seeded at ~20,000 cells/cm2 the day before transfection. Self-delivering Accell-siRNA 
pools (Dharmacon) targeting HMGB1, plus a non-targeting control (NTC; fluorescently-tagged to allow 
transfection efficiency to be monitored), were added to the cells at a final concentration of 1 mM. 
Knockdown efficiency was assessed 72 h after transfection using RT-qPCR and immunofluorescence. For 
the knockdown in lung adenocarcinoma lines and IMR90 cells, standard siRNA transfections were carried 
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Total RNA isolation, sequencing, and analysis 
 
Control and HMGB1-knockdown were harvested in Trizol LS (Life Technologies) and total RNA was 
isolated and DNase I-treated using the DirectZol RNA miniprep kit (Zymo Research). Following selection 
on poly(dT) beads, barcoded cDNA libraries were generated using the TruSeq RNA library kit (Illumina) 
and were paired-end sequenced to at least 50 million read pairs on a HiSeq4000 platform (Illumina). Raw 
reads were mapped to the human reference genome (hg19) using default settings of the STAR aligner 
(Dobin et al, 2013), followed by quantification of unique counts using featureCounts (Liao et al, 2014). 
Counts were further normalized via the ‘‘top quantile‘‘ function of RUVseq (Risso et al, 2014) to correct 
for unwanted variation, before differential gene expression was estimated using DESeq2 (Love et al, 2014). 
Genes with an FDR <0.01 and an absolute (log2) fold-change of >0.6 were selected as differentially-
expressed and are listed in Table S3B. For splicing analysis, a reference index on the basis of hg19 
annotation was first constructed, combined with all splice sites contained in the mapped RNA-seq reads. 
Raw reads were then aligned using Whippet (Sterne-Weiler et al, 2018) to the constructed index in order 
to quantify and annotate alternative splicing events. Subsequent box/bean plots were plotted using 
BoxPlotR (http://shiny.chemgrid.org/boxplotr/), and GO term/pathway enrichment plots using Metascape 




P-values associated with Student’s t-tests and Fischer’s exact tests were calculated using GraphPad 
(https://graphpad.com/), and those associated with the Wilcoxon-Mann-Whitney test using the U test 
interface (https://www.socscistatistics.com/tests/mannwhitney/Default2.aspx). Unless otherwise stated, P-

















3.2.6 Supplementary figures 
 
 
Figure 3.2.S1. HMGB1 depletion mostly occurs in enlarged nuclei. 
(A) Pie charts (top) show senescent IMR90 cell populations containing consistently larger nuclei, which can be 
enriched via FACS sorting. Bar graphs (bottom) show stratification of population by increasing nuclear size 
(compared to the population average). 
(B)  Representative immunofluorescence images of proliferating (top row) and senescent FACS-sorted IMR90 
(bottom row) show reduced HMGB1 levels in enlarged nuclei. Bar: 5 μm. 
(C)  Bar graphs show reduced mean HMGB1 (left) and H3K27me3 levels ± S.D. (right) in proliferating (grey), 
senescent (green), and FACS-sorted IMR90 (black) stratified according to nuclear size from images like those 
in panel B. N indicates the number of cells analyzed in each subgroup. 
(D) Bar graphs show mean HMGB1/B2 protein levels ± S.D. in the growth medium of proliferating (grey) or 










Figure 3.2.S2. Single-cell sequencing of nascent RNA. 
(A) Strategy for nascent scRNA-seq involves isolation of intact HUVEC nuclei, detachment of non- transcribed 
chromatin (blue) via DNase I digestion, and in situ polyadenylation of nascent RNA (red) at transcription sites 
(spheres), before processing on a 10X Genomics platform. 
(B)  t-SNE clustering of proliferating and senescent cell populations (grey oval) revealed 4 distinct clusters (blue, red, 
purple, and green; N indicates the number of cells per cluster). 
(C)  Bar graphs show (-log) enrichment P-values for GO terms associated with differentially-expressed genes amongst 
clusters in panel B. 
(D) Heatmaps show normalized expression of exemplary senescence marker genes in single cells. 
(E)  Correlation of HMGB1 expression to that of genes from panel D in single proliferating (top row) or senescent HUVEC 














Figure 3.2.S3. HMGB1 Chromatin-binding features in proliferating cells  
(A) Genome browser views showing HMGB1 ChIP-seq signal from loci in chromosomes 1, 16, and 22 of both 
HUVEC and IMR90 (black); input tracks (grey) provide a control. 
(B)  Plots show the cumulative distribution of HMGB1 binding peaks along HUVEC chromosomes 2, 6 and 9 
(green); the distributions of CTCF peaks (black) provide a reference. 
(C)  Venn diagrams show minimal overlap between HMGB1 binding peaks from HUVEC and IMR90. (D)Logos 
for the five most enriched de novo motifs discovered under accessible HMGB1 peaks. 
(D) Heatmap shows most enriched TF binding motifs under accessible HMGB1 peaks; up- (>0.6 log2- fold change; 
orange) or downregulated TFs (<-0.6 log2-fold change; green) are indicated. 
(E)  Box plots show the fold-change in mRNA levels (log2) of genes differentially-expressed upon senescence and 
directly bound by HMGB1 in HUVECs (top) and IMR90 (bottom). The most enriched GO terms associated with 
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Figure 3.2.S4. HMGB1 sCLIP controls and analysis. 
(A) Electrophoretic profiles of control (beads only; black dotted square) and HMGB1 IP (orange dotted rectangle) 
probed for RNA (top) or the HMGB1 protein (bottom) in both sCLIP replicates. The 35-kDa band of the 
molecular mass ladder is indicated. 
(B)  Electrophoretic profiles of RNA eluted from control (beads only; black dotted square) or HMGB1 IP (orange 
dotted rectangle) in both sCLIP replicates. The 112-nt band of the molecular mass ladder is indicated (red star) 
and corresponds to ~144 pg of RNA. 
(C)  Scatter plots show the correlation of sCLIP data from two independent biological replicates compared per 
binding peak (left) or per bound mRNA normalized read count (right). Spearman correlation values (R2) are 
indicated. 
(D) Output of ssHMM motif analyses of sCLIP data showing sequence probabilities for HMGB1-bound hexameric 
motifs predicted to form different structures using either the complete (top) or masked reference human genome 
(bottom; hg19). 
(E)  Box plots show fold-change in expression (log2) of mRNAs differentially-regulated upon senescence and 
directly bound by HMGB1 in IMR90 sCLIP. The most enriched GO terms associated with each subgroup and 





























Figure 3.2.S5. Effects of HMGB1 knockdown in proliferating HUVECs and IMR90. 
(A) Representative immunofluorescence images of siHMGB1-treated HUVECs show reduced HMGB1 levels 
compared to control cells (left), and bean plots quantify knockdown efficiency (middle; N indicates the number of 
cells analyzed). Bar plots (right) show normalized HMGB1 mRNA levels (± S.D.; N=2) in knockdown compared 
to control cells. Bar: 5 μm. *: P<0.01; Wilcoxon-Mann- Whitney and unpaired two-tailed Student’s t-test for bean 
and bar plots, respectively. 
(B)  Representative brightfield images of siHMGB1-treated HUVECs show elevated β-galactosidase activity levels 
compared to control cells (left), and bar plots quantify this increase (right; N indicates the number of cells 
analyzed). *: P<0.01; Fisher’s exact test. 
 
Results  
(C) As in panel A, but for LMNB1 levels (left), and bean plots quantify this (right; N indicates the number of cells 
analyzed). Bar: 10 μm. No statistically significant difference (n.s.); Wilcoxon- Mann-Whitney test. 
(D) As in panel A, but for BrdU incorporation (left), and bar plots quantify BrdU-positive cells (right; N indicates 
the number of cells analyzed). Bar: 10 μm. P=0.123; Fisher’s exact test. 
(E)  As in panel A, but for p21 levels (left), and bar plots quantify p21-positive cells (right; N indicates the number 
of cells analyzed). Bar: 10 μm. P=0.098; Fisher’s exact test. 
(F)  Line plots (left) show the mean distribution of IMR90 HMGB1 ChIP-seq signal along gene bodies of genes 
up- (orange) or downregulated upon HMGB1 knockdown (green; N indicates the number of directly HMGB1-
bound genes). Bar plots show the most enriched GO terms associated with either gene set and their enrichment 
P-values (middle/right), and those relevant to senescence are highlighted (bold). 

























3.2 Chapter III – Repurposing a small-molecule HMGB inhibitor to induce rapid 
and uniform SASPless senescence 
 
This project was conceived and coordinated by Dr. A. Papantonis. The manuscript was written 
by Konstantinos Sofiadis and Dr. A. Papantonis. I was involved in the majority of the 
experimental procedures. Natasa Josipovic performed all the bioinformatic analyses. Nadine 
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3.3.1 Abstract  
 
Cellular senescence is a state of permanent cell cycle arrest that acts as a potent tumour-suppressive 
mechanism. However, recent evidence links senescence to age-associated diseases, including to more 
permissive tumour development. A major role in this homeostatic imbalance is attributed to the 
SASP, the dynamic proinflammatory secretome of senescent cells. Fine tuning of the balance between 
senescence induction and SASP magnitude is important to counteract the development of senescence-
associated pathophysiological phenotypes. Here, we are repurposing a small-molecule anti-
inflammatory agent, inflachromene (ICM), previously described to block HMGB eviction from the 
nucleus and show that it irreversibly induces SASPless senescence within few days. This coincides 
with a blockage of autophagic flux mediated by the ICM-driven alteration of HMGB1 kinetics. 


















 Cellular Senescence is a natural barrier against the aberrant proliferation of malignant cells 
(Campisi, 2013). Although its initial definition describes a potentially beneficial process for cellular 
homeostasis, accumulating evidence render senescence a hallmark of organismal aging (López-Otín et al., 
2013). One of the major features of cellular senescence, and a key contributor to organismal aging, is the 
senescence-associated secreted phenotype (SASP), as a result of which numerous pro-inflammatory 
cytokines, chemokines, and growth factors are secreted from senescent cells (Coppé et al., 2010). The 
beneficial role attributed to the SASP involves wound healing and immuno-clearance of senescence cells 
(Watanabe et al., 2017), whereas extensive and chronic inflammation due to senescent cell accumulation 
in tissue contributes to the progression of age-related diseases and tumour development (Coppé et al., 
2010).  In fact, it was shown that targeted elimination of senescent cells either by genetic manipulations 
(Baker et al., 2011; Jeon et al., 2017) or via administration of senolytic drugs (Chang et al., 2016; Xu et al., 
2018; Yosef et al., 2016) increases health- and lifespan of mice. Thus, controlling the secretion of SASP 
factors and specifically target the senescent cells represents an era of senolytic drugs development (van 
Deursen, 2019). 
Various factors have been described as contributors of senescence induction, including the high 
mobility group proteins (HMGBs) (Davalos et al., 2013; Sofiadis et al., 2019; Zirkel et al., 2018). HMGBs 
are highly abundant in proliferating cells, but also actively evicted from the nuclei of cells entering 
senescence (Davalos et al., 2013; Sofiadis et al., 2019; Zirkel et al., 2018). In fact, the sub-cellular 
localization of HMGBs and their relative levels determine the function of these versatile proteins. Notably, 
in the nucleus of proliferative cells, HMGBs possess a dual function by acting as both architectural proteins 
capable of increasing the accessibility of transcription factors to enhance the transcriptional output (Štros, 
2010), and as regulators of nascent and mature RNAs (Sofiadis et al., 2019). Finally, for cellular senescence 
HMGB1 is actively secreted into extracellular space, where it can diffuse and bind to TLR and RAGE 
receptors acting as a key SASP factor (Davalos et al., 2013). Thus, manipulation of the sub-cellular 
localization of HMGBs could affect multiple pathways with senescence and SASP being among them.  
Recently, a small benzopyranyl tetracycle drug called inflachromene (ICM) was introduced as an 
anti-inflammatory agent blocking the translocation of HMGBs from cell nuclei by altering their post-
translational modification state (Lee et al., 2014). Increased nuclear levels of HMGBs  suppress spreading 
of microglia-mediated inflammation and ameliorate the effects of experimental autoimmune 
encephalomyelitis (EAE) and sepsis (Cho et al., 2017; Lee et al., 2014). However, the exact mechanism 
that determines the fate of HMGB1 in the absence of translocation, the subsequent diminished inflammation 
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Contrary to previous data, we report here that just a few days of ICM treatment irreversibly block 
proliferation of human primary cells and induce a homogeneous senescence-like program. We can show 
that the induction of this type of senescence is due to the global HMGB1/2 loss rather than due to a block 
of its translocation to the cytoplasm. This loss also leads to diminished autophagic flux. Furthermore, we 
show that the ICM-induced senescence (IIS) lacks SASP, due to poor HMGB1 secretion and loss of 
HMGB1-mediated paracrine signaling. We also suggest that these changes attributed to ICM are mediated 
by alterations in the chromatin architecture due to the ICM-modulation of HMGB kinetics. Taken together, 
ICM represents a useful tool for manipulating HMGB1/2 to such an extent that cancer cells addicted to 
high HMGB titers can be selectively killed by this small-molecule agent. 
3.3.3 Results 
 
ICM triggers a replicative senescence-like transcriptional program 
Inflachromene was previously reported as a selective inhibitor of HMGB nuclear eviction (Lee et al., 2014). 
We hypothesized that an ICM-mediated block of HMGBs export might prove sufficient to block or stall 
senescence induction. To test this, we obtained two distinct primary human cell types previously used in 
our senescence studies from individual donors/isolations: human umbilical vein endothelial cells 
(HUVECs; mesodermal) from two single donors and two isolates of fetal lung fibroblasts (IMR90s; 
endodermal). Surprisingly, treatment with previously reported concentrations of ICM (5 and 10 μΜ) rapidly 
arrested population growth of both cell types even after treatment for as few as three days. Since we did 
not observe cell death, we sought to decipher whether lower cell numbers were due to cell cycle arrest. We 
cultured equal number of DMSO- and ICM-treated cells and confirmed the gradual drop of proliferation 
rates (Figure 3.3.1A), which persisted even after ICM removal (data not shown). Beta-galactosidase 
staining showed positive staining in the ICM- treated cells (Figure 3.3.1B), indicating that the cell cycle 
arrest is possibly the result of ICM-induced senescence (ISS). Fluorescence-activated cell sorting (FACS) 
of cells stained with PI to differentiate for the various stages of the cell cycle showed that ICM induces an 
S-phase arrest (Figure 3.3.1C). 
Although β-galactosidase staining is extensively used as a senescence marker, it does not allow for 
a confident characterization of senescence. Therefore, we decided to interrogate the transcriptional profiles 
of IMR90s at different lengths of ICM treatment looking for a senescence signature. To this end, we used 
a previously described method that isolates RNA from the sites of active transcription and we performed 
“factory” RNA-seq (Melnik et al., 2016). We next compared this factory RNA-seq data with genes 
previously identified as differentially-expressed upon entry into replicative senescence (Zirkel et al., 2018). 
Direct comparison of the two datasets resulted a high correlation of a large number of genes between ICM-
treated and replicative senescence conditions (Figure 3.3.1D). Finally, we intersected differentially 
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We found a large number (>1100) of shared down-regulated genes (Figure 3.3.1E). Gene-ontology (GO) 
analysis of this shared gene set also generated a pronounced senescence signature (cell cycle, cell division, 







Page | 121  
 
Figure 3.3.1. ICM promotes cell-cycle in human cells 
(A) Control and ICM-treated cells were tested for proliferation rates through Celigo Image Cytometer (left) and β-
galactosidase activity (right) 
(B)  Cell cycle progression was measured by FACS analysis 
(C)  Plots showing differentially expressed mRNAs (±0.6-log2 fold change or more; Padj<0.05) after RNA-seq data 
normalization for IMR90 factory RNA three and six days and IMR90 mRNA from replicative senescence (RS).  
(D) Overlap of down-regulated genes across IMR90s treated with ICM for three and six days (left). GO analysis 
shows pathways associated with downregulated genes. Nodes containing genes involved in cell cycle, DNA 
conformation change, DNA replication, cell division are highlighted
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ICM-induced HMGB loss triggers chromatin changes 
Nascent RNA-seq from ICM-treated cells presented profiles similar to replicative senescence with both 
HMGB1 and -2 strongly downregulated. Since ICM was claimed to be a potent inhibitor of their nuclear 
export (Lee et al., 2014), we asked whether ISS induction is dependent on HMGB nuclear levels. To 
test this, we performed immunofluorescence stainings and Western blots to assess HMGB levels and 
subcellular localization at different time-points. Interestingly, both approaches showed progressive loss 
of HMGB1 and -2 from the nucleus of ICM-treated cells in sharp contrast to the initial report regarding 
ICM (Kim et al., 2018; Lee et al., 2014) (Figure 3.3.2A-B). This nuclear loss of HMGBs was 
accompanied by the emergence of key senescent markers (Figure 3.3.2B). 
We previously documented the functional versatility of HMGBs in the nucleus of proliferating 
cells and their impact on senescence entry (Davalos et al., 2013; Narita et al., 2006; Sofiadis et al., 2019; 
Zirkel et al., 2018) RNA-seq comparisons highlight a clear subset of architectural chromatin proteins 
(Figure 3.3.1E) rapidly decreasing transcriptional even upon only three days of ICM treatment. 
Similarly, western blotting confirmed that changes in the levels of different chromatin-associated factors 
coincides with the emergence of senescence (Figure 3.3.2B). We sought to find IIS is also marked by 
the previously reported hallmark of replicative senescence, the formation of senescence-induced CTCF 
clusters (SICCs) or the hallmark of oncogene-induced senescence, the formation of senescence 
associated-heterochromatin foci (SAHF) (Narita et al., 2003). Indeed, 3-day ICM treatment was 
sufficient to induce SICCs in almost half of the cell population, a phenotype that becomes almost 
uniform across cells after longer exposure (Figure 3.3.2C). Similarly, albeit to less extent, closer 
inspection of the DAPI distribution in the nucleus shows a gradual increase of a puncta formation in the 
nuclei of ICM-treated cells. Interestingly this punctuated DAPI-staining overlaps dense H3K9me3 
clusters, suggesting a clear redistribution of the heterochromatin following ICM treatment that is 
reminiscent of, but not identical to, SAHF formation (Figure 3.3.2E).  
Results 




Figure 3.3.2. ICM induces chromatin changes 
(A) Representative immunofluorescence images of IMR90 show reduced HMGB1 and HMGB2 levels in ICM 
treated cells (left) and bean plots quantify this reduction (right; N indicates the number of cells analyzed per 
condition) 
(B)  Western blots show changing protein levels in IMR90 upon ICM treatment 
(C)  Representative immunofluorescence images of IMR90 show accumulation of SICC and decrease HMG2 
levels in ICM treated cells (left) and bar plots quantify the number of cells with and w/o SICC  
(D) Representative immunofluorescence images of IMR90 show punctuated formation of DAPI and H3K9me3 
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IIS induction coincides with diminished autophagic flux 
Since ICM was recently documented to block autophagic flux (Kim et al., 2018) and our factory RNA-
seq data contain a subset of differentially-expressed genes associated to macroautophagy genes, we 
asked whether IIS induction is linked to suppressed autophagy. Whole-cell label-free proteomics 
revealed strong upregulation of autophagy-related proteins (Figure 3.3.3A). Generally, autophagy 
progression is mediated by the fusion of autophagosomes with autolysosomes to form lysosomes and 
load their cargo for degradation (Nakamura and Yoshimori, 2017). To monitor the autophagic flux we 
an LC3 dual fluorescent rerporter that senses pH changes during the transition of neutral 
autophagosomes into acidic autophagolysomes. We observed robust accumulation of LC3-positive 
signal in ICM-treated cells compared to the control population, and this signal completely disappeared 
upon longer treatment with the drug (Figure 3.3.3B). Accumulating LC3 punctae were makred by 
extensive overlap between the GFP and RFP in the LC3-positive cells indicating block of autophagic 
flux. Similarly, while total LC3 levels remained constant upon ICM treatment, the absence of oxidized 
LC3B in the western blots confirmed the absence of even bassaly-activated autophagy. To further 
confirm this ICM-mediated block of autophagy, we used a panel of different antibodies related to 
autophagy in western blots. Interestingly, the highest expression for the majority of these factors was at 
day 3, while longer exposure to ICM restored LC3 expression levels (Figure 3.3.3C). Furthermore, we 
observed strong accumulation of p62 in both western blots and immunofluorescence images, whereas 
ATG7 levels decreased upon ICM treatment and ATG5 ones remained unaffected. Finally, the 
characterized target of HMGB1 (Kang et al., 2010), Beclin 1 remained constant as also previously 
reported (Figure 3.3.3C). 
Since our data suggested ICM-mediated accumulation of LC3 signal, but no further progression 
of autophagy, we focused on p62, the major regulator of autophagosomes. Our recent work where we 
performed Clip against HGMBs revealed p62 was a direct target of HMGB1 but not HMGB2 (Sofiadis 
et al., 2019). This is in line with the characterized role of HMGB1, but not of HMGB2, in the regulation 
of autophagy. We stained ICM-treated cells with HMGB1 and p62 and observed strong emergence of 
p62 punctae specifically in HMGB1-depleted cells. In fact, the accumulation of p62 signal was 
proportional to the concentration of ICM used, but inversely correlated to HMGB1 nuclear levels. To 
gain further insight in the HMGB1-p62 interplay, we knocked-down HMGB1 and assessed the 
expression levels of several autophagy factors. Interestingly, we observed upregulation of p62 and 
mTOR, which represent upstream mediators of autophagy. Taken together, ICM induces an autophagic 
block in primary human cells by altering the levels and kinetics of HMGB1. 
Autophagy and translation share upstream effectors, and the increase of mTOR led us to 
hypothesize that blocking autophagy might lead to a subsequent lack of nutrients affecting the 
translational rates. Thus, we generated the first genome-wide ribosome profiling for replicative 
senescence, in parallel to that of IIS. However, despite the pronounced autophagy block, we did not 
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observe changes that specifically concerned translation, as any changes seen in polysome-associated 
footprints was essentially always accompanied by a respective change in mRNA abundance (Figure 
3E). Thus, with very few exceptions, any observed changes in the protein abundance in either replicative 
or ICM-mediated senescence are not controlled at the translational level. Thus, IIS can be primarily 





Figure 3.3.3. ICM autophagic flux 
(A) Mass-spectrometry show of whole lysates shows 615 proteins down-regulated upon ICM treatment 
compare to DMSO (left). GO analysis shows pathways related to these proteins. The most enriched GO 
terms associated with each subgroup and their enrichment P-values are shown. 
(B)  Representative immunofluorescence images of IMR90 show accumulation of LC3b in the ICM-treated 
cells compare to DMSO and replicative senescent IM90s. 
(C)  Western blots show changes in the protein levels of autophagic protein upon ICM treatment 
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(D) Representative immunofluorescence images of IMR90 show accumulation of p62 in the ICM-treated cells 
compare to DMSO-treated cells 
(E) Plots showing a comparison differentially expressed mRNAs (±0.6-log2 fold change or more; Padj<0.05) 
and ribosome bound mRNAs after RNA-seq and Ribo-seq data normalization for ICM treated cells, 
proliferating and senescent IMR90). 
 
IIS is strongly depleted of proinflammatory SASP  
SASP represents one of the most striking features of senescence linked to both its beneficial and 
detrimental consequences(Coppé et al., 2010). ICM was initially described as an anti-inflammatory 
agent. Since SASP represents a bona fide response of senescence, we revisited transcriptomic profiles 
of IIS and RS cells and upon closer inspection saw that despite the significant overlap of genes associated 
with senescence, there exists a large subset of genes that are upregulated in the RS- but downregulated 
in ISS-cells. These genes gave GO terms directly linked to the SASP (e.g., MAPK signaling pathway, 
TNF/NF-κB signaling, response to LPS; Figure 3.3.4A). We validated the changed expression levels of 
marker SASP genes in IIS using RT-qPCR and observed that many interleukins and other SASP genes 
were downregulated upon 6-day ICM treatment, despite cells being fully senescent (Figure 3.3.4B). 
Apart from transcriptional regulation of the SASP pathway, we assessed secretion of proinflammatory 
factors. To this end, we collected the supernatant from TNF-treated cells co-treated with DMSO or ICM, 
while RS cells were used as controls for probing cytokine arrays. Despite limited sensitivity ranges, we 
could observe changes in some factors (Figure 3.3.1C; red boxes) confirming how IIS leads to cell cycle 
arrest devoid of major proinflammatory cues that characterize the SASP.  
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Figure 3.3.4. ICM induces a SASPless senescence 
(A) Overlap of down-regulated genes and up-regulated across IMR90s treated with ICM and replicative 
senescent IMR90 respectively (left). GO analysis shows pathways associated with shared in both datasets. 
he most enriched GO terms associated with each subgroup and their enrichment P-values are shown. 
(B)  qPCR analysis (mean fold-change ±S.D., N=3)  confirm the absence of SASP emergence upon ICM 
treatment  
(C)  Cytokine array showed the levels of multiple SASP factors in TNFα+DMSO and TNFα+ICM-treated 
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ICM is potent inhibitor of cancer cell proliferation  
Nuclear loss of HMGB1 and its ensuing transcriptional changes are senescence hallmarks and represent 
an inherent antitumourigenic mechanism (Rai and Adams, 2013). However, HMGB1 is very often 
overexpressed in patient tumour specimens, and it has been suggested that its increased titers might 
result in either the enhancement of cell survival or the regulation of cell death via diverse pathways that 
include inflammation, cell proliferation, and autophagy (Nagatani et al, 2001; Kang et al, 2013). We 
focused on non-small cell lung adenocarcinoma patient-derived lines, because high HMGB1 expression 
therein is a predictor of poor patient survival. We used different lines, where cell proliferation and 
survival was significantly impaired following HMGB1-knockdown for 72 h. Interestingly, the extent of 
proliferative impediment in each line was almost proportional to its proliferation rate, with the faster 
H1975 cells arresting completely and the slower H1650 still exhibiting some population increase upon 
knockdown. Nonetheless, HMGB1-knockdown in these lines showed convergent changes in the 
expression of senescence markers like HMGB2, LMNB1, EZH2 or SMC2, which are actually 
overexpressed in correlation to HMGB1 levels in lung adenocarcinoma tumours (data from the TCGA 
cohort). Since knocking down HMGB1 in this context also decreased HMGB2 levels, and we recently 
showed that reduced HMGB2 levels result in the formation of SICCs, we examined whether such  CTCF 
clusters formed differentially in these lines. Indeed, we saw that the most affected H1975 cells exhibited 
larger and more prominent SICCs upon HMGB1-knockdown, compared to the least affected H1650 
cells that essentially displayed no SICCs; the intermediately-affected A549 presented SICCs in both 
control and knockdown cells. Thus, differences in proliferative capacity and SICC emergence correlate 
with the anti-proliferative extent of HMGB1 depletion in these cancer lines, highlighting how targeting 
HMGB1 might need to be considered in therapeutic interventions for cancer treatment. 
Results 





Figure 3.3.4. ICM induces a SASPless senescence 
(A) Dot plots show HMGB1 expression levels (in transcripts per million) across individual patient samples 
from 8 cancer types (orange) matched to levels in normal tissue (blue; all data from the TCGA). Mean 
expression (black line) and number of samples per each type (right) are shown. 
(B)  Data points show mean changes (±S.E.M.; N=3) in cell counts of control or HMGB1-knockdown H1975 
(orange), A549 (blue), and H1650 lung adenocarcinoma cells (black) over 72 h; trend lines are fitted using 
least mean square regression.  
(C)  As in panel B, but for relative proliferation rates of wild-type cells in MTT assays over 48 h. 
(D) Lung cancer cell types were tested for proliferation rates under different ICM concentration through 


















The fragile balance between the beneficial effects of senescence as a tumour suppressive mechanism 
and its detrimental ones as a source of chronic inflammation (Coppé et al., 2010) highlights the need to 
develop strategies either to directly target senescent cells or to target the magnitude of their 
inflammatory secretion. An increasing number of studies focus on the development of senolytic drugs 
in order to address this need(Childs et al., 2015; Xu et al., 2018). On the other hand, we took advantage 
of a previously developed drug that is thought to target HMGBs and, thus, their important role in 
senescence, inflammation and tumour progression. Previous studies, including ours, highlighted the 
various roles of these proteins affecting multiple pathways in the different cellular sub-compartments 
and their paracrine role in the extracellular milieu upon the entry of cellular senescence (Davalos et al., 
2013; Sofiadis et al., 2019; Zirkel et al., 2018). 
The ability of ICM to target both HMGBs offers the possibility to interfere with various cellular 
processes and assess potential outcomes. We chose to repurpose ICM for our studies in order to alter 
the kinetics of these factors and potentially the emergence of the senescent phenotype. Intriguingly, 10 
μM of ICM lead to very similar profiles to that of RS, thereby arresting cell proliferation within as few 
as 3 days. Transcriptomic analyses revealed extensive overlap between IIS and RS as regards pathways 
strongly linked to cell cycle and genome architecture regulation. Prominent factors of this latter group 
are the HMGBs, and we showed that this transcriptional shutdown is actually coupled to their decreased 
nuclear levels (in contrast to initial ICM reports). The absence of HMGBs from the IIS nuclei results in 
altered heterochromatin and lamin levels, much reminiscent of RS (Sofiadis et al., 2019; Zirkel et al., 
2018).  
However, despite general convergence, our transcriptomic comparison also showed that in IIS 
macroautophagy and SASP gene expression are up- and down-regulated compared to levels in RS, 
respectively. As previous reports showed that ICM inhibits the interaction of HMGB1 with Beclin (Lee 
et al., 2014) that would induce autophagy (Kang et al., 2010), we characterized this more to show that 
the initial cascade favouring autophagy is highly activated with the production of high levels of 
autophagosomes, perhaps precisely to compensate for the autophagy block imposed. This autophagic 
blockage coincides with the gradual loss of the HMGBs from cell nuclei and the emergence of the key 
senescent markers so we believe that the depleted autophagy is a key stimulus for IIS. Still, the main 
effect here is that this loss of HMGB1 (and HMGB2) sequesters the initiating paracrine effects that 
induce SASP in the first place. This is important, as it renders ICM a potent inhibitor capable of inducing 
cell-autonomous senescence independent of any of the side effects of inflammation. Moreover, it 
generates essentially uniformly senescent cell populations within 3-6 days that can now allow for the 
study of the core senescent program and its implementation (compared to the highly heterogeneous and 
SASP-rich RS populations). 
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 Finally, we took advantage of three lung carcinoma cell lines differentially influenced by 
HMGB1 levels to show that ICM suffices to decrease their proliferation rate an effect that is correlated 
to the expression levels of HMGB1. Thus, we further propose ICM as a selective inhibitor of aberrant 
cell proliferation through the modulation of HMGBs and without the caveats of overt inflammatory 
phenotypes. It is not impossible to then imagine ICM as a pro-senescence cancer treatment in 
combination with other chemotherapy agents, and this indeed merits further work.  
3.3.5 Materials and methods 
 
Primary human cell lines and senescence markers 
HUVECs from single, apparently healthy, donors (passage 2; Lonza) were were grown in complete 
Endopan-2 supplemented with 2% FBS under 5% CO2. Cells were constantly seeded at _10,000 
cells/cm2, except late passages that were seeded at ~20,000 cells/cm2. Single IMR90 isolates (I90-10 
and -79, passage 5; Coriell Biorepository) were grown in MEM (M4655, Sigma-Aldrich) supplemented 
with non-essential amino acids and 10% FBS under 5% CO2. Lung cancer cells were grown to RPMI 
1640 medium (Gibco) supplemented with 10% FBS. Inflachromeme was added for 3 and 6 days in 
concentrations of 5 and 10 μΜ for downstream applications. Cell proliferation was monitored by Celigo 
Image Cytometer after culturing 2000 cells for every sample in triplicates followed by 10 μΜ ICM and 
DMSO treatment for 6 days. Measurements of the cell confluency were obtained every day. B-
galactosidase assay was used followed the manufacture’s instructions (Cell signaling). 
Immunofluorescence and image analysis 
Cells were grown on coverslips from the stage indicated; they were fixed in 4% PFA/PBS for 15 min at 
room temperature. After washing once in PBS, cells were permeabilized with 0.5% Triton-X/PBS for 
10 min at room temperature. Blocking with 1% BSA/PBS for 1h was followed by incubation with the 
indicated primary antibodies for 1-2 h. Cells were washed twice with PBS for 5 min before incubating 
with secondary antibodies for 1 h at room temperature. Nuclei washed three times with PBS for 10 min 
and coverslips mounted onto slides in Prolong Gold Antifade with DAPI (Invitrogen). For image 
acquisition, a widefield Leica DMI 6000B with a HCX PL APO 63x/1.40 (Oil) objective was used.. 
LC3 stainings were performed with Premo™ Autophagy Tandem Sensor RFP-GFP-LC3B Kit 
according to the manufacturer’s instructions. 
Protein extraction and western blotting 
For assessing protein abundance at the different cell states, approx. 4 x 106 cells were gently scraped off 
15-cm dishes, and pelleted for 5 min at 600 x g. The supernatant was discarded, and the pellet 
resuspended in 100 mL of ice-cold RIPA lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM 
EDTA pH 8.0, 1 mM EGTA pH 8.0, 1% NP-40, 1% sodium deoxycholate) containing 1x protease 
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inhibitor cocktail (Roche), incubated for 20 min on ice, sonicated for 3 cycles (30 sec on, 30 sec off, 
low input) and centrifuged for 15 min at > 20,000 x g to pellet cell debris and collect the supernatant. 
The concentration of the nuclear extracts was determined using the Pierce BCA Protein Assay Kit 
(Thermo Fisher Scientific), before extracts were aliquoted and stored at -80oC to be used for western 
blotting. Resolved proteins were detected using the antisera and dilutions listed in the Key Resources 
Table. 
RNA isolation, sequencing, and analysis 
Cell of different types/conditions were harvested in Trizol LS (Life Technologies) and total RNA was 
isolated and DNase I-treated using the Direct-zol RNA miniprep kit (Zymo Research). Following, 
rRNA-depletion using the RiboZero Gold kit (Illumina), barcoded cDNA libraries were generated using 
the TruSeq RNA library kit (Illumina). The resulting libraries were paired-end sequenced to at least 50 
million read pairs on a HiSeq4000 platform (Illumina), and raw reads were mapped to the human 
reference genome (hg19) and analyzed via the QuickNGS pipeline (Wagle et al., 2015) to obtain read 
counts. Then, read counts from different single-donors/conditions were normalized using the RUVSeq 
package (Risso et al., 2014). Please note that, in our hands, normalization using either synthetic spike-
in controls or the intrinsic ‘‘top quantile‘‘function of the RUVseq package is essentially interchangeable. 
Finally, for analysis of nascent RNA in IMR90 the ‘‘factory RNA-seq‘‘approach was applied on _5 
million proliferating or ICM treated cells (Melnik et al., 2016), RNA was isolated and sequenced as 
above, and intronic read counts were obtained and differentially analyzed for the two conditions using 
the iRNAseq package (Madsen et al.,2015). All box/bean plots were plotted using the BoxPlotR tool 
online (http://shiny.chemgrid.org/boxplotr/), and GO term/pathway enrichment analyses using 
Metascape (http://metascape.org/gp/index.html; Tripathi et al., 2015). Differentially-regulated genes per 
each cell type are listed in Table S2. Ribo-seq was permormed in collaboration with RIBO-MAPS. We 




P-values associated with Student’s t-tests and Fischer’s exact tests were calculated using 
GraphPad (https://graphpad.com/), and those associated with the Wilcoxon-Mann-Whitney test 
using the U test interface (https://www.socscistatistics.com/tests/mannwhitney/Default2.aspx). 
Unless otherwise stated, P-values <0.01 were deemed as statistically significant. 
 
Discussion 




The coordinated activation and execution of DNA replication and cell division in proliferating 
cells is governed through inherent mechanisms that reassure the expansion of the cell population in a 
controlled manner. These mechanisms are also responsible for the re-establishment of the cell signature 
and the progression of the respective functions of the newly synthesized cells to preserve the normal 
homeostasis. During mitosis the chromatin folding heavily dissolves, the architectural features disappear 
and the condensed chromosomes acquire a homogeneous folding state (Gibcus et al., 2018; Naumova 
et al., 2013). The three-dimensional genomic organization immediately emerge upon the re-entry of 
daughter cells in interphase to segregate the genome in the active euchromatin and the repressed 
heterochromatin, shaping the transcriptional landscape. On the other hand, senescent cells are devoid of 
cellular division and the mechanisms underlying their genomic organization in the arrested state are still 
elusive. Up to date, multiple changes related to chromatin have been described to accompany senescence 
and whether these changes comprise cause, consequence or a concurrent event in respect to the 
emergence of the classical senescence pathways and the establishment of the cell cycle arrest is yet to 
be described. Here, we attempt to understand some of the rules shaping the genomic organization during 
senescence and particularly the events promoting the transition from the proliferating state to the arrested 
one. We are focusing to the architectural proteins, HMGB1 and HMGB2, abundantly present in the 
nucleus of growing cells, but dynamically translocated in the extracellular space during senescence and 
we describe the impact of this translocation on the chromatin folding and the transcriptional programs 
characterizing each state.  
 
4.1. The loss of HMGBs marks the entry of senescence and coincides with 
chromatin changes. 
  
Previous studies in the context of senescence provided sparse information about the behavior of 
high mobility proteins and the few reports published up to date mostly focusing on HMGAs and 
HMGB1. We showed that both HMGBs actively decrease their nuclear levels by evicting out of the 
nucleus of senescence-primed cells in a sharp contrast with HMGAs that increase their expression levels 
upon senescence and contribute to the formation of SAHF (Narita et al., 2006). We confirmed that this 
eviction contributes to the senescence-associated phenotypes as we detected HMGB1 in the extracellular 
space acting as a SASP factor, a function previously described (Davalos et al., 2013). Thus, we focused 
on the nuclear events that HMGBs dictate in the proliferating cells and the changes their dynamic 
translocation confers during the entry of senescence, a knowledge that was still missing. To study the 
role of HMGBs we took advantage of the replicative exhaustion that primary cells reach and we 
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confirmed that these cells drove into senescence after a finite number of population doublings in a donor- 
and cell type–dependent manner, showing the strong idiosyncratic nature of senescence (Lecot et al., 
2016). We employed RNA-seq and we showed that proliferating and senescent states are characterized 
by a distinct transcriptional repertoire, instructing the functional necessities of each state. Notably, direct 
comparison of the differential gene expression analysis acquired in the three cell types clearly 
demonstrated a selective up-regulation of genes involved in senescence-associated pathways (cell 
growth, p53 responses and ECM organization) and a robust down-regulation of genes involved in 
proliferating and cell cycle-associated pathways (cell-cycle regulation, replication DNA metabolism), 
recapitulating the existence knowledge regarding senescence (Narita et al., 2003). Interestingly, apart 
from the expected cell cycle associated terms, the shared down-regulation subset contained a 
significantly enriched group of proteins involving in genome architecture (DNA conformation, 
chromatin organization, and DNA packaging). The presence of this sub-group in the dataset gained our 
attention, as it implies that the genomic organization follows the general adaptation of the cellular 
homeostasis during the cellular senescence. HMGB1/2 were among the most highly affected down-
regulated genes and the fact that these proteins are highly abundant in the nucleus of proliferating cells 
to control the transcriptional output and the genome folding, rendered them interesting candidates to 
focus on. Western blots and immuno-fluorescence studies determined that their protein levels 
significantly decrease from the majority of the nuclei linearly as the cells losing their proliferating 
capacity, in a sharp contrast with the behavior of HMGA1, which robustly increase during senescence 
(Narita et al., 2006). In fact, we demonstrated that the disappearance of nuclear HMGBs coincides with 
the emergence of previously well-described markers like LAMNB1 decrease and subsequent altered 
nuclear morphology, drop of the proliferation rate and increase of p21 and positive b-galactosidase 
staining. Finally we showed that nuclear loss of the HMGB1 is due to active secretion rather than 
proteolytic degradation (at least not the absolute levels), confirming the previous characterized paracrine 
role of HMGB1 during senescence (Davalos et al., 2013).  
This dynamic change of the architectural proteins we and other groups observed is of a great 
importance, but whether these changes precede the initiation of the senescence-associated 
transcriptional profile or represent a consequence was still unclear. Since we are focusing on the early 
events of senescence the population was heterogeneous (albeit in favor of the senescence cells) adding 
more complexity to the already well-documented heterogeneity of senescent populations (Hernandez-
Segura et al., 2017). We took advantage of this otherwise obstacle and we characterized the sequence 
of the molecular events governing the entry of senescence by employing single RNA-seq from IMR90’s 
and pseudo-time course analysis of single-cell RNA-seq data and we clustered the sub-populations based 
on their expression profiles. Interestingly, we showed that the dynamic loss of HMGBs from the nuclei 
of the senescent cells precedes the emergence of key senescence markers like the loss of LMNB1 and 
the increase of CDKN1A. Analysis of the single-cell data formed a cluster of senescent cells 
characterized by the concurrent activation of SASP factors –a feature that represents a late-event of 
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senescence- and the most robust decrease of HMGB2. The single-cell analysis revealed also the kinetics 
of the two HMGBs, showing that the HMGB2 decrease precedes the one of HMGB1, while the latter 
seems to coincide with the emergence of the characteristic senescent markers and the initiation of SASP. 
Collectively, this analysis clearly demonstrated that the presence of both HMGBs is important to control 
the cellular function of the proliferating cells, however their transcriptional shutdown and their active 
decrease of their nuclear levels is a prerequisite to the emergence of characteristic senescence-associated 
features.  
Finally, we also stained the HMGBs-depleted nuclei with H3K9me3 and H3K27me3 to assess 
whether our replicative senescence cells form SAHF, but as it was previously reported the formation of 
SAHF is context dependent  and very rare if any particularly in replicative senescent cells (Kosar et al., 
2011). Nevertheless, we also observed a re-shuffling of the histone marks with a shift from facultative 
to constitutive heterochromatin, a feature that is reminiscent to the inhibitory nature of the SAHF (Narita 
et al., 2003). Taken together the decrease of the HMGBs nuclear levels represent an important early 
event of the entry to senescence that initiates genome architecture changes leading the gradual 
emergence of the senescence-associated phenotypes. It remains an open question whether the restoration 
of each HMGB or simultaneously could stall or delay the emergence of senescence and the associated 
features we observed.  
 
4.2 Genome-wide chromatin re-arrangements dictate the entry of cellular 
senescence 
  
Cellular senescence represents a complicated homeostatic mechanism that influences almost 
every aspect of the normal cellular function. Interaction profiles through Hi-C have been generated 
before in oncogene-induced senescence (Chandra and Narita, 2013) and recently in deep replicative 
senescence (Criscione et al., 2016). As it was mentioned there are caveats in both studies as the one is 
performed in a non-physiological context (OIS) and the second one focuses on the “deep” replicative 
senescence. Here, we tried to understand the events leading to senescence in a slightly different spectrum 
as we focused on how genome organization changes could potentially influence the transcriptional 
transition from the proliferating state to the senescent one, a link that was still missing. Our 
transcriptomic datasets acquired from individual proliferating and senescent human donor cells clearly 
demonstrated that the switch from a transcriptional program comprised of proliferation-associated and 
cell cycle genes to a senescent one coincides with transcriptional changes to various architectural factors, 
suggesting a potential involvement of the genome organization towards the entry of senescence. 
The increased heterochromatinization and the extensive changes in the expression levels of 
architectural proteins, prone us to generate the genome-wide interaction profile in our cell populations. 
We performed Hi-C in all the three cell types with technical and biological replicates and we efficiently 
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generated the interaction maps for both the proliferating and senescent cells in a resolution as high as 
20- kbp. These are the first generated interaction maps focusing on the dynamic events modifying the 
chromatin folding during the entry of replicative senescence. The 200-kpb-generated Hi-C maps were 
reproducible between the different donors of the same cell type, but they differ between the different 
cell types recapitulating the diversity in the epigenetic state and the intrinsic characteristics unique to 
each of these different cells types. Moreover, the fact that the interaction profiles differ among then, 
reinforces the general concept that senescence is strongly cell- and context- dependent (Lecot et al., 
2016). Nevertheless, despite the apparent cell type specific changes, our generated Hi-C maps possess 
shared properties between the different cell types and contain all the features of the high-order structure, 
allowing us to generalize some of our conclusions and link them with the entry of cellular senescence. 
The segregation of the high-order structure in A and B compartments is usually associated with 
the transcriptional competency of the genomic regions (Lieberman-aiden et al., 2009). Interestingly and 
in contrast to the study of Criscione (Criscione et al., 2016), we observed a minor switch of regions 
between A and B compartments, a finding that is quite surprising considering the transcriptional switch 
and the re-shuffling of the histone marks. A closer inspection to the study of Criscione (Criscione et al., 
2016) reveals that despite the extensive compartment switching, genes associated with senescence 
represent only a small subset (from 8 to 14%) switches from A to B and an even smaller fraction (1 to 
4%) from B to A compartments. Thus, it seems that genes associated with senescence are poised to a 
transcriptional-primed state and other than compartment switch is the main trigger for activation. 
Despite the lack of compartment switch, we did observe changes in the high-order structure, especially 
when we assess the inter- and intra-chromosomal interactions. The analysis of the inter-chromosomal 
interaction revealed that all the three cell types displayed decreased cell-type specific interactions 
indicating a less-mobile chromatin arrangement in the nuclear space. This in line with the observations 
of the oncogene-induced senescence (Chandra and Narita, 2013) but differ from the “deep” replicate 
senescence of Criscione (Criscione et al., 2016). The intra-chromosomal interactions also support the 
most compacted chromatin arrangement during replicative senescence as we showed the emergence of 
stronger long-range interactions and stronger insulation between higher-order domains. Both inter- and 
intra-chromosomal interaction-profiles are in line with the increase of constitutive heterochromatin and 
the acquired compacted structure of the chromatin during senescence. In fact, the observed loss of 
LMNB1 in our senescent cells might explain the strict structure of the senescent chromatin and resemble 
the model Chandra proposed during oncogene-induced senescence (Chandra et al., 2015). Additionally, 
this restricted configuration possibly instructs the transcriptional switch-off of the proliferation genes 
and a general stricter control of the transcriptional output similarly to SAHF formation (Narita et al., 
2003). 
Having describe the general view of the chromatin folding we sought to assess the organization 
of the genome in TAD level. As it was mentioned before, TADs generally preserve their structure during 
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changes in the cellular homeostasis even in extreme examples as the differentiation of stem cells to 
somatic (Dixon et al., 2015). Using our generated Hi-C maps and the “TADtool” software (Kruse et al., 
2016) we showed that entry of senescence is accompanied by extensive re-arrangement of TADs 
margins genome-wide (mainly shifting the boundary and fusing neighboring TADs while the separation 
of TADs was less pronounced). The resulted almost 50% in IMR90’s and MSCs, and the impressive 
70% altered TADs in HUVECs pinpoints the strong link between chromatin organization and the 
induction of senescence. Interestingly, this link is not only restricted to the structural organization, but 
also strongly attributes to the establishment of the transcriptional profile characterizing the proliferating 
or the senescent state. “Topologically-intrinsic lexicographic ordering” or TiLO (Johnson, 2014) clearly 
demonstrated the spatial clustering of functionally related TADs as the number and the identity of TADs 
comprising each cluster was highly correlated either the proliferating or the senescent state and the 
signature pathways each of these states are linked to. In fact, considering the absence of compartment 
switch in our replicative senescence model, it seems that the coordinated clustering of the TADs is the 
driving force of the expression of genes related to senescence. This is of a great importance because it 
underscores TADs not only as a self-organizing structure but also, as a functional entity capable to 
dynamically cluster in the 3D space and orchestrate the transcriptional repertoire. 
 
4.3 The nuclear loss of HMGB2 instructs the senescence associate transcriptional 
activity and induces rapid genomic re-organization 
  
High mobility group proteins are very abundant proteins in the nucleus of all our three different 
cells types. During senescence, both HMGB1 and HMGB2 decrease their nuclear protein levels and 
robustly switch off their transcriptional activity. Up to date, the function of HMGBs in the nucleus was 
focused on their role as architectural proteins in the context of transcriptional enhancement (Ueda and 
Yoshida, 2010). Their actual contribution in the genomic organization and the changes their dynamic 
eviction results to was still elusive. Although the loss of HMGBs from the nucleus and the role of 
HMGB1 as a SASP factor upon senescence was shown before, the consequences of their absence in the 
nucleus and how this contributes to the senescence state was still not described. Here, we provide a very 
comprehensive description of their nuclear role as architectural proteins by identifying their binding 
sites genome-wide circumventing their incompatibility with standard fixative methods (Teves et al., 
2016) and the hit-and-run binding fashion (Štros, 2010) by using a tailored chip protocol.  
Despite the aforementioned limitations, we managed to identify more than 1574 and 1188 
HMGB2 binding sites in proliferating HUVECs and IMR90s respectively, and 391 in senescent 
IMR90’s. Although the number of the peaks does not match their actual high abundancy in the nucleus 
of proliferating cells, it is still sufficient to provide the binding profile of these proteins and their 
associated transcriptional pathways involved. Interestingly, HMGB2’s binding sites in proliferating 
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cells reside in promoters and gene-bodies and when we searched of the relative GO terms of the 
surrounding genes both the up-and the down-regulated genes were enriched with senescence-associated 
pathways. The role of HMGB2 in proliferating cells is not only restricted in the regulation of the 
transcriptional landscape as we showed the implication of HMGB2 in the genomic organization. Namely 
a significant subset of the HMGB2 peaks resides at TAD boundaries contributing in the demarcation of 
TADs complementing the well-characterized role of CTCF (Ong and Corces, 2014). Similarly to Monte 
et al (Monte et al., 2016), our findings suggest that certain genomic sites could be occupied of either 
HMGB2 or CTCF but we showed that the is not mediated through direct interaction between the two 
proteins.  Nevertheless, the substantial HMGB2 peaks at the TAD boundaries suggest HGMB2 as a 
potent contributor in the establishment of the genome organization especially considering the persistent 
binding of HMGBs during mitosis (Pallier C, Scaffidi , Chopineau-Proust S, Agresti A, Nordmann P, 
Bianchi M, 2003).  
The binding profile of HMGB2 and the interplay with CTCF especially at the TAD boundaries 
seems to instruct the genomic organization upon the entry of senescence. Intriguingly, we showed that 
the occupancy of HMGB2 in both sides of the TAD or the reciprocal occupancy with HMGB2 on the 
one and CTCF on the other side dictate the integrity of the TADs during the entry of senescence. 
Namely, we clearly demonstrated that the demarcation of TADs by HMGB2 on both sides is sufficient 
to preserve the TAD’s integrity upon senescence-entry, whereas demarcation of TADs by HMGB2 and 
CTCF in the two side of the TADs preferentially lead to shift of the boundary in senescent cells. Taking 
into account that the majority of the HMGB2-bound genes are up-regulated upon the entry of senescence 
and the absence of A and B compartment switch, we could deduce that the HGMB2 translocation and 
the resulting changes in the TADs integrity they are bound to, are the main drivers of the emergence of 
senescence and the accompanied transcriptional switch. Especially the fact that the majority of the 
HMGB2 bound genes consist of up-regulated upon the entry of senescence and plenty of them are 
associated with relevant to senescence pathways, reinforces the interplay between HMGB2 nuclear loss, 
chromatin organization and transcriptional switch upon senescence. Interestingly despite the general 
decrease of the protein levels, we could still identify sites of persistent HMGB2 binding in senescent 
cells, however none of these peaks are overlapping with any SASP factor arguing with the findings 
observed for OIS (Aird et al., 2016). Thus, we conclude that the contribution of HMGB2 in SASP is not 
related to a direct binding on SASP genes and possibly the expression of genes represent a downstream 
target of the transcriptional alterations or the chromatin re-arrangements controlled by HMGB2. 
As it was mentioned before, the transcriptional shutdown of HMGBs and the re-arrangement of 
the genomic structure precede the increase of senescence markers implying the importance of this 
intermediate step. To gain further insight we efficiently performed HMGB2 knockdown taking 
advantage of the self-delivering siRNAs and we focused on changes of the architectural proteins. Super 
resolution and fluorescent microscopy demonstrated the crosstalk between CTCF and HMGB2, as cells 
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depleted of HMGB2-nuclear signaling promote the formation of discrete CTCF foci. This robust 
clustering of the CTCF, reminiscent of the SAHF produced in oncogene-induced senescence (Narita et 
al., 2003), was not a result of altered levels of binding on the  pre-existing  CTCF sites of formation of 
“neoCTCF” binding sites, recapitulating the mutual exclusive binding profile of the two proteins seen 
in ChIP-seq and underlining the dynamic genomic re-arrangements upon the loss of HMGB2. 
Importantly we repeated the double CTCF and HMGB2 stainings in our senescent cells and we clearly 
demonstrated a dynamic CTCF clustering in the HMGB2-depleted nuclei of senescent cells, conferring 
the CTCF clustering as a distinct feature of senescence. We went a step forward by applying Hi-ChIP, 
targeting the interacting regions bound by CTCF and we proved the loss of HMGB2-binding suffices to 
bring sites bound by CTCF in close proximity genomic and promote the clustering. Therefore, the 
formation of these senescence-associated CTCF clustering (SICC) results due to the loss of the HMGB2-
mediated local insulation on adjacent CTCF loops and highlights the pivotal role of HMGB2 in the 
genomic architecture. Finally, we demonstrated that the CTCF clustering is directly mediated by 
HMGB2 loss and not by a downstream pathway, but re-introducing the HMGB2 in the senescent cells 
and decreasing the formation of CTCF foci. Strikingly, the fact that we were not able to completely 
deplete the formation of CTCF or reverse them in later stages of senescence suggests that the formation 
of these foci is an important feature of the senescent cells and a powerful mediator of senescence 
maintenance. 
The contribution of HMGB2 to the SICC formation suggested that the absence of HMGB2 from 
the nucleus of senescent cells is one of the main drivers of the chromatin alterations and that it could 
mimic some of the features accompanying senescence. Indeed, using the self-delivering siRNAs we 
efficiently knock-down HMGB2 and generated the Hi-maps and we observe that the absence of nuclear 
HMGB2 recapitulates the results of Hi-C, highlighting that HMGB2 is the upstream effector molecule 
for the architectural changes seen. Moreover, the absence of HMGB2 promotes the 
heterochromatinization seen in Hi-C mediated by the increase of HP1a and the decrease of H3K27me3. 
Surprisingly despite the fact that the HMGB2 knockdown affected the genomic organization it was not 
sufficient to drive genes-specific transcriptional alterations but rather an overall reduction of the nascent-
RNA production. The latter finding in combination to the absence of common senescence markers (B-
galactosidase assay, cell cycle arrest) might propose that the short-term nature of the knockdown 
represent a technical obstacle to recapitulate the complete senescence-associated repertoire. 
Nevertheless, HMGB2 similarly to HMGA1 is responsible to guide the formation of high-order structure 
in the nucleus of senescent cells albeit it does it by decreasing its nuclear levels in sharp contrast with 
the increased presence of HMGA1. The model describing the impact of HMGB2 upon the entry to 
senescence and the crosstalk with CTCF is depicted in Figure 4.1. 
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Figure 4.1 Organization of senescence chromatin in SICC 
In young cells HMGB2 binds chromatin and insulates neighboring CTCF-mediated loops. This insulation is lost 
as HMGB2 decreases upon the entry of senescence resulting to CTCF clustering. 
 
4.4 HMGB1 complements HMGB1 to TAD demarcation but its nuclear loss is 
associated with distinct to HMGB1 genomic re-arrangements  
  
 The high sequence similarity of HMGB1 and HMGB2 could also reflect similar mode of action 
and functional redundancy. The trend they follow upon senescence also reflects some similarity as they 
both switch off their expression levels and dynamically decrease their nuclear protein levels.  On the 
contrary, it seems that only HMGB1 translocates out of the nucleus and increases its levels in the culture 
medium where it acts as a SASP factor. To compare the ab nucleo function of HMGBs we performed 
the tailored Chip-seq protocol similarly to HMGB2. The HMGB1 peaks were associated with gene 
promoters, active genes and H3K27ac-bound regions reinforcing its characterized role as transcriptional 
activator. Interestingly, the resulted genes do not contain any of the well-documented SASP factor 
suggesting that the contribution of HMGB1 to SASP is not mediated through direct binding on these 
genes. On the other hand, a subset of these peaks is associated with the NOTCH/TGFb signaling cascade 
which represents the second wave of the paracrine signaling (Acosta et al., 2013; Hoare et al., 2016).   
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It is worth noted, that the peaks of the two HMGBs are rarely overlapping suggesting a clear 
distinction of the pathways each protein controls. Similar to HMGB2, 21% of the HMGB1 resides in 
boundaries demarcating the TAD, but in sharp to HMGB2 contrast, these TADs are devoid of CTCF. 
Furthermore, we showed that this demarcation is lost upon the entry of senescence as we observed an 
obvious loss of the TADs insulation following the loss of the nuclear HMGB1. Although both HMGB1 
and CTCF demarcate the TADs and their loss results in architectural changes, the impact on TADs upon 
the entry of senescence is different between the two proteins, as in the case of HMGB1-demarcated 
TADs either shift their boundary or collapse into a larger TAD and these alterations are irrespective of 
CTCF binding. Taken together, while the mode of binding is similar, HMGBs differentiate their binding 
targets and the demarcation of TADs in respect to CTCF.  The latter is convincingly shown by the fact 
that the knockdown of HMGB1 does not suffice for the formation of CTCF in sharp contrast with 
HMGB2. On the other hand, HMGB1 largely associates with upregulation of genes with GO terms 
associated with SASP (IL4 and IL13 signaling pathway, positive regulation of secretion, IL17 signaling 
pathway). This finding underlines more the observation that HMGB1 leaves the nucleus with slower 
kinetics than HMGB2 and involves in the induction of SASP, a cascade that also emerges later during 
senescence. It also supports the results of the single-analysis drawing the sequence of the molecular 
events towards the entry of senescence.  
Taken all together, we were able to identify the actual sequence of the events that govern the 
induction of senescence. Initially gradual loss of HMGB2 induces chromatin re-arrangements with the 
CTCF clustering representing a prominent feature possibly for the strict maintenance of the compacted 
and replicative-incompatible senescence state. HMGB1 represents a later event of the senescence entry 
and the first wave of the HMGB2-based architectural changes, reinforcing the action of HMGB2 as a 
second wave of architectural changes in order to re-organize the 3D genome architecture of the senescent 
cells. Finally, yet importantly, the loss of HMGB1 marks the initiation of active secretion of the SASP 
factor to impact on the neighboring cells.  
 
4.5 HMGB1 is a bona fide RNA-binding protein regulating the nascent-RNA 
turnover of SASP factors 
 
As it was mentioned before, our main focus regarding HMGBs was centered in their role as 
transcription factors. The identification of the protein factors associated with HMGBs through co-
immunoprecipitation coupled with mass-spectrometry led us to characterize a broad spectrum of RBPs 
associate with HMGBs, capable of regulating the nascent RNA turnover. Interestingly, the overlap of 
the immunoprecipitated factors was 25% for HMGB1 (46 out of 182) and 32% for HMGB2 (46 out of 
143). These high percentages drops considerably when we exclude the RBPs described by the work of 
Castello (Castello et al., 2016) to 9% and 11% for HMGB1 and HMGB2 respectively. The very high 
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occupancy of RBPs in the shared proteins implies that at least there is a functional redundancy between 
the two proteins regarding their role in the nascent-RNA regulation in sharp contrast with their 
architectural role and their roles outside of the eukaryotic nucleus. Collectively, since all the 
aforementioned findings combined with the results of Castello attributing HMGBs an RNA-binding 
capacity (Castello et al., 2016),  let us to characterize HMGBs as bona fide RNA binding proteins. The 
RNA binding capacity of HMGBs is of a great importance as it adds another layer of the ab nucleo roles 
of these proteins and the induction of the senescence transcriptional program but also increases the 
complexity to describe their contribution in the senescence phenotype. 
To convincingly show the RNA-binding functionality of HMGBs we performed Clip and we 
identified various RNA targets bound by HMGBs. The ability of HMGBs to bind and regulate RNA 
targets is of a great importance especially in the context of senescence as it describes an extra layer of 
regulation, which was unprecedented up until now.  The two proteins share a significant number of RNA 
binding targets suggesting some functional redundancy as RNA regulators. Interestingly the shared 
targets are closely associated with the senescence profile and specifically with the induction of SASP as 
many of bound genes are inflammatory targets. The ability of HMGB1 to control the SASP at the RNA 
level adds another layer to the already complex feedback loop encompassing the cell cycle arrest, 
chromatin architecture, nascent mRNA production and the secretion of SASP factors. We sought to gain 
further insight in the regulation of nascent RNA production of SASP factors from HMGB1 and we 
focused on the RNA-binding protein ILF3 an important regulator of the expression of SASP genes 
(Tominaga-Yamanaka et al., 2012). Mass-spectrometry identify ILF3 as a direct HMGB1 protein 
partner and Clip showed that ILF3 RNA is bound by HMGB1. Furthermore ILF3 was part of the down-
regulated genes upon both HMGB1-knockdown and replicate senescence following the behavior of 
HMGBs upon the entry of senescence.  
Taken together we showed that HMGBs are capable of RNA binding, regulating the entry of 
senescence trough the nascent-RNA production. This finding adds another layer of this multifaceted 
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